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1ABSTRACT
Background
The prevalence of tuberculosis in South African miners is substantially higher than that of 
in the general population. Through exposure to dust which leads to different degrees of 
silicosis, and by working in enclosed spaces where coughed out bacilli can survive in droplet 
nuclei and be inhaled by other workers, miners are especially prone to to become infected 
with M. tuberculosis and develop the disease. It is not only the working conditions which 
promote transmission of M. tuberculosis, but the living conditions as well. Most miners live 
and sleep in rooms shared by up to eight other men, which increases the opportunity for 
transmission, leading to both primary and reinfection tuberculosis. A serious complication 
o f tuberculosis in the mines has been the emergence o f multidrug-resistant (MDR) strains 
which fortunately, at this stage, is still at a relatively low level. In addition to increased risk 
o f becoming infected with tubercle bacilli, miners, because o f mine-related stress factors and 
the common occurrence o f intercurrent viral infection which depress cell-mediated immunity 
may also experience reactivation o f dormant tuberculosis more commonly in the mining 
environment. This process will be further enhanced by the rapidly increasing incidence of 
HIV disease.
In order to understand and devise strategies for the control of tuberculosis in the miners and 
other high- incidence populations, it would be useful to determine the relative frequencies 
of primary infection or recently-acquired reinfection and reactivation tuberculosis and to 
identify risk factors associated with transmission and drug resistant. Such, knowledge could
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lead to the optimal use o f scarce health care resources and prioritisation o f interventions for 
tuberculosis control.
Objectives
The objectives o f this study were: 1) to determine by IS6110-based DNA fingerprinting, the 
extent o f homogeneity/ heterogeneity i.e RFLP polymorphism which existed amongst 
approximately 50% o fM  tuberculosis isolates which were available for the study from the 
Freegold Flealth Region mines during a six-month period in 1994. 2) to similarly determine 
the population structure of drug-resistant M. tuberculosis isolates in the Freegold Health 
Region mines during two study periods in 1994 and 1995-1977; 3) to identify possible risk 
factors which may be associated with transmission o f M. tuberculosis ; 4) to determine in 
mouse model, possible differences in virulence between three MDR strains within the highly 
prevalent Family 1 isolates and differences between those isolates and an H37Rv 
international strain o f M. tuberculosis ; 5) to identify a protein or proteins in culture filtrates 
o f M. tuberculosis o f varying degree of virulence in the mouse model obtained from 
Colorado State University, USA that may be linked to virulence.
Methods
The insertion sequence IS6110- based RFLP analysis o f M. tuberculosis was used to 
characterise all the isolates in these studies. Possible risk factors relating to geographic 
location o f patients, working place and treatment history in clustered and non-clustered 
patients for isolates with fingerprints o f more than five bands were assessed statistically by
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univariate and multiple logistic regression analysis.
Virulence was assessed in a pilot study according to growth rates in the lungs of 
intravenously challenged BALB/c mice and survival times in these experimental animals
Profiles o f culture filtrate proteins prepared by two dimensional gel electrophoresis were 
analysed to establish possible associations between specific proteins and degrees of virulence 
o f strains previously determined in animals, and between these two parameters and the RFLP 
patterns o f the strains.
Results
One hundred and thirty-nine o f the patients (72% ) in 1994 study period had isolates with 
unique RFLP patterns, while 78 (40.4%) had isolates that belonged to 24 clusters of identical 
IS6110-based RFLP patterns designated identical band pattern (IBP) strains. Based on 
clones, defined as clusters comprising isolates with identical RFLP band patterns but 
exhibiting more than five bands per isolate, there were 65 isolates in 20 clones (33.7%). The 
20 clones consisted o f 8 clusters of two isolates, 7 clusters o f three isolates, 2 clusters of five 
isolates and 1 cluster each o f four, six and eight isolates. Based on strict criteria of 1S6110- 
based clones-based clustering, an estimated minimum of 26.2% of tuberculosis cases were 
due to recent transmission within the mining community.
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Miners from the Free State were associated with a significantly higher risk o f being in a 
clone-based cluster (P=0.01), while the Eastern Cape as a source o f miners was associated 
with a significantly lower risk of being in clusters (P=0.02) compared to other provinces. 
Patients who had failed treatment at entry to the study were more likely to be in cluster 
(adjusted odds ratio 2.38, P=0.04, 95% confidence interval (1.04-5.40).
In several instances, epidemiological links between patients whose isolates were found to be 
in clone based clusters were apparent. Approximately 18% o f all evaluable clone-based 
clustered cases could be linked to a mine shaft and 7.8% cases originated from the same 
village, strongly suggesting a common source o f recent infection. The corresponding figure 
for sharing a mine or a geographic region was 53.2% and 62.5% respectively.
Many strains with different RFLP patterns showed common band patterns. These strains 
were therefore grouped into RFLP families, such that all the members of each family were 
identical or differed by one to three bands and showed > 80% homology based on RFLP band 
patterns. This yielded 23 families which varied in size from 2 to 50 per family. The 
percentage transmission over time, based on RFLP family clusters was calculated to be 
69.9% while 81.2% o f isolates could be grouped in families. Twenty percent come from the 
same village while approximately 40% shared a mine shaft and 80% a mine or a geographical 
region respectively.
Two major families (41.2% of total isolates) o f closely related isolates were identified in
V1994 (Family 1 and Family 2). The strains in each o f the families shared the majority of 
their IS6110 DNA-containing restriction fragments. These two RFLP families contained 7 
and 3 clones respectively, and 8, 6 and 5 isolates were found in the largest clone-based 
clusters, providing evidence of micro-epidemics. It is proposed that members of families 
which did not fall within a clone as defined in this study, are strains that have become 
endemic in the mines and over a period, during which minor genetic changes in strains could 
have occurred . These strains represent either recent transmission or transmission in the past 
followed by recent reactivation while in the mine.
There was an equal risk o f infection with a defined M. tuberculosis clone for HIV- 
seropositive and HIV-seronegative individuals. There was no evidence of an RFLP- 
identifiable clone infecting HIV-positive rather than HIV-negative patients which could have 
been associated with decreased virulence.
The finding that retreatment patients were significantly associated with clustering has 
important implications. These patients are likely to expectorate large numbers o f tubercle 
bacilli for prolonged periods of time and constitute a high priority target group for future 
preventive planning.
Southern blot analysis o f drug- resistant M. tuberculosis strains showed considerable 
diversity in banding patterns. The 19 drug-resistant isolates from the 1994 period revealed 
eighteen patterns while the 26 MDR strains isolated during 1995-1997 study period exhibited
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sixteen IS6110 banding patterns. Three and 12 isolates from 19 drug-resistant and 26 MDR 
strains respectively, showed identical or near identical patterns. At least four MDR clones 
and another INH mono-resistant clone were identified in the mines and , based on identical 
band patterns, 12 possible transmission linkages amongst drug-resistant isolates could be 
demonstrated.
M. tuberculosis clinical isolates with defined in vivo growth characteristics in mouse lungs 
were examined for their IS6110-based RFLP patterns and protein profiles. O f the 31 clinical 
isolates subjected to RFLP analysis, 23, 5, and 3 were previously grouped (in terms of 
virulence) as rapid, moderate and slow growing strains in mouse lungs, respectively. In all, 
the number o f the IS6110 copies per isolate ranged from 1 to 20. Among the 23 clinical 
isolates displaying the rapid in vivo growth phenotype, 14 different IS6110 RFLP patterns 
were observed, while all strains categorised as having slow or moderate in vivo growth 
phenotypes showed different RFLP patterns.
Protein profiles o f culture filtrates demonstrated only minor differences between individual 
strains. Flowever, one basic protein at approximately 12 kDa was notable in that it was 
abundant in eight highly virulent strains and weakly expressed in further six strains. Among 
the latter group, one strain (CSU 24), categorised as o f low virulence while the other five 
were classified as highly virulent). This protein was however, absent from number o f highly 
virulent strains, including FI37Rv. Other proteins of 55, 35, and 16 kDa appeared to be 
differentially expressed by the clinical isolates. All moderately virulent strains (five) and two
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out of three weakly virulent strains (CSU 24 was the only exception) failed to express the 12 
kDa protein.
Conclusions
In the six mines studied, evidence is presented that recently transmitted tuberculosis may 
account for approximately 37% of the cases o f active tuberculosis and approximately 42% 
of drug- resistant cases. Recent transmission of tuberculosis, and not only reactivation of 
dormant disease, therefore contributes substantially to the high incidence o f tuberculosis in 
the mines. The findings that only 19% and 6.5% of IBP clusters could be linked by 
proximity in the work place and village respectively, suggest that most instances of 
transmission may occur on a casual basis without evidence o f prolonged close contact. 
However, clusters could also have been formed following by repeated cycles of transmission 
and therefore may not necessarily indicate recent transmission.
The study revealed that more than 1/3 of tuberculosis patients in the six mines were infected 
by two RFLP families o f M. tuberculosis. These genotypes became prevalent in the mines 
through the expansion o f clones generated either cyclically over a period of time or as a 
result of recent spread. There as no evidence that this expansion was related to the recent 
escalation ofHIV/AIDS.
Although many strains in the mines are closely related, there is sufficient diversity to make 
RFLP analysis, using IS6110, useful for the detection o f clustering o f human isolates of
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M. tuberculosis. It is therefore a technique that holds great promise for the monitoring of 
the transmission of tuberculosis in the mines and thereby contributing substantially to 
improved disease control.
There were several limitations applicable to the studies presented in this thesis. The most 
important o f these are the fact that only about 50% of isolates during 1994 period were 
available for study and that the duration of that study was only six months. These 
shortcomings resulted in an underestimate o f recent transmission rates in the mining 
communities studied.
It was also unfortunate that o f isolates from clone 3 in RFLP family 1 and other clones in this 
family and RFLP family 2 were not available to the author while he was in USA for 
including in his culture filtrate studies which found the 12kDa protein to be prominent in 
several highly transmissible international strains.
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11: GENERAL INTRODUCTION
1.1. History of tuberculosis
Tuberculosis probably occurred as an endemic disease among animals long before it infected 
human (Steele and Ranney, 1958). Mycobacterium bovis was the most likely species involved, 
and the first human infections may have been with M. bovis. Since M. tuberculosis infects all 
primates species it is also possible that this species existed in subhuman primates before it 
became established in human populations.
Tuberculosis probably occurred as a sporadic and unimportant disease of humans in its early 
history. Epidemic spread began slowly with the increasing population density. This spread and 
the selection pressure it exerted have occurred at different times around the globe. The epidemic 
slowly expanded worldwide because of infected Europeans travelling to and colonising distant 
regions (Diamond 1992). In the 1700s and the 1800s tuberculosis prevalence peaked in Western 
Europe and the United States and was the largest cause of death (Bloom and Murray 1992). One 
to two centuries later, tuberculosis had spread in full force to Eastern Europe. Asia, Africa, and 
South America (Daniel et al. 1994).
Donald, (University o f Stellenbosch Medical School, Cape Town) related some intriguing 
concepts on the natural history and epidemiology of tuberculosis in South Africa (Donald 1997). 
From a pan-Africa perspective, tuberculosis is well documented to have been present in Egypt 
from as far as back as 3000 BC. However, in spite o f the long established shipping links 
between central and eastern Africa and Asia, there is scant evidence that tuberculosis ever 
became established along the east coast of Africa. Reports by many reliable observers show that
2it is unlikely that tuberculosis occurred to any great extent among indigenous peoples of South 
Africa but was rather established following the colonisation o f Africa by the European settlers 
and then the rapid urbanisation that followed (Livingstone 1857). Thus colonisation introduced 
sources of infection and caused rapid urbanisation for purposes of commence and trade. Besides 
the explosion of tuberculosis in indigenous peoples, the turn of the century saw a large influx of 
tuberculosis sufferers from Europe to South Africa. By the 1920s. tuberculosis was showing 
endemic features in indigenous rural population of South Africa and beyond. About that time, 
tuberculosis was recognised as a highly common health problem between the black and coloured 
peoples of South Africa.
National notification commenced in 1921 in South Africa, and an incidence o f43/100 000 cases 
was observed to rise to 365/100 000 in 1958. which declined to 162/100 000 in 1986. mirroring 
global trends at that time, before rising again to 221 /100 000 in 1993.These figures do not include 
the independent homelands. An exceptionally high incidence has been recorded among the 
coloured population o f the Western Cape Province in 1993. Various rates up to as high as 
713/1000 000 were proposed for this group compared to the national incidence of 225/100 000 
(Donald 1997).
3Although the infectious nature of tuberculosis was established by Villemin around 1865. the 
protean nature of its clinical manifestations delayed understanding of the disease until Koch's 
discovery of the causative agent in 1882. Koch regularly found the organism associated with the 
clinical disease, isolated it in pure culture, reproduced the disease in animals, and recovered the 
bacillus in pure culture from the experimental animals (Koch 1932).
1.2. The burden of tuberculosis in Africa
1.2.1. General aspects
In their 1997 reports on the tuberculosis epidemic and on anti-tuberculosis drug resistance in the 
world, WHO paints a bleak picture of the global failure o f health service providers to deal with 
the burden of tuberculosis (WHO. 1997). In the 216 reporting member countries o f the WHO. 
representing a total population o f 5.72 billion, there were an estimated 7.4 million new cases of 
tuberculosis in 1995. This represents a rate of 130 cases among every 100 000 persons.
In Africa the case rate was reported 216 per 100 000 in 1997. The 11 countries o f the southern 
Africa subregion contribute approximately 275 000 cases every year to the total case load in 
Africa. Almost half of these come from South Africa. In an analysis of tuberculosis trends and 
the impact o f HIV infection on the situation in the subregion, the National Tuberculosis Research 
Programme of the MRC in South Africa estimates that by 2001 the smear positive case rate 
would have increased from an estimated 198 per 100 000 for the region as a whole in 1997. to 
681 per 100 000 if tuberculosis control efforts are not optimised (WHO 1997). To aggravate the 
situation, 69% of these cases would be directly attributable to HIV-infection.
4A serious complication of the tuberculosis problem in the world, including southern Africa has 
been the emergence o f multidrug-resistant (MDR) strains of the organism causing the disease. 
Patients infected with MDR require prolonged chemotherapy with very expensive medication 
that will at best cures only half o f them. Such treatments cost at least ten times as much as the 
cost of curing an ordinary tuberculosis patient infected with drug-sensitive bacteria. Very few 
countries can afford this additional burden.
In ‘order to determine the magnitude of the MDR problem in southern Africa, and the 
implications for National Tuberculosis Programmes (NTPs), surveys are being conducted in 
various countries as part of the activities of the WHO/IUATLD Global Working Group on 
tuberculosis Drug Resistance Surveillance (WHO, 1997). To date, information is available for 
four countries in Southern Africa: Botswana, Lesotho, South Africa, and Swaziland.
Results confirmed that initial resistance to first line drugs is relatively low in southern Africa 
compared to some other regions in Africa and Asia where the problem is up to five times more 
common. Resistance rates range between 4% and 12% for isoniazid, and between 4% and 7% 
for streptomycin. For rifampicin it is 1% and for ethambutol 1%; MDR is fortunately still low 
at 1 %, suggesting that resistance strains are uncommonly transmitted from person to person. On 
the other hand, rates for acquired resistance, that is resistance which has arisen in patients 
previously inadequately treated for tuberculosis, are at least three times higher than in patients 
not previously exposed to anti-tuberculosis medications. The high rates of an acquired resistance 
point to a failure o f control programmes to effectively manage case-holding and treatment
adherence.
51.2.2. The South African situation
1.2.2.1. General aspects
South Africa is burdened by one of the worst tuberculosis epidemics in the world, with disease 
rates more than double those observed in other developing countries and up to 60 times higher 
than those currently seen in the USA or Western Europe (WHO 1997). In 1998. the MRC 
National Tuberculosis Programme estimated that the country had 195 776 cases (less than 55% 
reported), or 446 per 100 000 of the total population. Of these, 35.8% (73 679 cases) were also 
infected with HIV. The Western Cape Province is the worst affected at the moment but the 
epidemic is now growing fastest in Kwazulu-Natal and in the central Provinces (Table 1.1). 
Although South Africa has lagged behind other African countries in terms of time and initially 
incidence (probably because of geographical, social and political barriers), the HIV epidemic has 
increased rapidly and exponentially during the last six years in South Africa which currently has 
one of the highest incidence figures of HIV/AIDS in the world.
6Table 1.1. Estimated incidences of tuberculosis according to HIV infection status in South Africa
Provinces Smear -positive 
cases/100 000 
(Reported cases)
Smear- negative 
cases/100 000 
(Unreported cases)
Proportion of 
HIV-positive 
Tuberculosis 
cases
Eastern Cape 270 329 30.1%
Free State 150 183 41.8%
Gauteng 201 245 34.9%
KwaZulu-Natal 214 261 54.7%
Mpumalanga 152 185 49.2%
Northern Cape 183 223 23.3%
Northern Province 140 171 26.4%
North West 144 176 35.6%
Western Cape 302 369 21.7%
South Africa 201 245 37.7%
Source: National Tuberculosis Research Program. Medical Research Council, Pretoria, 1998 
Number based on 1998 estimates
The tuberculosis problem in South Africa should be viewed in the context of historical neglect and 
poor management systems, compounded by the legacy of fragmented health services. Prior to the 
introduction of the tuberculosis register in 1995 cure rates were unknown, and consequently 
control efforts could not challenge poor performance. The implication o f this failure is evident 
from the fact that in 1997 a cure rate of only 54% could be recorded, with the consequence of 
continued high rates of transmission and drug resistance in the country.
7Tuberculosis was declared a top health priority by the Department o f Health in November 1996 
and National Health Minister Zurna committed her Department to implementing a new control 
programme based on the directly observed therapy (DOTS) strategy of the World Health 
Organisation (Department of Health 1996). The pace and extent of implementation of the 
programme have, however, proved to be less than optimal. Estimates by the MRC National 
Tuberculosis Programme indicate that current trends in the epidemic will continue unless effective 
control is achieved, resulting in 3.5 million new cases of tuberculosis over the next decade and 
at least 90 000 patients dying (WHO 1997). The financial implications are staggering: Given that 
more than US$100 million is spent annually on tuberculosis in South Africa, in excess of US$3 
billion would be required over the next ten years if current increases in tuberculosis rates are 
allowed to continue unabated. On the other hand, significant reductions in transmission of HIV 
infection together with effective tuberculosis control would mean a turnaround in the tuberculosis 
epidemic by the year 2003. At least 1.7 million tuberculosis cases will be prevented and more 
than US$400 million would be saved.
I.2.2.2. Situation in the South African gold mining industry
Tuberculosis has long been recognised as an important health hazard in the South African gold 
mining industry and has been notified since 191 l(Watkins-Pitchford 1927). The incidence of 
tuberculosis in this industry had more than doubled since the advent o f the HIV epidemic, and is 
currently estimated to be in the order of 2 000 per 100 000 population per year (Churchyard cl al. 
1999; Murray et al. 1999). Among the South African gold miners with tuberculosis, the 
prevalence of HIV infection has increased rapidly, to approximately 50% of all cases (Churchyard
et al. 1999).
8Gold miners are exposed to silica-containing dust, and silicosis has been shown to be a strong risk 
factor for overt tuberculosis (Cowie 1994; Snider 1978). It is likely that the high tuberculosis 
incidence in miners preceding the HIV epidemic was largely due to the effect of silica exposure 
which poses a risk, even in miners who do not show evidence o f silicosis (Murray el al. 1996). 
Silicosis prevalence in South African miners has been shown to be high: in an autopsy-based 
study of miners dying of trauma. Murray el al. showed that the prevalence of silicosis increased 
from 9.3% to 12.8% between 1975 and 1991 (Murray el al. 1996). Silicosis prevalence increased 
with age and duration of service. The authors concluded that in view of current labour stabilisation 
in the South African gold mining industry, miners are exposed to silica for longer periods of time, 
and thus we can expect further increases in the prevalence o f silicosis and therefore tuberculosis.
In addition to these risk factors, significant ongoing transmission of tuberculosis, despite active 
screening programmes and DOT, appears to be contributing to the high incidence o f tuberculosis 
in the South African gold-mining community. Recent molecular epidemiological studies of 
tuberculosis in the miners have shown clustering of identical strains of between 50-67%. 
suggesting that at least 50% oftuberculosis cases were due to transmission within mine population 
(Godfrey-Faussett el al. 2000). The congregate, social and working conditions of miners are likely 
to potentiate the transmission of tuberculosis.
1.2.3. Comparative rates elsewhere in the world
Although case rates oftuberculosis in sub-Saharan Africa are very high and the burden o f disease 
large, the largest number oftuberculosis cases is to be found in Asia and Western Pacific and HIV 
is beginning to spread into these regions. The seroprevalence of HIV in tuberculosis patients in 
Bombay, India, has risen from 2% in 1988 to 9% in 1992-93, and in Northern Thailand from 5%
9in 1989 to 26% in early 1992 (Raviglione el al. 1995).
If there is no improvement in the current tuberculosis control programmes, it has been estimated 
that tuberculosis cases will rise from 7.5 million in 1990 to 10.2 millions in 2000 (Raviglione el 
al. 1993). Deaths w ill increase from 2.5 million to 3.5 million. This represents an extra 90 million 
new cases and 30 million deaths in the decade. The proportion of cases attributed to HIV is 
estimated to increase from 4%in 1990 to 13% in 2 000. Therefore, although HIV is having a much 
greater impact in some areas compared with others, at global level the lack o f investment in 
effective control programmes in developing countries in the last 20-30 years, combined with 
continued population growth in these regions, is largely responsible for the deteriorating situation.
In the developed world, notably in the USA but also in a number of European countries, including 
The Netherlands and England, tuberculosis cases have been increasing since the m id-1980s. T his 
increase in developed countries is probably mainly due to immigration from developing countries 
(Harries, 1994). HIV is also playing a part in the increase of cases in the developed world, 
particularly in the USA, where the co-infection of the tubercle bacillus and HIV is increasing in 
some inner city areas, particularly New York (Weltman and Rose, 1994). This is being 
compounded by multi-drug resistance. An increase in poverty, unemployment, the numbers of 
people living below critical income level and homelessness are factors contributing to this 
situation.
1.3. Epidemiology of tuberculosis
Tuberculosis is primarily acquired by inhalation of dried residues of droplets containing tubercle 
bacilli expelled in an aerosol created by coughing, sneezing, or talking (Bloom and Murray.
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1992). These droplet nuclei remain suspended in the air for prolonged periods, and particles 1 
to 10pm in diameter are sufficiently small to reach the alveoli and initiate infection. The most 
important source is an undiagnosed infectious person with cavitary tuberculosis.
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Figure 1.1. Diagrammatic representation of natural history of tuberculosis in individuals as they age 
(Modified from Smith and Moss, 1994)
As shown in Figure 1.1 tuberculosis develops in an individual as a consequence of one of three 
processes: Progression o f primary infection, endogenous reactivation or exogenous reinfection 
(Smith and Moss, 1994).
The occurrence o f primary infection depends on the number o f active infectious tuberculosis cases 
in the community. Following primary infection, a relatively small proportion of individuals
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develop progressive primary disease mostly within two to five years (Medical Research Council 
1972). Estimates of the size of the risk of progressive primary disease following primary infection 
vary from five to 10 percent (Smith and Moss 1994). Most people do not develop disease 
following infection and mount an effective immune response to the initial infection that limits 
proliferation o f the bacilli, and leads to long-lasting immunity both to further infection and 
reactivation of dormant bacilli remaining from the original infection.
At later stages, the immunity of some persons who have been previously infected may wane, and 
they are then at risk of developing active tuberculosis because of either reactivation o f dormant 
bacilli or following exogenous reinfection.
Recent advances in molecular typing techniques have been used to elucidate the occurrence of 
recent or reactivation tuberculosis as well as to define transmission patterns in outbreaks of 
tuberculosis See section 1.6. 6)
1.4. Host factors for the development of tuberculosis
Resistance to tuberculosis is expressed in two ways: resistance to the acquisition o f infection and 
resistance to the development of disease after infection is established. Although the mechanisms 
by which uninfected persons resist infection with
M. tuberculosis are uncertain, macrophages are believed to play a central role in this process, 
initially through ingestion of bacilli, and ultimately through production of cytokines that enhance
the immune defences.
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Racial differences in susceptibility to tuberculosis infection have been reported. Blacks have 
been shown to be approximately twice as likely as whites to develop tuberculosis infection after 
equivalent exposure to a source case, possibly because macrophages o f blacks are more 
permissive of growth of M. tuberculosis (Rich 1944; Stead et al. 1990). This racial difference in 
susceptibility has been attributed to the prolonged selection pressure brought about on whites by 
the tuberculosis epidemic throughout Europe for many generations prior to the first introduction 
of tuberculosis into sub-Saharan Africa. Recently. Bellamy et al. (1998) described a significant 
association between alleles of the human NRMP1 gene and the susceptibility of an African 
population to tuberculosis.
Many studies based on clinical observations (Dooley et al. 1992; Fischl et al. 1992; Pape et al. 
1983; Piot et al. 1984; and Pitchenikn et al. 1993 ), and on epidemiological surveys of 
tuberculosis and HIV seroprevalence (de Cock et al. 1992; Onorato et al. 1992 and Selwyn et at. 
1989) have provided evidence that HIV infection is a risk factor for the development of active 
and often lethal tuberculosis. This might be explained by increased reactivation of previously 
acquired dormant mycobacteria and enhanced susceptibility to both reinfection and primary 
infection. It was previously suggested that reactivation is responsible for the majority of HIV 
associated tuberculosis (Selwyn et al. 1989). However, the study of DNA fingerprints of M 
tuberculosis isolates obtained from AIDS patients using the technique o f restriction fragment 
length polymorphism (RFLP) analysis showed that reinfection and new infection also occur in 
AIDS patients (Daley et al. 1992; Godfrey-Faussett and Stoker 1992; and Small et al. 1993).
Other factors such as malnutrition, alcoholism, diabetes mellitus and heavy tobacco smoking have
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been stated to increase the risk of reactivation of tuberculosis twofold to fivefold (Barnes el al. 
1996; Drobniewski. 1997; Haney el al. 1996; Torrea el al. 1996 and Vogetseder et al. 1994).
1.5. Mycobacterial virulence factors
In developing countries, tuberculosis is most prevalent in young adults and this is partly related 
to the increased risk of tuberculosis in those who are HIV seropositive. However, even among 
HIV-negative young adults, the incidence of active disease is proportionately higher in young 
adult than in other age groups. In these presumably healthy people, the manifestations of disease 
may depend on the properties of the organism rather than on host factors as this group has no 
known underlying immunological defect that would predispose to active disease. In fact, the 
incidence of active disease in a population may be influenced greatly by the distribution of clones 
with certain virulence properties (Valway et al. 1998; Zhang et al. 1999).
With the advent of whole genome sequencing of M. tuberculosis (Cole et al. 1998) and 
considerable information on the nucleotide sequences o f less virulent Mycobacterium hovis. 
Mycobacterium africanum and Mycobacterium microti several genes and their products have 
been identified as potential candidates for virulence determinants which still need to be confirmed 
(Gordon et al. 1999).
Several putative mycobacterial virulence determinants have however been studied in some detail 
and are summarised below :
1.5.1. Resistance to oxidizing agents and virulence
Resistance to hydrogen peroxide as a virulence determinant emerged from comparison of strains 
of high and low virulence in the guinea pig. Extensive studies of these strains of
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M. tuberculosis showed a very high correlation between virulence in the guinea pig and 
susceptibility to killing by hydrogen peroxide (Mitchison et al. 1963; Nair et al. 1964). A similar 
conclusion came from a study of strains mutated to be isoniazid-resistant, which are attenuated 
in the guinea pig and have increased sensitivity to killing by peroxide (Morse et al. 1954). Further 
evidence that peroxidase resistance was a virulence attribute came when it was shown that 
peroxide sensitive mutants o f M  tuberculosis survive less well than peroxide-resistant parents in 
the organs of guinea pigs (Jackett et al. 1981).
1.5.1.1. katG as a tuberculosis virulence gene
For many years, there has been evidence that strains of the M. tuberculosis complex with 
defective catalase activity have reduced virulence in experimental animals, presumably because 
of their increased sensitivity to oxidative stress. Recently evidence to confirm that katG is a 
virulence gene has been obtained. Transformation of INH-resistant and avirulent strains with a 
katG gene resulted in recombinants able to produce catalase / peroxidase and virulence to guinea 
pigs, verifying that katG is a virulence determinant for at least some strains o f M.bovis (Wilson 
et al. 1995). However, there are many clinical isolates o f the M. tuberculosis complex that have 
lost KatG activity but remain virulent. In these cases, it is likely that the dual selection pressures 
of surviving in an infected host and developing isoniazid resistance have produced strains that 
have lost KatG activity but have some compensating mutations that enable them to remain 
virulent. Recently, in some isoniazid-resistant strains mutations in the promoter region oi'a gene 
that appears to encode an alkylhydroperoxidase activity were identified (Wilson and Collins. 
1996). These mutations caused upregulation of gene expression, and it is possible that this is the 
mechanism by which KatG-inactive strains maintain virulence.
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1.5.1.2. Nitric oxide and reactive nitrogen intermediates
There are many reports that nitric oxide is lethal to microorganisms, including mycobacteria. 
Recent studies have shown that virulence o f M. avium in the mouse (Doi cl at. 1993) and 
virulence o f M. tubeculosis in the guinea pig (O'Brien cl al. 1994) correlates with resistance to 
killing by nitric oxide. The importance of nitric oxide killing of M. tuberculosis in human 
macrophages has been firmly established (Rich cl al. 1997): "Thus M. tuberculosis-infected 
human alveolar macrophages are capable of producing NO and NO production correlates with 
intracellular growth inhibition of M  tuberculosis in alveolar macrophages suggesting that NO 
may serve either directly or indirectly as a mycobactericidal mediator in human tissue 
macrophages". Similar findings were reported by Rhodes and Orme (1997) using strains of M. 
tuberculosis o f different virulence exposed to murine bone marrow-derived macrophages. Their 
results indicate that reactive nitrogen intermediates (RNIs) can kill A/, tuberculosis under stringent 
conditions but under less harsh physiological conditions the effects o f RNIs range from partial to 
negligible inhibition.
1.5.2. Mycobacterial cell envelope components
The cell envelope o f mycobacteria is rich in lipids. For many years lipids have been suspected to 
play a role in the virulence o f mycobacteria. An association between the fatty acid composition 
of mycobacterial lipid and virulence has been suggested, virulence being associated with low 
unsaturated to saturated fatty acids (Nandedkar 1982).
The ability to stimulate release of a tumour necrosis factor (TNF-a ) is noteworthy because it has 
been proposed that much of the pathology seen in tuberculosis is due to the unregulated action of
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TNF-a (Rook 1990). Thus the ability of mycobacterial cell envelope components to stimulate 
excessively release o f this cytokine may represent an important virulence mechanism involving 
the type of tuberculosis in which the Th 1 response predominates. Virulence of M. tuberculosis has 
been associated with lipoarabinomannans (LAM) (Brennan and Nikaido 1995). LAMs from the 
more virulent strains o f M. tuberculosis do not induce as much TNF-a. when compared with less 
virulent strains (Adams et al. 1994; Chattterjee et al. 1992 ; Roach et al. 1994). TNF-a together 
with INF-a and other Thl immunoregulatory cytokines play an important role in host resistance 
to M. tuberculosis and other pathogens. Conversely a switch to Th2 responses involving 1L-4. IL 
10 and other mediators results in tuberculosis lesions seen in patients with AIDS which are diffuse 
and associated with systemic spread. Two structural forms of LAM have been described on the 
basis of the arrangement o f terminal sugars (Chatterjee et al. 1991; Chatterjee et al. 1992). One 
form (AraLAM) has predominately arabinose termini, while in the other form (ManLAM). the 
arabinose residues are extensively capped with mannose residues. Several recent studies have 
reported that mannose capping alters the biological activity of LAM. Thus, ManLAM from M. 
tuberculosis Erdman and M. leprae is 100-fold less effective in inducing TNF-a production 
(Adams et al. 1993; Chatterjee et al. 1992 ). The ability o f LAM to act as a second signal for 
macrophage activation and to induce early response genes in macrophages also is abrogated by 
the presence of a mannose cap (Adams et al. 1993; Anthony et al. 1994; Roach et al. 1994 ).
In addition to LAM, the mycobacterial cell envelope contains other factors with biological 
activities suggesting that they may be virulent factors. Mycobacteria produce a number of 
glycolipids of unusual structure (Besra and Brennan 1994). Two classes o f acylated toxins have 
attracted attention as virulence factors. Trehalose 6, 6'-dimycolate or cord factor has a range of 
biological activities (Goren 1982), including lethal toxicity for mice, but its role and that o f other
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glycolipids in virulence has tended to be discounted (Grange 1985) because they are found in both 
virulent and saprophytic species of mycobacteria (Goren 1972).
Mycobacterial sulpholipid also has been considered as a virulence determinant. Sulpholipid is 
toxic to phagocytes and it may be suggested as contribute to inflammation by stimulating 
oxidative activity o f phagosomes at sub-lethal concentrations (Zhang et al. 1988). It is also 
responsible for the inhibition of phagosome-lysosome fusion by M. tuberculosis by virtue of its 
polyanion nature (Goren et al. 1982 ). Initially a strong association was found between virulent 
strains of M. tuberculosis and high levels of sulpholipids (Goren et al. 1974 ). Furthermore, 
attenuation of H37Ra compared with H37Rv was accompanied by a substantial decrease in 
sulpholipids (Goren et al. 1982 ). Subsequent studies however, showed that Western strains were 
fully virulent in the guinea pig yet had low amounts of sulpholipid (Grange et al. 1978; Goren et 
al. 1982). Thus, sulpholipids as a determinant of virulence were discounted (Goren et al. 1982).
1.5.3. Interaction with phagosomes and lysosomes
A key characteristic of M. tuberculosis that contributes to its virulence is its ability to grow inside 
monocytes and macrophages. The question of how M. tuberculosis enters macrophages is still 
unanswered. The balance of evidence indicates that M. tuberculosis is probably phagocytosed by 
the normal phagocytic processes mediated by C3b or iC3b opsonization, but the possibility that 
the bacteria stimulate their own uptake by phagocytes using invasins cannot be ruled out. Uptake 
via complement factors has been suggested as a virulent attribute by providing a cell- entry 
mechanism avoiding triggering a potentially lethal respiratory burst (Schlesinger et al. 1990). 
However, in some circumstances, M. tuberculosis can trigger a special respiratory burst but here 
there was no correlation between extent of triggering and virulence (O'Brien et al. 1991). Also.
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binding to mannose receptors occurs with some strains of M. tuberculosis.
Following attachment and subsequent phagocytosis M. tuberculosis, sustained intracellular 
bacterial growth depends on the ability to avoid destruction by lysosomal enymes, ROI. and 
reactive nitrogen intermediates (RN1). A capacity to block the fusion of mycobacterium-containing 
phagosomes with lysosomes could be critical for the survival. A careful study of the fate of the 
bacteria in the phagocytes has shown that there may be two stages to the invasion process. In the 
first stage, the bacteria are found in phagolysosomes (McDough et ul. 1993). Some of them are 
killed and degraded by the phagocytes, but others survive and multiply. In the second stage, some 
of the bacteria that have survived in the phagolysosome are seen budding off from the 
phagolysosome in vesicles whose membranes appear to be impaired.
Importantly, M. tuberculosis appears to have the ability to disrupt the normal functioning of the 
phagosome, preventing them from developing into hydrolase-rich compartments. Several 
laboratories have reported a failure o f mycobacterium-containing vesicles to fuse with endosomal 
vesicles containing other ingested material, such as electron dense colloids(Armstrong and Hart 
1971; de Chastellier et ul. 1993; Clemens and Horwitz 1995). This restricted capacity of 
mycobacterial phagosomes to fuse with other vesicles suggested that their biochemical composition 
is altered, blocking association o f phagosomes with host molecules that are harmful to the bacteria. 
This possibility was confirmed by studies that revealed that vacuolar membrane surrounding the 
bacilli lacked a proton-ATPase, which may be responsible for phagosomal acidification. Moreover, 
containment of viable within these specialised vesicles may reduce the capacity of mycobacterial 
antigens to be processed, associated with major histocompatibility complex (MHC) class 11
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proteins, and/or transported to the cell surface. While one study also reported the presence of free 
within the macrophage cytosol, other investigators have been unable to replicate this findings.
1.6. Molecular Epidemiology
1.6.1. Introduction
An important consideration for tuberculosis control programmes should be to analyse the 
transmission of the disease in epidemiological studies in which individual strains can accurately 
be traced. Four to eight weeks are required for the growth of M. tuberculosis strains, thus the 
utilization of phenotypic markers requires a similar lapse in time. Such studies have however, until 
recently, been limited due to the lack of highly polymorphic strain markers able to distinguish the 
various bacilli infecting unrelated individuals. Previously, the only method available to type M. 
tuberculosis strains was phage typing (Snider el al. 1984). However this method has been used by 
few laboratories due to considerable technical problems and also the fact that only a limited 
number o f phage types can be distinguished.
1.6.2. Ribotvping
Ribosomal RNA genes have been shown to be present in multiple copies in many bacterial species. 
Since part o f their sequence are conserved among very distant species, they have been used as 
Drobes for generating RFLP fingerprinting. This method, which has been named ribotyping. is not 
aseful for the differentiation o f M. tuberculosis strains and provides very limited polymorphism
since this species harbours only a single RNA gene copy.
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1.6.3. Chromosomal DNA-based typing methods
Several molecular methods can be used to demonstrate relatedness or differentiate between 
bacterial strains. Genotypic fingerprinting utilizes slight differences in the total chromosome that 
are generally not related to phenotypic differences. The cleavage of M. tuberculosis total DNA by 
restriction enzymes (which cut the DNA at specific sites), and the separation of the fragments by 
electrophoresis on a gel, produces a banding pattern following ethidium bromide straining of the 
gel. However the mobility of the vast majority o f the fragments overlaps, and thus at least four 
different restriction enzymes are needed to obtain reasonable strain differentiation.
1.6.4. Pulse-field gel electrophoresis
Use of restriction enzymes with long AT-rich recognition sequences (Mazurek el al. 1991) 
generates fewer fragments, but separation o f such large fragments can be accomplished only by 
using the cumbersome technique of pulsed-field gel electrophoresis.
1.6.5. Repetitive sequences in M tuberculosis
Various repetitive DNA elements that contribute to strain variation have been discovered in A/. 
tuberculosis (Table 1.2). Four o f these are insertion sequences, and the remainder are short 
repetitive DNA sequences with no known function or phenotype.
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Table 1.2. Repetitive DNA sequences in M. tuberculosis complex
Element Size(bp) Source Copv no. Related to
IS6110 1.355 M. tuberculosis 0-25 IS family of
Enterobacteriaceae
IS 1081a 1,324 M. bovis 5-7 IS256 of S.aureus
DR 36 M.bovis BCG 10-50
MPTRh 10 M. tuberculosis >100 Chi and REP" from
E.coli
PGRS 30 M. tuberculosis >100
“Also being found in M.xenopi
bAlso being found in M.gordonae, M. kunsasii, M.asiaticum, M. gustri. and M. ,szulgui
cChi, E. coli recombination signal; RFLP, repetitive extragenic palindrome
1.6.5.1. Insertion sequence IS6110
IS6110 is a 1,355-bp IS that was initially identified in M. tuberculosis (Thierry et al. 1990) and 
subsequently found to be distributed throughout the M. tuberculosis complex (Cave et al. 1991; 
Hermans et al. 1990; van Soolingen et al. 1991; Zainuddin and Dale 1989). Two well known and 
virtually identical insertion elements to the IS6110 are IS986 isolated from another strain of M. 
tuberculosis (Zainuddin and Dale 1989) and IS987 demonstrated in M.bovis BCG (Hermans et al. 
1991). These three sequences differ in only a few base pairs and therefore are considered to be 
essentially the same elements. Sequence comparison shows that IS6110 is related to the I S3 family 
of insertion elements, an IS family initially discovered in Gram-negative bacteria (McAdam et al.
1990; Thierry et al. 1990).
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The IS6110 is usually present in multiple copies in various positions in the genomes of the clinical 
isolates of M. tuberculosis but only a single or few copies in M.bovis (Collins et al. 1993; Cousins 
et al. 1993; Zainuddin and Dale 1989). BCG strains may be divided into two groups with either 
one or two copies o f IS6110 (Fomukong et al. 1992). IS6110 sequences were previously thought 
to be randomly inserted in the M. tuberculosis genome but it is known that there are preferred sites 
for insertion(McHugh and Gillespie 1998 )
IS6110 shows highly polymorphic banding patterns in M. tuberculosis isolates, due to insertion at 
a very wide range o f chromosomal sites. The degree of polymorphism is well suited to 
epidemiological analysis and the fingerprint patterns are readily analysed using a computer 
programme such as GelCompar (Applied Maths, Kortijk. Belgium). The polymorphism of IS61 10 
is presumed to be due to its ability to transpose within the genome with little target sequence 
specificity (Mendiola et al. 1994), and indeed transposition of clone IS986 has been experimentally 
verified in both M  smegmatis and BCG (Fomukong and Dale 1995). Therefore it might be expected 
that the profiles would change over time. However, the patterns appear to be stable during 
prolonged growth in vitro or in vivo (Hermans et al. 1990; van Soolingen el al. 1991) and 
development of drug resistance does not alter the fingerprint pattern (Cave et al. 1994). On the other 
hand, minor variations in fingerprint patterns have sometimes been observed in epidemiologically 
related isolates (van Soolingen et al. 1991).
Although most M. tuberculosis strains carry multiple copies of IS6110. a significant minority of 
strains carry only one or two copies ( Fomukong et al. 1994; Gillespie et al. 1995; van Soolingen 
et al. 1993; Yuen et al. 1993). These strains show much less polymorphism; in this case the use of
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other probes (especially PGRS or DR) enables differentiation of epidemiological unrelated strains. 
Furthermore, a small number of M tuberculosis isolates lack IS6110 altogether, which is 
especially significant in relation to the use of IS6110 as target for PCR.
1.6.5.2. Insertion sequence IS 1081
IS 1081 is the only other known transposable element in M. tuberculosis. It was discovered by 
Collins while attempting to clone M/wv/.v-specific DNA sequences (Collins and Stephens 1901). 
This element is 1.324 bp long with 15 bp inverted repeat ends and contains a large open reading 
frame (ORF). The IS 1081 is present in all M. tuberculosis complex strains and M  xenopi (Small 
and van Embden 1994 ). The insertion sequence is repeated 5 to 7 times in M. tuberculosis 
complex. However, very little polymorphism is observed in the locations of this sequence.
1.6.5.3. IS1547 and IS-like elements
IS 1547 and the IS-like element are present in one or two copies per genome(Cole et al. 1998; Fang 
et al. 1998, Mariani et al. 1993). The discrimination of IS1547-associated restriction fragment 
lengthy polymorphism was found to be low in comparison to IS6110-associated RFLP (Fang et al. 
1998).
1.6.5.4. New insertion sequences
The establishment o f the complete genomic DNA sequence of H37Rv disclosed the presence of 25 
unknown ISs which are present in one to three copies, two prophages, and a novel type repetitive 
sequence, the REPI3E12 family (Cole et al. 1998). The REPI3E12 elements ranged in size from
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1352 to 1436 bp and are present in seven copies throughout the genome of (Cole et al. 1998: 
Gordon et al. 1999).
1.6.5. 6. Repetitive DNA
Five types of short repetitive DNA associated with some degree o f genetic diversity have been 
identified in complex.
1.6.5.6.1. The direct repeat (DR) cluster and spoligotyping
The insertion site o f IS6110 in BCG is found in an unusual chromosomal region containing a 
variable number o f directly repeated sequences (DR), 36 bp long, interspersed with unique spacer 
sequences of 36-41 bp (Herman et al. 1992). The majority of M. tuberculosis complex strains, 
including those o f M. tuberculosis and M/wv/.v with a single copy, contain a copy of 1S6110 within 
one of the DR sequence in this region. It has been suggested that this is a preferred site for 
integration of IS6110, or alternatively it may represent the original site of insertion when IS6110 
was first acquired by the ancestor of the M. tuberculosis complex. This region is polymorphic, both 
in the number o f the DR copies, and in the structure o f the spacer region: this polymorphism may 
arise from interaction between adjacent or distant DRs as well as by IS-mediated rearrangements 
(Groenen et al. 1993).
A novel method to simultaneously detect and type complex, designated “spoligotyping" was 
described by Kamerbeek et al. (1997). In this method the DRs are used as a target for in vitro DNA 
amplification and the variation in the spacer is exploited to obtain different hybridisation patterns 
of the amplified DNA with multiple synthetic oligonucleotide, which are convalently bound to the
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membrane. DR-based probes are valuable for differentiation of strains o f M. tuberculosis for 
which IS6110 does not provide sufficient discrimination (van Soolingen cl al. 1993, 1994).
1.6.5.6.2. The major polymorphic tandem repeats (MPTR)
MPTR were first located downstream of the gro EL-1 gene ( Doran ct al. 1992; Hermans ct al. 
1990; Shinnick 1987) and are structurally similar to the DR clusters; consisting of lObp direct 
repeats separated by a 5 bp unique DNA spacer. The MPTR copy number has been estimated at 
about 80 per genome (Hermans ct al. 1992), although mapping studies with ordered cosmid suggest 
that they are confined to nine loci (Poulet and Cole 1994). Unlike, the previously described 
elements, MPTR have been detected in species other than those of M. tuberculosis complex such 
as M  gordonae and M kansasii.
1.6.5.6.3. The polymorphic GC-rich repetitive sequence (PGRS)
The PGRS elements appear to be the most abundant repetitive sequences in the 
M..tuberculosis complex, occurring at 26 to 30 loci. They display significant polymorphism (Ross 
etal. 1992; Poulet and Cole 1994; van Soolingen ct al. 1993), which makes them potentially useful 
in epidemiological studies. Several copies have been cloned and sequenced (De Wit ct al. 1990; 
Doran ct al. 1993; Poulet and Cole 1994; Ross ct al. 1992), and these vary both in size (0.7 to 1.3 
kb) and nucleotide sequence, exhibiting about 70% sequence identity. A characteristic feature of 
PGRS is its GC-richness (about 80%). The host range of PGRS extends from the M. tuberculosis 
complex to other mycobacteria species, such as M. kansnsii, M  gordonae, M. marinum, M. microti. 
M. gastn, and M. szulgai (Poulet and Cole 1994; Ross ct al. 1992). MPTR and PGRS elements 
share some similarities in their nucleotide consensus sequence, host range, high copy number.
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polymorphism, and stability.
1.6.5.6.4. Exact tandem repeats (ETR)
Six ETR loci has been identified (Frothingham and Meeker-O'Connell 1998; Gordon et al. 1999). 
Unlike MPTR and PGRS, these ETR loci contain tandem repeat o f identical DNA sequences. Each 
locus has a unique repeated sequence, ranging in size from 53 to 79 bp
1.6.5.6.5. GTG repeat.
A repeat of triplet GTG is present at multiple chromosomal loci and could form the basis for typing 
of M  tuberculosis strains (Wiid et al. 1994).
1.6.5.7. PCR-based methods
Numerous amplification-based methods are being developed for typing mycobacteria, as they do 
not require the extraction o f large amounts o f DNA and potentially enable typing to done from 
clinical specimens. PCR with arbitrary primers (Random Amplified Polymorphic DNA, RAPD) 
has been shown to produce polymorphic banding patterns with M. tuberculosis, confirming the 
epidemiological relationships in several clusters of A7. tuberculosis infection (Palittapongarnpim 
etal. 1993).
Ross and Dwyer (1993) described a M. tuberculosis typing method using primers derived from 
IS6110; polymorphic amplified products were observed, resulting from priming between 1S6110 
and nonspecific sites on the genome. Another approach using primers based on MPTR and nested 
primers from IS6110 is described (Plikaytis et al. 1993) Termed Isamplipriting , this technique
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yields reproducible banding patterns directly from clinical samples. Mixed-linked PCR (1 laas c7 
al. 1993) uses one primer specific for 1S6110 and a second that is complementary to a linker ligated 
to the restriction digested DNA; one strand of the linker contain uracil and is removed by uracil N- 
glycosylase to ensure specific amplification. A similar technique termed ligation-mediated PCR 
(Palittapongarnpim et al. 1993) employs a non-phosphorylated linker.
1.6.6. Use of molecular fingerprinting in epidemiological studies.
Discovery o f repetitive elements in M. tuberculosis genome has enabled strains differentiation by 
restriction fragment length polymorphism (RFLP). RFLP typing using the insertion sequence 
1S6110 has been used successfully to examine nosocomial infections (Dooley el al 1992; 1 Iewlett 
e tu i  1991; Edlin et al. 1992) institutional outbreaks (Campbell*?/ al. 1993; Grei finger et al. 1992; 
Valway et al. 1994) and transmission o f multidrug-resistant (MDR) tuberculosis (Beck-Sague et 
al. 1992; Brian et al 1 992; Coronado et a l 1 993)
Several population-based epidemiological studies that combine conventional and molecular biology 
methods have been published and suggest that patients in developed countries whose M. 
tuberculosis strains have identical RFLP patterns could be classified into epidemiologically linked 
clusters, although few cases o f transmission has been identified by conventional contact 
tracing(Small et al. 1994; Genewein et al. 1993; Alland et al. 1994; Yang et al. 1992 ). Clustering 
in this settings reflects recent transmission or a common source o f infection. These combined 
studies have shown that recent transmission contributes substantially to the increase in the incidence
of tuberculosis in some areas.
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Analysis of microbiological, clinical, social, and demographic data associated with these 
epidemiologically-related cases can be used to great advantage in defining risk factors contributing 
towards transmission o f strains shown to be identical on molecular fingerprinting techniques.
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2 RESTRICTIO N FRAGM ENT LENGTH POLYM ORPHISM  STUDY OF 
MYCOBACTERIUM TUBERCULOSIS IN THE FREEGOLD HEALTH REGION USING 
IS6110 AS A PROBE
2.1. Introduction
Gold mining is an important industry in South Africa, employing about 300 0000 men. The South 
African gold mining industry has reported a TB incidence in excess o f2000 per 100 000 population 
(Churchyard et al. 1999; Murray et al. 1999). After trauma, tuberculosis is the single largest cause 
of mortality among mine workers (Leon et al. 1995). Among South African gold miners with 
tuberculosis, the prevalence o f HIV has increased rapidly to approximately 50% of all cases 
(Churchyard et al. 1999). Gold deposits are found in quartz seams and miners are exposed to silica- 
containing dust. Silicosis has been shown to be a strong risk factor for developing clinical overt 
tuberculosis (Cowie 1994; Snider 1978) to the extent that even without clinical evidence of 
silicosis, silica exposure was shown to predispose to tuberculosis (Murray et al. 1996). The 
prevalence o f silicosis in South Africa is high, and increasing, probably as a result o f changes in 
labour recruitment policies, resulting in a more stable and therefore older workforce than was a the 
case in few decade ago (Corbett et al. 1999; Murray et al. 1996).
It is not only the working conditions which make miners more prone to active tuberculosis, but the 
living conditions as well. Most miners live and sleep in rooms shared with up to eight other men. 
which increases the opportunity for transmission and reinfection tuberculosis. Evidence of 
extensive transmission of tuberculosis in a gold-mining population in South Africa has recently been 
documented (Godfrey-Faussett et al. 2000). These miners fall victim to tuberculosis, and they carry
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the organism back to their families and communities, further adding fuel to the current tuberculosis 
epidemic in the country.
Transmission of tuberculosis from person- to- person can be documented by restriction fragment 
length polymorphism (RFLP) analysis o f the distribution of the conserved insertion sequence 
IS6110 (described in the general introduction), which varies in copy number and location in the M. 
tuberculosis genome. There is broad variability of RFLP patterns of strains from epidemiologically 
unrelated patients, whereas identical RLFP patterns are found in isolates from patients who were 
clearly infected from a common source involving either several patients or reflecting recent person- 
to-person transmission with the same strain. This molecular technique therefore provides a valid 
measure of recent infection which has progressed to active tuberculosis (Alland et al. 1994; Daley 
et al. 1992; Mazurek et al. 1991; Small et al. 1994). Matching fingerprints may however also 
demonstrate transmission in the past between patients who acquired primary tuberculosis, followed 
by dormancy and subsequent reactivation, often years after the primary infection. This situation has 
been shown to occur in populations where tuberculosis is highly prevalent e.g. in Ethiopia and 
Tunisia (Hermans et al. 1995) and French Polynesia (Torrea et al. 1995). In this context o f poor 
countries where tuberculosis is common, Godfrey- Fausset in a commentary in The Lancet in 1999, 
emphasized that “ clusters will be formed by repeated generations o f transmission limited by 
emigration and stability of the DNA fingerprint itself. Unless there is much mobility o f population, 
clusters may have little to do with recent infection”(Godfrey-Fausset 1999). In a recent review 
article on the use o f RFLP-based DNA fingerprinting in developing countries, Cohn and O'Brien 
(1998) discussed differences in the transmission o f tuberculosis between such poor regions and 
industrialized counties. Based on a comparison between African countries and the Netherlands (van 
Soolingen et al. 1991), they concluded that more recent transmission occurs in areas of high
31
incidence while more reactivation disease and importation of cases are reflected in DNA 
fingerprinting-based studies in areas o f low incidence. Unlike Godfrey-Faussett (1999), Cohn and 
O’Brien (1998) did not discuss the process of cycles of transmission over generations which could 
lead to occurrence o f dominant clones in high incidence regions.
A recent study involving 28522 working men in four gold mines in South Africa concluded that 
at least 50% of tuberculosis cases were due to transmission withing mining community. The main 
risk factor for clustering in this study was found to be treatment failure. Patients with multiple- 
drug-resistant disease were more likely to have failed treatment but were less likely to be clustered 
than those with a sensitive strain. HIV was common but not associated with clustering.(Godfrey- 
Faussett et al. 2000)
The main objectives o f the study recorded in this chapter were:
• To determine by IS6110-based DNA fingerprinting, the extent of homogeneity/ 
heterogeneity i.e RFLP polymorphism which existed amongst approximately 50% of M. 
tuberculosis isolates available from the Freegold Health Region mines during a six-month 
period in 1994 and
• To identify possible risk factors which may be associated with the transmission of
M. tuberculosis clones ( i.e isolates with identical IS6110-based RFLP band patterns 
comprising >6 bands/isolates) in these mines.
2.2. Materials and methods
2.2.1. Study population, patients and cultures
Patients investigated during the study period were predominantly black migrant miners working for
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the Freegold Health Region (FGHR) mines situated in the Free State Province of South Africa. The 
incidence o f tuberculosis in miners from mines in that region in 1994 was approximately 1200/100 
000 per annum for the population (Churchyard et al. 1999). The FGHR has an estimated working 
force o f 53000 persons (G.J.Churchyard, Aurum Research, Welkom, personal communication). 
Ninety percent of miners, all males work underground in six different mines. Miners live in a single 
sex hostels located at each mine shaft and return home once a year from leave.
2.2.1.1. Management of tuberculosis in FGHR mines
The Ernest Oppenheimer Hospital administration provides the sole source of tertiary care for mine 
employees, and designated members of the hospital administration manage the TB control 
programme.
Directly observed therapy, short-course (DOTS) policy was introduced in 1993 and this strategy is 
relatively easy to accommodate and administer in the well-regimented mining industry.
Some cases o f TB are detected by active case finding through the mass miniature radiograph 
(MMR) screening programme (done once a year). Patients with new chest radiographic changes are 
investigated further with standardise-size chest radiograph, sputum microscopy and culture. Most 
cases in the present study were however, identified by passive case detection i.e patients who 
presented with symptoms to the medical service rather than being identified through a screening 
programme.
2.2.1.2. Patients included in study
A group of 193 patients admitted to the EOH of the Freegold Health Region mines from whom
33
M. tuberculosis was isolated cultured during the period between 1 January and 31 June 1994 and 
whose isolates were available to the author was included in this study. These isolates constitute 
about 50 percent of all patients hospitalised at EOH with culture-proven tuberculosis during that 
period. They represent available cultures which remained viable and uncontaminated after either 
having been isolated directly and stored at the SAIMR laboratories in Johannesburg or having 
survived transportation from the EOH laboratories in Welkom to the SAIMR in Johannesburg. 
Some cultures were listed as having been stored but could not be retrieved and were lost to the 
study.
The period was limited to six months as the initial design of the project was confined to the 
description o f the population structure of M tuberculosis isolates based on 1S6110-derived RFLP 
polymorphism o f M. tuberculosis strains in miners, linking clusters mainly to work place and place 
of origin. It did not initially include, nor anticipate, a detailed epidemiological component such as 
assessment of risk factors contributing towards transmission as those aspects were to form part of 
a separate study under the direction o f another author. It is realised that in order to assess rates of 
recent transmission a study period in excess of 24 months would have been more appropriate, 
especially in light o f the recent decision to extend the scope of the study when the previously 
planned separate study involving risk factor was reassigned to the present author (see discussion, 
section 2.4)
2.2.1.3, Data collection
Patient data concerning sex, age, findings of microscopy for acid-fast bacilli, status of patients' 
treatment (new treatment or retreatment cases), seropositivity for infection with the human 
immunodeficiency virus (HIV) in consenting patients, work place relating to mine and mine shaft.
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and place of origin, were compiled by the hospital administration and were extracted from a central 
computerised database. Using a biostatistical approach, these data were analysed to establish 
possible epidemiological linkages, involving the transmission of organisms in mine-related settings 
and risk factors related to transmission.
2.2.1.4. Treatment information
Computerised information on treatment was limited to patients who received treatment at the mine 
hospital for the first time (new treatment cases) and those that were treated for tuberculosis before 
their present admission (retreatment cases). This group includes treatment failures and patients with 
recurrent episodes of tuberculosis.
2.2.1.5. M. tuberculosis strains
Sputum and other samples from patients were cultured using a culture system based a radiometric 
detection signal (BACTEC)(Johnston Laboratories. Cockeysville, Maryland. USA) either at the 
Ernest Oppenheimer Hospital (EOH) or at the South African Institute of Medical Research 
(SAIMR) in Johannesburg. Positive cultures were subcultured on Lowenstein-Jensen (LJ) slants. 
The drug susceptibility o f the isolates to ethambutol streptomycin, isoniazid. rifampicin. 
ethionomide, rifabutin, kanamycin and pyrazinamide were tested using the BACTEC system 
(Siddiqi 1988). Cultures were stored on L-J slopes at 4 °C.
2.2.2. DNA fingerprinting
DNA fingerprinting of the investigated isolates was performed as described previously (van Embden 
et al. 1993; van Soolingen el al. 1994) except that the markers used for estimating the sizes of 
separated fragments were digoxigenin-labelled marker III and internal markers were not used. The
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technique o f fingerprinting entails the growth of M. tuberculosis, extraction of DNA. restriction 
endonuclease digestion. Southern blotting of the digested fragments and probing with the IS element 
(van Embden et al. 1993; van Soolingen et al. 1994).
2.2.2.1. DNA extraction using SDS
Colonies were scraped from L-J slopes and harvested into 0.5 ml o f lysis buffer (15% sucrose, 
0.05M Tris pH8.5, 0.05M EDTA. lmg/ml D-cycloserine). After SDS was added to a final 
concentration o f 2%, the solution was incubated up to 24 hours at 37 °C and 30 minutes at 80 °C. 
The lysate was purified by two extractions with phenol ichloro form solution (1:1 v/v) and once with 
chloroform alone. The DNA was dialysed overnight against distilled water at 4 °C
2.2.2.2 Restriction endonuclease digestion
Approximately 1 ug o f DNA was digested overnight at 37 °C with 10 units of Pvu II in a buffer 
supplied by the manufacturer (Boehringer Mannheim).
2.2.2.3 Separation of fragments by electrophoresis
The digested fragments were separated by electrophoresis through 1% agarose gel (20cm gel) in 
TAE buffer (0.04M Tris-acetate, 0.001 M EDTA, pH 8). The gel was run at 1.5 V/cm for 16-24  
hours at 4 °C. The markers used for estimating the sizes of separated fragments were digoxigenin- 
labelled marker III (a mixture of fragments from Lambda DNA digested with Eco RI and Hind III) 
which consists of 13 fragments. These were 21.226, 5.148,4.973,4.268,3.530. 2.027, 1.904, 1.584. 
1.375, 0.947, 0.831, 0.564 and 0.125 kilobase pairs each in size (Boehringer Mannheim).
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A 245bp probe was prepared by PCR from  IS 61 10 using  prim er (5'- 
CGTGAGGGCATCGAGGTGGC) that corresponds to base pair 631 through 650 and primer 2 
(5'GCGTAGGCGTCGGTGACAAA) that corresponds to base pair 856 through 875 of the IS6110 
insertion (van Soolingen et al. 1994). The PCR mixture consisted of 50nM NaCl; 5mM MgC12; 
1 OmM Tris-HCl; 0.01 % (w/v) gelatin pH 9.6; dNTP mix, (2.5mM each ), primers (50ng/l each) and 
1.25U Taq polymerase.
2 .2 .2 .4 . S y n th es is  o f  th e  p ro b e
The cycling parameters o f denaturing-annealing-synthesizing cycles were as follows:
3 min. 94 HC Once 
1 min. 94 °C |
1 min. 65 °C | 25 cycles
2 min. 72 °C |
4 min. 72 °C Once
The PCR product was run on 2% gel and the fragment with the correct size (245-bp) was cut from 
the gel and purified by Gene-clean II kit as recommended by the manufacturer (Bio 101 Inc.). The 
probe was non-radioactively labelled by the use o f the digoxigenin labelling system as described by 
the manufacturer (Boehringer Mannheim).
2.2.2.5. Southern blotting
Prior to transferring the DNA to the Hybond-N, nylon membrane (Amersham life science), the gel 
was treated in depurination solution (0.25M HC1), for 15 minutes, denaturation solution (0.5M 
NaOH, 1M NaCl) for 30 minutes and finally in neutralising solution (0.5M Tris-HCl, 1.5M NaCl,
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pH 7.4) for 30 minutes.
The Hybond-N membranes for Southern blotting were prepared according to the manufacturer's 
recommendation (Amersham Life Science) and the DNA was transferred by capillary action using 
20X SSC (3M NaCl, 0.3M sodium citrate) a transfer buffer overnight. After blotting, the nucleic 
acids were fixed to the membrane by baking at 120 HC for 30 minutes.
2.2.2.6. Prehybridisation and hybridisation
The membranes were prehybridised for at least 2 hours at 68 °C in a hybridisation solution 
containing 5XSSC, l%w/v blocking reagent, 0,1% N-lauroysarcosine, and 0.2% sodium dodecyl 
sulfate (SDS). After prehybridisation heat-denatured DNA probe was added and the membrane was 
incubated overnight at 68 °C. Following hybridisation the membrane was washed twice for 5 
minutes at room temperature with 2XSSC, 0.1 % SDS and twice for 15 minutes at 68 °C with 0.1 \  
SSC. 0.1% SDS.
2.2.2.7. Detection procedures
The presence of digoxigenin-labelled DNA probe was determined with alkaline phosphatase 
conjugate antibody as described by the manufacturer (Boehringer Mannheim).
2.2.2.8. Computer-assisted analysis of DNA fingerprints
The IS6110 fingerprint pattern were digitised with HP1 lc scanner( Hewlet-Packard, Hopkin. Min). 
Conversion of digitised fingerprint pattern, normalisation and cluster analysis were carried out with 
Gelcompare software (Window 95 , Version 4.0, Applied Maths, Kotrijk, Belgium). The fingerprint 
patterns were analysed for similarity by using the Dice coefficient, and a dendrogram was calculated
38
with the unweighted-pair group method using average linkage(UPGMA) according to the supplier's 
instructions. Band positions were determined by using the peak finder function of the Gelcompare 
software and were controlled manually by comparison with the original IS6110 fingerprint blots.
2.2.2.9. Statistical analysis
Statistical analyses were performed by Epi-Info, version 6.02 (Centers for Disease Control and 
Prevention. Atlanta, GA, USA). Chi-square determinations were performed to test the univariate 
risk factor for belonging to a cluster or family. When cell sizes were expected to be smaller than 
five, Fisher’ exact test was used. Adjusted odds ratios with 95% confidence intervals were 
calculated in comparison of categorical variables.
Multiple logistic regression models were fitted to identify the most important risk factors for 
clustering. Potential explanatory variables considered were place of origin, mine shaft. HlV-status. 
drug-resistant profile, treatment episode, duration of employment and age.
2.2.2.10. Failure to perform secondary DNA fingerprinting.
When the initial IS6110-based DNA fingerprinting was performed n 1994. secondary typing of 
isolates exhibiting <5 RFLP bands was not envisaged. By the time it was considered to be relevant, 
stored DNA from isolates had been degraded to such an extent that attempts at secondary typing 
proved to be unsuccessful. Unfortunately, in the process o f moving from SAIMR laboratories in 
Johannesburg to the MRC laboratories in Pretoria the original cultures were lost.
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Isolate. A pure culture o f bacteria in monoculture from a primary clinical material, identified to 
the species level
Strain. An isolate or a group of isolates showing traits distinctive from those of other isolates of 
the same species
Clone, general definition. A set of microbial isolates that have been recovered independently 
from different sources, in different locations and perhaps at different times, but showing so many 
identical phenotypic and genetic traits that the most likely explanation for this identity is a common 
origin(Leger 1992).
Clone, specific definition. A clone in the context of the present study is confined to a set of M. 
tuberculosis isolates which exhibits an identical IS6110-based RFLP pattern, provided more than 
five bands are present in each of the isolates.
Identical band pattern (IBP) isolates. Strains which are indistinguishable, i.e. 100% identical, on 
IS6110-based fingerprinting.
Low copy number isolates. Isolates exhibiting the same number o f copies o f IS6110 fragments 
of identical molecular weight but which contained less than six copies per isolate 
RFLP family strains. Strains which share at least 80% of IS6110- based RFLP band patterns 
including the position and grouping of bands.
Clustering of isolates was based on three different genotypic criteria forming three different types 
of clusters which will be clearly specified in the text of the thesis:
IBP clusters. Groups of two or more isolates exhibiting the same number of copies of 
IS6110 fragments o f identical molecular weight i.e. identical RFLP patterns.
Clone-based clusters or clone clusters. Groups of two or more IBP isolates with more than
2 .2 .2 .1 1 . D efin itio n  o f  term s
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5 copies (RFLP bands) in each of the isolates.
RFLP-family clusters. Groups o f two or more isolates exhibiting near-identical RFLP band 
patterns defined as >80% RFLP band pattern homology, based on number, position and 
grouping of bands
Recent infection. Infection acquired recently without necessarily exhibiting overt disease.
Recent transmission. Evidence of recent spread of a strain from one patient to another, based on 
the demonstration o f clone-based clusters of pulmonary-derived isolates, i.e. strains with identical 
band patterns and >6 1S6110 copies.
Recently acquired tuberculosis. Clinically overt tuberculosis disease which was recently acquired, 
with the implication that the period between infection as a result o f transmission and disease 
manifestation is short.
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All 193 patients were males. The age distribution o f the patients is shown in Figure 2.1. The average 
age of the mine workers was 38 years. All patients presented with pulmonary tuberculosis.
2.3 . R esu lts
2 .3 .1 . P a tien t ch a ra cter is tic s
AGE DISTRIBUTION
40  ...................
A ge (years)
Figure 2.1. Age distribution of tuberculosis patients from Freegold Heafth Region mines
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Geographical origin was determined for 186 patients(96%): 70 were from Eastern Cape Province. 
66 from Lesotho, 38 from Free State Province, 3 from Mozambique, 3 from Kwazulu-Natal, 4 
from Swaziland and 1 from Gauteng Province.
All patients in this study were working underground in six different mines. O f the 181 patients on 
which information relating to mine or mine shaft was available, 23 worked in FSG. 21 in FSS , 28 in 
Freddies, 36 in Pres Brand , 39 in Pres Steyn and 34 in W Holdings. Table 2.1 show the distribution 
of miners in each mine shaft. A total of 34 mine shafts was recorded in this study.
Table 2.1. Distribution of miners with tuberculosis in different mine shafts
01 02 03 04 05 06 07 08 09 10
FSG 8 5 4 1 NE 1 1 NE NE
FSS 1 6 11 2> NE NE NE NE NE NE
Freddies 2 NE NE NE 15 NE ->J NE 6 2
Pres Brand 5 9 5 8 9 NE NE NE NE NE
Pres Steyn 7 10 2 18 1 1 NE NE NE NE
W Holdings 9 6 i 7 6 3 2 NE NE NE
NE = Mine shaft does not exist /function or no miner was recorded from that mine shaft
Due to the mobility of the work force in the mines, the number of miners in each mine or shaft could 
only be approximated and as these figures were not required for analysis of risk factors associated 
with transmission of M. tuberculosis, no attempt was made to access these data. The miners lived in 
hostels and each of hostel accommodated miners from a particular shaft. A small number of miners 
may however have been transferred from one shaft to another, yet remained in the original hostel, 
while others may have been reassigned to a different hostel on closure o f either a shaft or a hostel. A
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hostel comprised rooms of varying size, each of which being occupied by 2 to 8 men.
HIV serological status was available for 180 (93%) patients, and was negative for 153 (85%). positive 
for 27 (15 %) and unknown for 13 patients.
2.3.2 IS6110- associated DNA polymorphism of M. tuberculosis isolates collected from Freehold 
Health Region miners.
The genetic polymorphism of 193 M. tuberculosis isolates obtained from patients was investigated 
by Southern blot analysis of the genomic DNA with the IS6110 probe. Hybridisation of Pvu-II- 
digested DNA with right arm of IS6110 showed that the copy number of 1S6110. as determined from 
the number of bands hybridising the probe, ranged from 1 to 19 according to the strain, with a median 
of 13 copies per isolate (Figure 2.2). Most strains (172 total) had more than 5 copies of IS6110 per 
genome and only one isolate carried a single copy of the insertion sequence. The heterogeneity of 
isolates based on the ratio of band patterns to clusters was lower for isolates with 1 to 5 IS6110 
copies (Table 2.2), suggesting that secondary typing of low copy number strains may yield additional
unique patterns.
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Figure 2.2. Number of IS6110 copies in M. tu b e rc u lo s is  from Freegold Health Region miners
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Table 2.2. Distribution of isolates, IBP clusters and IS6110-based band patterns.
No.of IS6110 
copies/pattern
No of isolates Total isolates in 
clusters
No of IBP 
clusters
Total
patterns
Heterogeneity' 
patterns: clusters
1-5 bands 21 13 4 10 2.5
6-10 bands 57 20 5 44 8.8
11-15 bands 104 42 14 76 5.4
16-19 bands 1 1 nJ 1 13 13.0
a) Degree of heterogeneity based on the ratio of number of patterns to number of clusters
On the basis o f computer-assisted comparison of DNA fingerprints for M. tuberculosis isolates, a 
dendrogram showing the similarity between any two isolates or groups o f isolates was constructed 
(Figure 2.3). One hundred and thirty- nine distinct 1S6110 fingerprint patterns were distinguished in 
the 193 isolates analysed; 24 banding patterns were shared by >2 isolates (i.e. clusters with identical 
band patterns (IBPs). These 24 IBP clusters involved 78 isolates (Table 2.4 and Table 2.5). IBP clusters 
varied in size from 2 to 8 isolates. The majority of clusters were small: 10 clusters consisted of 3 
isolates and 8 clusters o f 2 isolates (Table 2.3).
Table 2. 3. Band frequency and size of 24 IBP clusters found in the study population
No. of isolates per cluster No. of IS6110 bands No. of clusters
2 6-15 8
->J 2-19 10
4 3-14 2
5 8-13 2
6 13 1
8 14 1
4 6
•6 2tJ 66 <:6 i>6 od 76 &0 90 160
j .... ...... ,L..t.,.L,...TL,..J...„.,L.J...
Figure 2^; Dendrogram based on eomputer-assisted comparison of IS6! 10 DNA fingerprints of! 93 isolates of M. tuberculosis
Table 2.4. Distribution o f  total and evaluable numbers o f  M. tuberculosis isolates in R F L P  families and IB P  and clone clusters from mining
environment and place o f origin.
Isolates in genotype groups Total Percentage
Isolates with 1S6110-based fingerprint 193c 100
Evaluable isolatesd in mines/ shafts 181 94
Evaluable isolates1 according to region 186 96
Evaluable isolates1 according to village 151 78
Isolates in 23 R F L P  families 158 82
Evaluable isolates1 in R F L P  families in mines /shafts 148 94
Evaluable isolates1 in R F L P  families in regions 154 97
Isolates in 24 IB P  clusters 78 40
Evaluable isolates1 in IB P  clusters in mines/shafts 75 96
Evaluable isolates1 in IB P  clusters in regions/villages 77 99
Isolates in 20 clones 65 34
Evaluable isolates1 in clones in mines/ shaft 62 95
Evaluable isolates1 in clones in regions/villages 64 99
Isolates in R F L P  families shared in mines 116 78
Isolates in R F L P  families shared in shafts 60 41
Isolates in R F L P  families shared in regions 115 75
Isolates in R F L P  families shared in village 30 20
Isolates in IB P  clusters shared in mines 36 48
Isolates in IB P  clusters shared in shafts 14 19
Isolates in IB P  clusters shared in regions 48 62
Isolates in IB P  clusters shared in villages 5 6.5
Isolates in clone clusters shared in mines 33 53
Isolates in clone clusters shared in shafts it 18
Isolates in clone clusters shared in regions 40 63
Isolates in clone clusters shared in villages 5 7.8
a) There were 6 mines involved
b) A  total o f 34 shafts were recorded where patients with T B  worked
c) There were 139 distinct IS6 1 10 patterns amongst the 193 isolates
d) Evaluable isolates denote isolates from patients on which information relating to mines shafts or villages and geographic region was 
available.
Table 2.5 Distribution of identical band pattern (IBP) clusters amongst mines and mine shafts
N U M B E R  O F  IB P  S T R A IN S  IN  M IN E/SH A FT
Cluster compositin Shared in mine number Not shared Shared in shafts in mine number
N E
IB P  C luster IS 6 I I I I  copies* R F L P
famils
Total
isolates
1 2 3 4 5 6 1 2 3 4 5 6
C L  1 14 FM  1 X 0 it 3 33 3 0 2 33 3. 2 0 0 0
C L  2 1? FM  1 0 0 0 33 0 33 3 33 33 0 0 33 0 (l
C L ? 1? FM  1 0 33 2 " .3 0 0 U 0 33 .3 0 33 1
C L  4 14 FM  1 2 0 0 0 <3 0 31 2 0 33 0 II 0 3' "
C L  5 14 FM  1 4 <3 0 0 " 0 0 4 33 0 0 0 33 0 0
C L  6 16 FM  1 3 33 0 33 -I 0 0 2 0 ■3 (1 31 0 33 "
C L  7 9 FM  2 0 0 <1 (1 0 2 1 33 31 3. 33 3' 0 0
C L  X X FM  2 5 0 » 3 .1 0 2 1 33 0 2 (1 0 1) 0
C L  9 10 FM  2 2 0 0 <3 II 0 2 0 0 3. 0 0 0 «
C L  lu 12 FM  ? 2 0 0 <3 0 (1 0 2 0 3. II 0 (1 0 "
C L  11 11 FM  3 3 2 ■' 33 33 33 0 0 33 3. 0 II 33 0 1
C L  12 19 FM  4 0 '1 0 33 (1 3 33 0 33 0 3. 33 "
C L  1? 4 FM  5 3 0 <3 II 33 0 0 3 0 0 0 33 '3 0
C L  14 > FM  5 3 2 0 0 0 0 <1 1 33 33 0 0 0 0 0
C L  15 1? FM  6 3 o 0 33 0 II 0 1 It 33 33 0 33 3' 1
C L  16 11 FM  7 3 0 -■ .1 0 2 0 0 0 33 (1 33 0 33
C L  17 11 FM  9 3 0 0 II 33 33 0 1 0 0 33 0 0 0 »
C L  IX 12 FM  lo 3 0 3 0 -■ 0 (1 1 .3 2 33 0 0 3' «
C L  19 10 FM  lo 3 0 0 0 33 2 33 33 33 33 '3 3' 33 « 0
C L  20 3 FM  11 33 0 0 31 .1 3. 7 33 (1 '3 33 33 0 II
C L  21 FM  12 4 0 <1 0 .1 33 1 7 33 33 0 33 3' '3
C l. 22 ') FM  1? 3 0 0 3 " 33 33 1 0 33 2 33 0 '3
C L  2? ') FM  20 " 3 1' 7 3. 3' 1 33 33 3- '3 « 0 ■>
C L  24 <■ FM  2? 2 <3 3 33 33 0 33 33 '3 3. ' 33 II 3' "
T O T A L 7X 7 6 7 X 73 2 3' 3 0
Total shared in mines shafts ?<> 1 4
\ I ;  Not e\nlunblQ. IM  I'apuK M ine I FSG  .M ine 2 I.SS Mine ?  Freddies, Mine 4 President Brand Mine '  Piesidcnl Slc\n. Mine (• Western Holdings 
a) I olal number ol isolates in IB P  clusters shared in mines and shall respcelixel>
Table 2 6 Distribution of RFLP Family-based clusters in mines and mine shafts
RFLP Family Isolates per NUMBER OF RFLP FAMILY STRAINS SHARED IN MINES/SHAFTS NE'RFLP lamily
IN MINE NO1 Total
Strains
IN SHAFT IN MINE NO’ Total
strains
1 2 3 4 6 shared in mines 1 2 3 4 5 6
shared in 
shafts
1 ,n 4 7 X 13 y 46 I. 4 6 7 12 5 34 4
2 24 2 2 6 7 23 I. 2 4 0 3 4 II 1
3 y 2 2 (1 « 2 2 4 .1 I. 0 0 0 (l <1 »
4 y () 2 1) 2 3 (1 7 i. I 2 2 0 0 4 tl
* 7 3 U 2 <> 2. 0 5 2 0 ii 0 0 0 2 (1
0 6 2 0 0 0 II .I 3 I. 1) 0 0 0 II 0 1
7 2 () 0 0 2 2 5 0 0 0 0 0 (1 0 (1
X 4 ■> 0 (1 2 0 3 i) 1) 0 0 0 0 II tl
y 5 2 0 " 2 0 I 4 0 0 0 0 <1 0 0 0
in 5 2 -- 0 0 3 0 5 2 I 0 0 0 II 3 (1
11 4 0 0 0 <l 2 2 3 0 0 tl (1 2 0 3 0
12 4 3 0 <1 » 2 0 3 3 0 0 t) 0 (1 3 »
13 3 « 1) 2 0 2 (1 3 0 1) 2 0 ■I II 2 1)
14 t) 0 (1 I 0 2 II I 0 II 0 0 (1 0 »
1? 2 (1 » 1) t) 0 0 0 0 I 0 (1 0 0 0 II
16 2 " I) 0 0 I 21 0 0 0 (1 II tl 0 0 1
17 2 1) 0 (1 (1 2 2 II I I I) 0 0 II »
IX 2 <1 I II 2 2 I 3 II I 0 0 .1 (1 tl »
iy 2 0 I 0 2- 2 I 0 II 1. 2 1. I II 0 I
20 <> 2 -■ (1 2 ■I 3 II (1 0 0 0 (1 II "
21 2 ■i I 0 .1 2. I 0 1. I I I I 0 II I
22 2 " I II 22 2 I I I 1. I 1. II I "
23 2 " 2 II 2 I -1 2 I I I I I I 0 »
T O T A L I5X 2 o l> 17 2o 22. IX 1 H . 7 4 14 II 17 y -1" 7
NE~ Not valuable FM laniils Mine I FSCi Mine 2 FSS :Minc ' Freddies. Mine 4 President Binnd Mine ' Piesident Stc>n. Mine 6 Western Holdings
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2.3.3. Evidence of recently-acquired tuberculosis
2.3.3.1. Quantification of transmission
To calculate a percentage estimate of recently-acquired tuberculosis, it is assumed that the patient 
who recently transmitted its strain to other members represented by a cluster (source case) acquired 
his/her tuberculosis infection elsewhere in the past, with subsequent development reactivation 
tuberculosis (Small et al. 1994; Godfrey-Faussett et al. 2000). This assumption should be qualified 
by the possibility that more than one patient who acquired infection with the same clone some time 
in the past would develop reactivation tuberculosis during the relatively brief study period. This could 
happen when strains have become endemic in the mining community. Based on the premise the latter 
scenario is unlikely, the minimum percentage o f tuberculosis cases due to recently acquired 
tuberculosis in the miners (calculated according to the formula proposed by Small et al. 1994. as 
[Total No. in clusters]-[No. of clusters]/Total No. of strains) was 26.2% based on clones and 28.0% 
based on IBP clusters. If one assumes that all patients in different clones or IBP clusters developed 
recently acquired tuberculosis and that none of the members of a IBP cluster was an index case with 
reactivation tuberculosis i.e. that the source case was not identified in the present study, the 
percentage o f tuberculosis cases due to recently acquired tuberculosis in the Freegold Health Region 
miners could have been as high as 37.8% in the case o f clones and 40.4% for IBP clusters. This 
would be possible if the source cases were not captured in the study by being undiagnosed and/or left 
the mine before the study commenced or not on the mine while visiting a local community or in the 
eventuality of miners visiting a migrant area when on leave.
2.3.3.2. Evidence of geographically-linked transmission
The epidemiological relationship among patients in IBP clusters was obtained through the 
examination o f information relating to patients originating from the same geographic region or 
village and working in the same mine or mine shaft (the latter group would likely to have lived in 
the same hostel).
In several instances, epidemiological links between patients and IBP clusters were apparent. Of all 
evaluable IBP clustered cases 14 out o f 75 (18.7%) could be linked to a mine shaft and 5 out of 77
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( 6.5%) IBP clustered cases originated from the same village, strongly suggesting a common source 
of infection (Table 2.4 and Table 2.5). The corresponding figures for sharing a mine or a geographical 
region was 48.% and 61.5% respectively.
Based on clustering of clones as defined in this study, 11 out of 62 (17.7%) could be linked to a mine 
shaft and 5 out o f 64 (7.8%) originated from the same village. The figure for sharing a mine or a 
region was 53.2% and 62.5% respectively.
2.3.3.3. Description of two large clone-based clusters
As cluster 1 and cluster 3 had 14 and 13 IS6110 copies respectively, both clusters meet the definition 
of a clone-based cluster (>6 copies). The isolates that formed the largest cluster (Cluster 1, Family 
1) came from 8 miners. Six members of this cluster originated from different parts of the southern 
region, while two came from the same village suggesting in the latter instance a common source of 
infection. Overall six patients could be epidemiologically linked, giving direct evidence of recent 
transmission: five sharing a mine shaft ( Table 2.5) and another patient with a CL 1 fingerprint who 
came from the same village as one o f the five miners who shared a mine shaft.
The second largest cluster (Cluster 3, Family 1) involved six patients. All members of this cluster 
come from different regions and none could be linked to a mine shaft. Two worked at the FSS mine 
(Table 2.5).
2.3.4. Risk factors associated with clustering
2.3.4.1. Univariant analysis of risk factors
Sixty- five clustered stains defined as clones for the purpose of this study, were compared with 105 
non-clustered strains from mine patients to identify factors which may pose a risk o f transmission.
Table 2.7 presents the results o f univariant analysis to identify potential risk factors for transmission. 
Miners from the Free State were associated with a significantly high risk o f being in a cluster (P = 
0.01). In contrast to this finding, the Eastern Cape as a source o f miners was associated with a
52
significantly lower risk than other regions of being in clusters (P=0.02). No significant association 
between clustering and age, drug resistance profile, period of employment in the mine, previous 
history of tuberculosis and or HIV seropositive status of patients could be demonstrated.
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Table 2.7. Univariate analysis of risk factors for a patient to belong to a cluster/clone
Characteristic No. of patients Odds
Ratio
95%
Convidcnce
Interval
I’ value
Clustered Nonclustered
M IN E
FSG 7 9 1.24 0.39-3.92 0.68
FSS 10 10 1.67 0.59-4.71 0 28
Freddies 1 1 10 1.88 0.68-5.19 0.18
Pres Brand 10 24 0.58 0.24-1.42 0.20
Pres Steyn 13 24 0.81 0.35-1.85 0.58
W  Holdings 1 1 20 1.91 0.80-4.53 0.1 1
P L A C E  OF O R IG IN
Eastern Cape 16 45 0,43 0.20-0.90 0.02
Free State 20 14 2.73 1 18-6.36 0.01
Lesotho 24 37 0.99 0.49-1.99 0.97
Natal 0 2 Undefined 0.00-8.16 0.52
Swaziland 1 0 Undefined Undefined 0.40
Mozambique 2 2 1.55 l hide fined 0.65
H IV  Seropositive 14 1 1 2.16 0.84-5.58 0.08
Retreatment 13 15 1.56 0.63-3 85 0.29
Drug resistant 8 10 1.24 0.41-3.65 0.67
INH only 5 6 1.38 0.35-5.38 0.61
INH + R M P 0 3 Undefined Undefined Undefined
INH + Others 3 i Undefined Undefined l Indefincd
Period in the mine
1 -5 years 5 4 2.18 0.44-1 1 39 0.30
6-10 20 34 0.97 0.46-2.1 0.92
11-15 12 26 0.68 0.29-1.57 0.33
16-20 13 17 1.35 0.56-3.24 0.47
21-25 5 8 0.96 0.62-1.46 1.00
25 4 9 0.72 0.15-2.74 0.77
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2.3.4.1. Multiple logistic regression analysis of variables.
Treatment episode (retreatment versus new untreated cases) was significantly associated with 
transmission [OD] 2.38. P=0.04.95% confidence interval = 1.04-5.40) while HIV status (seropositive 
versus seronegative) approached statistical significance when variables which could be linked to 
clustering by multiple logistic regression models were examined (OD 2.24, P=0.07. 95% confidence 
interval =0.95-5.3).
2.3.5. RFLP- based Families
2.3.5.1. Closely related isolates and concept of RFLP families
In order generate a visual impression of strain relatedness between the banding patterns o f M. 
tuberculosis strains, a diagonal similarity matrix was generated (Figure 2.4). This matrix shows the 
degree o f relatedness of each IS6110 fingerprint banding pattern with any other in the collection. 
Similar strains generate a triangle below the diagonal, which vary in shade, darker shades representing 
closer relatedness. Two major clusters and six clusters o f moderate size are clearly visible while 
several small clusters o f closely related isolates are also evident. These near -identical clusters were 
designated families based on the following observations and criteria: Many strains with non-identical 
RFLP patterns showed common band patterns, including the position and grouping of bands. 
Characterisation o f families required that all the members o f a family were identical or differed by 
only one to three fingerprint bands, while still maintaining the general band structure of the 
fingerprint. Further stipulations were the sharing of at least three bands in identical positions when 
there were four or less bands, or, when strains had more than four bands, the requirement of at least 
80% homology between the strains. This exercise yielded 23 families which varied in size from 2 to 
50 (Table 2.6).
2.3.5.2. RFLP family clustering as evidence of transmission over time
Based on the assumption that an isolate belonging to RFLP family is likely to constitute an endemic 
strain, an RFLP- family cluster would serve as evidence o f transmission in the recent or more distant 
past ( Figure 2.6 and Discussion 2.4.4). The percentage transmission of endemic strains based on 
the Small et al. (\ 994) formula for the 158 isolates in 23 RFLP families out o f a total o f 193 isolates.
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would be 69.9%. Furthermore, 158 of 193 isolates (81.9%) were found in RFLP family clusters, giving 
an indication of the high proportion of endemic isolates being responsible for transmission in miners, 
either in the mining environment or from sources outside, including regions from where miners were 
recruited. The proportion of recent transmission based on IBP or clone clusters (78 isolates in 24 IBP 
or 65 isolates in 20 clone clusters out of 158 isolates in 23 RFLP families) is 34. 2% or 28.5% 
respectively.
Forty -one percent evaluable miners whose isolates were in RFLP- families shared a mine shaft and
20% (30 out of 151) come from the same village, presenting indications of the existence of common
sources of infection and/ or endemicity of strains (Table 2.4 and Table 2.6). The corresponding figures
for sharing a mine or a geographic region were 116 out of 151 ( 77%) and 115 out of 154 (78%) 
respectively.
2.3.6. Analysis of two dominant M. tuberculosis RFLP families from the mines.
The largest family (Family 1) included 50 isolates (25.9% of total) and the IS6110 copy number in 
this family ranged from 13 -16 per isolate (Figure 2.5). Twenty-five (50%) isolates with Family 1 type 
patterns occurred in seven clone-based clusters comprising two or more isolates, suggesting recent 
transmission involving these strains. The two largest IBP clusters consisted o f 8 and 6 strains 
respectively, and are very likely to have caused microepidemics (Section 2.3.3.3).
Patients within Family 1 originated from adjoining central and eastern regions in southern Africa, 
comprising Lesotho (14), Free State (11), and Eastern Cape (20) a well as from Mozambique (1) and 
Swaziland (1). Family 1 isolates are also widely distributed in the six different mines. However. 
73.9.0% (34 out of 46) o f all evaluable cases with the Family 1 fingerprint pattern occurred in 2 or 
more miners working in the same mine shaft, suggesting possible linkage between the cases over time 
(Table 2.6). Eighteen (39.1 %) recruited from the same village) providing additional evidence in favour 
of either transmission, recent or in the past. Taken together, a total of 42 (91.3%) o f patients in Family 
1 could be linked to either mine shaft or village of origin. None of the miners in families shared both 
mine shaft and village o f origin.
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65 75 85 90 95
Figure 2.4. Similarity matrices of 193 isolates from Freegold Health Region miners. Similarity coeffients from 65% to 
100% are shown by 5 different gray tones in matrices. Diagonal is formed by 100% similarity coeffient values of 
corresponding strains.
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Figure 2.5. Dendrogram illustrating relationship between M. tuberculosis strains belonging to Family 1 type pattern.
Strains from 53713 to 64176 included in Family !(;> 80% homology)
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The second dominant family, Family 2 (Figure 2.6), consisted of 24 isolates with IS6110 copies, 
ranging from 7-10 per bacterial cell. Ten strains within Family 2 formed three clone-based clusters 
consisting of 5, 3 and 2 isolates respectively. Patients in these were distributed unevenly in the six 
mines with more than half of all cases located in two mines (Table 2.5). O f 11 cases that shared a mine 
shaft, 2 were identical and 7 differed by one or two bands (Figure 2.6). Patients with the Family 2 
pattern originated from Lesotho (10), and the Eastern Cape (10) and Free State provinces (4) and 9 
could be linked to a village or town.
Comparison o f patients whose isolates were in dominant Family 1 and Family 2(74) with patients who 
were in the heterogenous group (98 total) reveal that working in Freddies mine (7 miners have 
isolates belonging to Family 1 and 6 to Family 2) was associated with a significant risk of belonging 
to dominant families [OD] 3.03; 95% confidence interval 8.89-1.07; P = 0.02).
No significant difference in age, prior tuberculosis treatment, HIV- M  tuberculosis co- infection 
status, drug resistance profiles, or period o f employment in the mine was observed between patient in 
dominant families and patients in the heterogenous group (Table 2.8).
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Figure 2.6. Dendrogram illustrating relationship between M tu b e rc u lo s is  isolates belonging to Family 2 type pattern. 
Strains from 72816 to 55911 included in Family 2 (£ 80% homology )
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Table 2.8. Univariate analysis of risk factors associated with dominant RFLP families
Characteristic No. of patients Odds 95%
Convidence
Interval
P value
Family 1+2(N=74) Heterogenous
(N=98)
Ratio
M IN E
FSG 7 9 1.03 0.33-3.23 0.95
FSS 7 13 0.68 0.23-1.97 0.44
Freddies 13 7 2.77 0.96-8.89 0.03
Pres Brand 11 23 0.57 0.24-1.34 0.16
Pres Steyn 17 20 1.16 0.53-2.57 0.69
W  Holdings 16 15 1.53 0.67-3.57 0.28
P L A C E  O F  O R IG IN
Eastern Cape 30 31 1.55 0.78-3.06 0.18
Free State 15 19 1.06 0.46-2.4 0.89
Lesotho 24 37 0.79 0.40-1.57 0.47
Natal 1 2 undefined undefined undefined
Swaziland 1 3 undefined undefined undefined
Mozambique 1 2 undefined undefined undefined
H IV  Seropositive 13 12 1.53 0.60-3.87 0.33
History o f tuberculosis 14 14 1.40 0.58-3.39 0.42
Drug resistant 8 10 1.07 0.36-3.13 0.90
IN H  only 6 5 1.64 0.42-6.52 0.42
IN H  + R M P 1 2 undefined undefined undefined
IN H  + Others 1 2 undefined undefined undefined
Period in the mine
1-5 years 4 5 1.24 1.01-1.51 LOO
6-10 25 29 1.21 0.60-2.44 0.56
11-15 13 25 0.62 0.27-1.40 0.21
16-20 15 15 1.06 0.46-2.40 0.89
21-25 7 6 1.36 0.40-4.57 0.58
25 2 11 0.22 0.02-1.06 0.04
Undefined^ Figures too low for defined statistical analysis.
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2.3.7. RFLP patterns of M. tuberculosis strains isolated from HIV -seropositive patients
2.3.7.I. Spectrum and cluster patterns
The RFLP patterns o f the isolates from 26 HIV-seropositive patients with tuberculosis are shown in 
Figure 2.7. A total o f 21 different IS6110 RFLP patterns was found. The number o f IS6110 copies 
per isolate of M. tuberculosis varied from 3 to 19; 25 of the 26 isolates exhibited 6 or more copies. 
Nine isolates within the HIV-seropositive group shared identical RFLP patterns with one or two 
isolates and were grouped into four clusters: CL 1 (3 isolates), CL 3 (2 isolates), CL 8 (2 isolates) and 
CL 16 (2 isolates). An additional 7 clusters (19 isolates) observed in the study included isolates from 
both HIV-seropositive and HIV-seronegative patients (Table 2.9). These were CL 21 (4 isolates); 
CL 11, CL 14 and CL 18 (3 isolates each) and clusters CL 15, CL 19, CL 24 (2 isolates each).
Twenty-four fingerprints o f isolates from HIV-seropositive patients were scattered within RFLP 
families (Family 1 to 24) and 12 out of 26 isolates from HIV-seropositive patients belonged to the two 
largest families, Family 1 and Family 2 (Table 2.9).
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Figure 2.7. Dendrogram showing 23 isolates obtained from HIV-seropositive patients.
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Table 2.9. Drug resistance profiles, IS6110 clusters status and location in mines of 26 HIV-positive tuberculosis patients
LAB NO Susceptibility Cluster Family Copy number Mine/shaft
54780 Sensitive Unique Unique 11 W Holdings 06
71744 Sensitive Unique Unique 10 Pres Brand 03
53709 Sensitive Unique FM 1 15 FSS 03
71146 INH-resistant Unique FM 1 15 Pres Steyn 04
55913 Sensitive CL 1 FM 1 14 Pres Steyn 02
65143 Sensitive CL 1 FM 1 14 Freddies 05
68049 Sensitive CL 1 FM 1 14 Freddies 09
54771 Sensitive CL 3 FM 1 13 FSS 02
70302 Sensitive CL 3 FM 1 13 Freddies 05
53697 Sensitive Unique FM 2 10 Freddies 05
58874 Sensitive Unique FM 2 9 Freddies 05
70074 Sensitive Unique FM 2 9 Freddies 05
58512 Sensitive CL 8 FM 2 8 FSS 03
63121 Sensitive CL 8 FM 2 8 Freddies 05
56945 Sensitive CL 11 FM 3 11 FSG 01
68034 Sensitive Unique FM 4 19 FSS 03
68054 Sensitive Unique FM 4 16 Pres Steyn 02
68035 Sensitive CL 14 FM 5 5 FSG 04
53628 Sensitive CL 15 FM 6 13 FSG 08
72821 INH-resistant CL 16 FM 7 11 Pres Brand 02
73949 Sensitive CL 16 FM 7 11 Pres Brand 05
58007 Sensitive Unique FM 8 10 W Holdings 05
64585 Sensitive CL 18 FM 10 12 FSS 02
72275 Sensitive CL 19 FM 10 10 Pres Steyn 01
58868 Sensitive CL 21 FM 12 3 FSG 01
59438 Sensitive CL 24 FM 23 6 FSS 01
Abbreviations: 1NH: Isoniazid; CL: IBP (identical band pattern) cluster; FM : RFLP (restriction fragment length polymorphism) taini 1 \ .
64
2.3.7.2. Comparison of RFLP patterns between HIV-seropositive and HIV-seronegative 
tuberculosis patients
The level o f diversity o f the DNA fingerprints observed in the HIV sero-negative tuberculosis group 
(106 patterns among the 134 isolates) was comparable to the level o f diversity in the HIV-seropositive 
tuberculosis group (20 patterns among 25 isolates)(P = 0.92).
The risk o f belonging to a group o f patients within a clone-based cluster was 56% (14 out 25) for the 
HIV-seropositive group and 37.3%(50 out 134) for the HIV- seronegative group (P=0.07), suggesting 
a possible trend of increased transmissibility in the HIV seropositive group which did not reach 
statistical significance. There were only two antimicrobial-resistant isolates in the HIV-seropositive 
group, both resistant to INH. One o f these belonged to CL 16 and is linked to a drug-susceptible isolate 
in this cluster (Table 2.5 and Table 2.9).
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2.4. Discussion
The present study revealed a total of 139 distinct RLFP patterns among 193 isolates analysed, 
indicating high strain diversity. The degree of strain diversity found in the present study is probably 
inflated because the short study period may have failed to reveal additional clusters likely to have 
occurred in subsequent months due to delayed reactivation of dormant/incubating tuberculosis. It was 
however, found that the isolates o f 78 o f the 193 patients (40.4%) belong to 1 o f 24 clustered RFLP 
patterns (IBP clusters) and thus may have been epidemiologically linked. An estimated 28.0- 40.4% 
of the 193 cases was due to recent infection that had progressed to active disease during the six months 
study period.
High clonal diversity o f M. tuberculosis has previously been reported in high incidence communities 
of Ravensmead and Uitsig, Cape Town, South Africa (Warren et al. 1996) as well as in countries with 
low prevalence o f tuberculosis and contrasts with a lower genetic heterogeneity reported in so-called 
high prevalence countries in Africa (Tunisia, Ethiopia) (Hermans et al. 1995) and in high-risk 
populations such as urban homeless (Barnes et al. 1996), hospitals (Beck-Sague et al. 1992; Coronado 
et al. 1993) and shelter dwellers (Nardell et al. 1986; Nolan et al. 1991) among whom interhuman 
transmission is frequent. The “unexpected” high clonal diversity encountered in communities in Cape 
Town as well as in miners found in the present study may well reflect the heterogeneous origins of 
these populations. These comprise immigrants from different European and Asian countries and sai lors 
and visitors/tourist to the Cape and migrant workers from different regions in southern Africa and 
elsewhere in the case o f the mining industry. Reports by many reliable observers show that it is 
unlikely that tuberculosis occurred to any great extent among indigenous peoples o f South Africa but 
was rather established following the colonisation o f Africa by the European settlers and then
2 .4 .1 . H etero g en e ity  o f  iso la tes
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accelerated due to the rapid urbanisation that followed (Livingstone 1857). Thus colonisation and rapid 
urbanisation for purposes o f commence and trade introduced multiple sources of infection into 
southern Africa. In South Africa, black miners have traditionally been a migrant work force and are 
recruited from in areas with a high incidence of tuberculosis. It is likely that many of these miners 
acquired their tuberculosis infection from diverse sources with European origins.
2.4.2. Low copy number isolates
Seventy-five percent o f the 193 investigated isolates o f M. tuberculosis in the present study were found 
to carry 8 to 14 copies o f the IS6110 element, while the proportion o f isolates with a low (<5) copy 
number was 10.8%. This low figure is comparable with those o f other studies o f strains from a South 
African gold-mining group (11.5%)(Godfrey-Faussett, etal. 2000), Denmark (8.6%)( Yang etal. 1992) 
Tunisia(5.5%)(Hermans et al. 1995), from Cape Town, South Africa(5%)(Warren et al. 1996 and from 
Nambia,( 13% ) (Haas et al. 1999). The low patterns to clusters ratio showed that, compared with the 
higher copy number isolates, relatively more clusters were present in the low copy number group. 
This low heterogeneity index emphasises the need for secondary typing o f this group of isolates in 
order to identify unique patterns within the clusters. This was unfortunately not done in the present 
study (See section 2.2.2.10). Polymorphic GC- rich sequence (PGRS) and spoligotyping are favoured 
methods for such subtyping (Ross, et al. 1992; Kamerbeek et al. 1997).
In the present study, a single copy of IS6110 insertion sequence was observed for one isolate recovered 
from a 48-years old man who originated from Mount Frere, Eastern Cape in South Africa. Such strains 
are relatively rare and have previously been reported in India (Van Embden et al. 1993).
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The true magnitude o f an increased burden o f tuberculosis due to recent infection in the Freegold 
Health Region is probably greater than our estimate (28.0%-40.4%) provided in the present study. The 
incidence of tuberculosis in South African miners (approximately 1200/100 000 in 1994) is extremely 
high and substantially higher (approximately four fold) than that in the general population. The 
working and sleeping conditions in the mines are conducive to interhuman transmission of M. 
tuberculosis and one might expect a large number o f tuberculosis cases caused by relatively few 
strains circulating in a population with a high rate of recent transmission (high percentage of 
clustering). This situation would be equivalent to countries with a high endemicity of tuberculosis 
(Hermans, et al. 1995)
Although evidence of direct transmission could not be demonstrated conclusively in majority of cases 
in the present study, geographical links relating to patients whose isolates were in IBP or clone clusters 
make transmission plausible. Approximately 19% (14 out o f 75) o f all evaluable IBP-clustered cases, 
involving 14 miners with two clusters o f three miners and four clusters o f two each, occurred in two 
or more patients in the same mine shaft while 5 out o f 77(6.5%) IBP clusters cases originated from the 
same village, strongly suggesting recent transmission. The figures for sharing a mine or a geographic 
region were 48% and 62% respectively.
Transmission could have occurred in many different settings other than mine shafts, such as in 
hostels, dining halls, bars, etc. A limitation o f the present study is that interviews with relevant miners 
in clusters were not performed. Only limited information regarding possible linkage between cases was 
obtained from affected miners by the mine authorities and an attempt to establish such linkages through 
an appropriate questionnaire did not form part of this study. In a recent study in rural Kwazulu-Natal,
2 .4 .3 . E v id en ce  o f  r ecen t in fectio n
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43% of isolates from 246 patients were found to be in clusters, a figure which is very close to the 
40.2% of the present study (Wilkinson et al. 1997; Wilkinson 1999).). The authors also could not 
demonstrate direct epidemiological links between most o f these clustered cases, although patients with 
close or intimate contact, such as a relative, were more likely to be in clusters. They interpreted the 
presence o f clusters as evidence o f recent infection and the lack o f epidemiological linkage as 
transmission through casual and not prolonged or intimate contact (Wilkinson et al. 1997; Wilkinson 
1999). An alternative possibility is that M. tuberculosis strains with matching RFLP patterns may be 
epidemiologically related as a result o f transmission that occurred some time in the past, either 
directly or indirectly, and that the affected cases under the stressful conditions in the mines then 
coincidentally reactivated during the period of the investigation.
More relevant to the present findings is a study in another group of mines in South Africa which has 
been published recently (Godfrey-Faussett et al. 2000). These researchers found that 67% of isolates 
from 371 miners could be assigned to 62 clusters with identical fingerprint patterns. An estimated 50% 
of isolates were therefore putatively involved in recent transmission (62 source cases subtracted from 
total number o f isolates). The transmission rate amongst this group was higher than that found in the 
present study (50% vs 28%) and included all isolates for the duration o f the study (one year, 1995). 
Plausible explanations why transmission appeared to be less frequent in Freegold Health Region mines 
relate to the longer duration of the Godfrey-Faussett et al. study (one year as opposed to 6 months) and 
the incomplete complement o f isolates (± 50%) available in the present study. A six-month extension 
of the present study would have provided extra time for appreciably more cases to have preceded to 
overt disease following infection, allowing for more clusters to be formed, while the exclusion o f the 
21 out o f 193 isolates (10.8%) low copy number isolates would also have reduced the estimated
percentage of recent transmission.
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2.4.4.1. Two dominant RFLP families in the mines
The criterion selected for the definition o f a cluster in relation to recent transmission was the 
requirement o f 100% RFLP pattern matching. However, the results demonstrate a relatively high 
level o f relatedness among a large number o f different patterns. If banding patterns differing by one 
to three bands, as defined earlier, were considered to be phylogenetically linked, 82% of Freegold 
Health Region isolates fall into 23 families o f identical or nearly identical patterns.
Two dominate families o f genetically related strains, Family 1 and Family 2, were identified and 
harboured 50 and 24 isolates respectively. Isolates in these two families account for 38.3% of the total 
number o f isolates from the Freegold Health Region. Strains in each family share more than two-thirds 
of their IS6110-containing restriction fragments, suggesting that M. tuberculosis strains in these two 
RFLP family groupings might have descended from expanded clones generated either cyclically in the 
past and as a result o f recent spread. This interpretation assumes that horizontal transfer o f IS6110 or 
genes in M. tuberculosis does not play a dominant role in the evolution o f clones over time. 
Unfortunately, it is not yet possible to translate the RFLP IS6110 patterns in terms o f time that has 
passed since the branching of a common ancestral clone. To do that, it would be necessary to know the 
average pace o f the molecular clock o f IS6110, that is, its average transposition frequency (Small and 
van Embden 1994).
The nature o f the force (s) that contributed to the selection and dissemination o f strains of these two 
families is unknown. Patients from these two dominant RFLP families did not differ significantly in 
their demographic characteristics from patients whose isolates were in other families or patients who 
harboured individual strains. Cases within Family 1, members o f Family 2 and isolates in the
2 .4 .4 . E n d em ic ity  o f  M. tuberculosis  s tra in s , as ev id en ced  by  d o m in a n t R F L P  fa m ilies.
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heterogenous group were also equally distributed between HIV-seropositive and HIV-seronegative 
miners. This is in keeping with previous studies in Tanzania and Thailand (Yang et al. 1995) which 
could not demonstrate different patterns o f IS6110- associated RFLPs between strains from HIV­
positive patients and isolates infecting patients who did not contract HIV infection.
The recent spread of HIV in the Freegold Health Region mines at the time o f the present study was 
therefore unlikely to be the main driving force behind the expansion of the clones that became Family 
1 and Family 2. Although retreatment o f patients was shown to be associated with cluster formation 
in the present study and by Godfrey-Faussett et al. (2000) erratic treatment o f tuberculosis is also not 
likely to be an important factor in the spread of these families in the mines, as DOTS is applied 
consistently to all miners with tuberculosis. Duration o f employment in miners was also not shown to 
be significantly associated with these clusters.
A possible clue to the dominance o f these two RFLP families is their statistically significant 
association with the Freddies mine. Three miners with CL 1 isolates in FM 1 and two with CL 8 
isolates in FM 2 provide direct evidence o f recent transmission involving miners from this mine. These 
two clones were also the largest encountered in the mines and comprised eight and five isolates 
respectively. It is possible that both RFLP families have become dominant in the mines because of 
recent and possibly past outbreaks in the mines (as evidenced by FM 1 and FM 2 -related clusters in 
the Freddies mine and the largest clusters in the study belonging to these two families) rather than 
acquisition o f the strains elsewhere and the patients subsequently presenting with reactivation 
tuberculosis in the mines.
Possible properties o f these two families that may account for the propensity to spread, such as the
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ability to cause disease in BCG-vaccinated patients or tendency to be more infectious in causing 
pulmonary disease remain to be studied. Based on the findings reported by Valway et al. (1998) 
repudiated to some extent by Manca et al. (1999) and North et al. (1999), rates of growth of 
representatives of these families in the lungs o f an aerosol animal model or lung, spleen and liver 
counts in an intravenous model as well as those of Zhang et al. (1999) in human macrophages, may 
help to elucidate aspects o f the transmission and pathogenicity o f M. tuberculosis strains (see Chapter 
4). Studies to identify the genes and gene products could lead to the identification of virulence factors 
of the tubercle bacillus that are important for aggressive in vivo growth or the propensity for easy 
transmission of disease. This in turn, could lead to the development o f a subunit vaccine that targets 
a critical virulence factor. Furthermore, if  specific host factors which interact with virulence factors 
are identified, tests to identify persons at high risk for active disease could be developed, as was 
suggested by Bellamy et al. (1998) who linked variations in the NRAMP1 gene encoding the natural- 
resistance-associated macrophage protein 1 with susceptibility to tuberculosis in West Africans.
2.4.4.2. Generation of endemic strains
Figure 2.8 gives a diagrammatic illustration o f how over an extended period o f time a series of 
transmission episodes would result in clusters comprising strains from multiple sources from the past. 
Following primary infection o f contacts, mainly children, by the original clonal strain, reactivation of 
dormant bacilli may occur in a small proportion o f infected persons following different periods after 
primary infection. These cases could again infect a number o f persons following which similar cycles 
could occur as a result o f reactivation o f dormant cases. As can be seen from the diagram, cycled 
strains which belong to the same clone can be isolated at the same time, without any obvious or direct 
epidemiological link between them. When such a clone is introduced into a population, it may spread 
over a number o f generations and become established in a community. The many cycles described
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above, during which extensive multiplication o f strains would have occurred, would have provided 
ample opportunity for the introduction o f minor insertional changes of IS6110 into the chromosome 
of strains, resulting in RFLP families of near identical fingerprints.
Figure 2.S; Patterns of clonal spread of M. tu b ercu lo sis , in patients with reactivation tuberculosis following 
dormancy of longer than two years.
X= Reactivation with disease; X0, X,, Xj, etc. denote numbered cycles of reactivation 
P = Primary infection followed by dormancy which may end in reactivation 
= Progression of dormancy to reactivation 
| = A bar = number of persons infected 
'T  = Clusters observed at a specific period in time
a =About SO percent of infected individuals who develop clinical TB within two years after primary infection
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2.4.4.3. Reactivation tuberculosis and endemicity of tuberculosis
The frequency of reactivation o f dormant tuberculosis would affect the extent o f endemicity o f strains 
in the mine population. Conditions in the mining environment are likely to facilitate reactivation of 
dormant tuberculosis. Stress, both physical and emotional as well as viral infections which may 
suppress cell-mediated immunity could induce reactivation while the recognised effect o f silica dust 
and the common practice of migratory miners to return to the same mine could further augment the 
establishment o f the clones in the mines.
Stress, both physical and psychological has been shown to affect immunity to infection adversely. In 
a review article, Peterson et al. (1991) pointed out that considerable research had been carried out 
identifying a variety o f psychological stressors e.g. bereavement, academic pressure and loss of self­
esteem and their immunosuppressive effects through several immune-regulatory mediators and 
neuroendocrine hormones (Bonneau et al. 1990; Khansari et al. 1990). Several aetiologies have been 
shown to induce immune suppression, including respiratory and herpes viruses while several bacterial 
and parasitic infections have also been incriminated (Peterson, et al 1991).
Specific examples o f viral disease which include influenza A virus and respiratory syncytial viral 
infections have been shown to suppress cell-mediated immunity (Roberts et al. 1986; Preston et al. 
1992) and the basis for such effects has been reviewed by McChesney and Oldstone (1987). Another 
example is the well documented immuno-suppressive effect o f measles virus in patients with 
tuberculosis (Kempe and Fulginiti 1995; Smithwick and Berkovich 1966).
Animal experiments in mice and rats have shown that both physical (forced exercise) and 
psychological stress (crowding) suppress immunity to tuberculosis, leading to increased mortality due
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to this organism (Tobach et al. 1956; Kreis et al. 1965)
2.4.4.4. Endemicity of dominant strains and interpretation of DNA fingerprinting
Evidence in keeping with the concept o f the establishment of dominant RFLP families/clones was 
provided by studies involving Ethiopia and Tunisia where tuberculosis is highly prevalent and 
relatively few RFLP-families were found, compared with a much larger percentage of unique strains 
in the Netherlands where the incidence o f tuberculosis is low (Hermans et al. 1995).
RFLP analysis to identify patterns o f tuberculosis transmission within a community is based on the 
premise that epidemiologically unrelated cases will have occurred as a result o f reactivation of dormant 
infection and thus have unique RFLP patterns, whereas cases that are linked as a consequence of recent 
infection will have the same patterns (i.e. appear in defined clusters). As mentioned in the introduction 
of this chapter, in poor countries where tuberculosis is highly endemic, clusters may be formed by 
repeated cycles o f transmission and may not necessarily indicate recent infection (Godfrey-Fausset, 
1999; Hermans et al. 1995). Godfrey-Faussett implied in his commentary in the Lancet (1999) that 
the validity o f linking clustering to recent infection in highly endemic regions would be strengthened 
by “much mobility o f population”. The fact that miners are recruited from many diverse regions is 
therefore likely to improve the predictive value o f linking IBP clusters to recent infection. Utilisation 
of migratory labour at the EOH is decreasing but still applies to a large number of miners employed 
by the mines. There are, however, factors inherent to the mining environment and to the labour 
management o f mines which could promote the establishment of “endemic strains” reflected by RFLP- 
based families, including IBP strains within families, and thus reduce strain diversity. Such factors 
include the practice o f migratory miners from defined rural communities returning to the same mines 
where they worked before, often for periods from 18 months or longer (G. J. Churchyard, personal
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communication). Furthermore, mining conditions which promote reactivation of dormant cases would 
lead to an increased “infectious pool” and thus favour further transmission. Such cycling of miners 
with dormant or overt tuberculosis to create a common infectious pool would facilitate the 
establishment o f endemic strains in mines.
The degree to which this process is operating in mines is uncertain but on balance it appears likely that 
many and probably the majority o f cases in an IBP /clone cluster would represent recent infection, 
while near identical strains defined as RFLP families would more likely give an indication of the extent 
to which endemic strains have become established. It is however, possible that some near identical 
isolates within a RFLP-family could be linked to recent infection as minor changes as a result of 
transposition may be encountered in outbreaks (Cave et al. 1994 Chevrel-Dellagi et al. 1993; Daley 
et al. 1993; Das et al. 1993; Hermans et al. 1990; Mazurek et al. 1991; Small et al. 1993; and 
Takahashi et al. 1993). The high percentage o f isolates in Family 1 (73.9%) and Family 2 (70%) of 
miners sharing a shaft (Table 2.5) provides epidemiological evidence that this could have been the 
case in the present study. Furthermore, the finding that 35 out o f 74 isolates (47.3%) o f RFLP- family 
1 and RFLP -family 2 incorporated ten clone clusters (2 to 8 isolates per cluster), provides convincing 
evidence of recent transmission involving endemic strains (clone-based clusters within predominant 
RFLP-families).
2.4.5. Risk factors of recent transmission
2.4.5.I. Recent transmission in the Free State and Eastern Cape mining recruits.
Univariant analysis o f the findings o f the present study suggests that being a patient from Free State 
region was associated with clustering involving clones. The reason for this is not clear. Analysis of 
isolates from Free State reveals that 13 isolates among Free State miners showed RFLP patterns
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identical to one or more isolates and were grouped into 5 clusters (4,3,2,2,2 per cluster respectively)
Miners from the Free State whose isolates were in clusters were distributed evenly in the mines (5 from 
Freddies, 2 from W Holding, 3 from Pres Brand, 3 from Pres Steyn, 2 from FSG and 1 from FSS 
mine) and none could be linked to a mine shaft. Furthermore patients in clusters originated from 
different villages or towns and only two miners in one cluster could be linked to a specific village or 
town. The lack o f evidence linking clustering to work place and or geographical region is consistent 
with reactivation o f endemic strains, but may also be due to casual contact between patients.
A possible explanation for the relatively high percentage of clusters in mine recruits from the Free 
State, may relate to the proximity of those recruits to the mines which have a much higher prevalence 
of tuberculosis than the rural recruiting areas. The Free State recruits are therefore more likely to be 
exposed to infectious (sputum-positive) persons in the immediate mining environment than their 
counterparts from distant regions.
The same reasoning may explain the relative fewer clusters in mine recruits from the Eastern Cape who 
are less exposed to the high prevalence mining environment. They may recently or over time, have 
acquired a greater variety o f strains in their region where tuberculosis is also very common. 
Reactivation o f their dormant tuberculosis o f diverse origin, while in the mines, will result in greater 
heterogeneity o f strains with less evidence of cluster formation.
2.4.5.2. Retreatment of patients as a risk of recent transmission
The most important risk factor found to be important for clustering in multiple logistic regression 
model in this study was retreatment episode. Retreatment patients in the present study include those
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who failed treatment as well as reinfection after a successful treatment episode. Patients on retreatment 
schedules remain culture positive for prolonged periods, even when their isolates remain susceptible 
to antituberculosis drugs, and therefore pose a considerable risk to contacts. Control measures should 
be introduced to reduce transmission originating from this group which has been identified as a high 
risk in this and other studies (Godfrey-Fausset et al. 2000).
2.4.5.3. HIV infection and recent transmission
According to the literature, increased clustering o f isolates from patients who rapidly progress from 
infection to active disease as a consequence of HIV infection can be expected ( Beck-Sague et al. 
1992; Daley et al. 1992; Small et al. 1994). Based on multiple logistic regression analysis, isolates 
from HIV- infected patients in the present study are estimated to be about twice more likely to be in 
clusters than HIV-seronegative patients, although it is likely that the limited data from the present study 
did not allow statistical significance at the 5% level. At 16.6%, the prevalence o f HIV infection in 
miners with tuberculosis was found to be relatively low in the Freegold Health Region mines during 
1994 study period. Since then, the rate o f HIV infection in miners at these mines increased 
dramatically to 45% in patients with tuberculosis in 1996, while the incidence o f tuberculosis in the 
mines increased to 2476/100 000 in 1996 (Churchyard et al. 1999). Based on experience elsewhere, 
it is likely that HIV infection and AIDS would, in time have a major impact on the transmission of 
tuberculosis in Freegold Health Region miners.
2.4.6. Usefulness of DNA fingerprinting for monitoring of control programme
Molecular typing methods have proved to be powerful tools in the investigation o f important aspects 
of the activity o f M. tuberculosis in a population. Linked to understanding aspects the pathogenesis of 
the disease, such as the differentiation between reactivation from dormant infection and recent
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transmission (Daley et al. 1992), molecular techniques have been used in specific situations to 
determine the relative frequency of recent infection in a community (Small et al. 1994). Studies 
utilising such methods also complemented our understanding of environmental and social factors that 
influence tuberculosis transmission which could have a bearing on the design of improved 
tuberculosis control strategies, i.e., the identification and modification o f settings that foster spread 
of the disease. Once different strategies are undertaken to control transmission, the monitoring of 
the efficacy of tuberculosis control programme can be accomplished with ongoing RFLP-based typing 
of isolates. This can be achieved by the early identification of micro-epidemics and by noting 
increasing or declining trends in cluster formation, especially in relation to larger clusters such as 
cluster 1 and cluster 3 o f the present study. An increasing trend would denote the likelihood of a 
deficient control programme while a decrease in cluster formation over time would reflect favourably 
on the programme. In a broader context, prospective fingerprinting of isolates in longitudinal studies 
could give a more accurate picture o f transmission patterns involving endemic strains ( IBP clusters 
within larger RFLP -families) as opposed to transmission of strains from diverse sources (IBP-clusters 
outside RFLP families).
Ongoing DNA fingerprinting o f isolates may also be useful in individual miners with tuberculosis, 
where consecutive isolates with the same fingerprint showing a change to resistance to a single 
antituberculosis agent would confirm the occurrence of acquired drug resistance. This may be seen 
when treatment failures occur or in cases with relapse. Primary drug resistance could be assumed if the 
initial isolate from a patient is already resistant to one or more drugs. If, however, such a strain forms 
part of an existing IBP cluster in the mine, recent transmission most likely occurred. Such findings 
could also provide evidence of an impending outbreak involving an MDR strain as was seen in MDR 
outbreaks in the USA (Hewlett et al. 1993; Campbell et al. 1993; Valway et al. 1994). These cases
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would constitute reinfection with primary drug-resistant strains.
2.4.7. Dominant RFLP families in the mines
The criterion selected for the definition of a cluster in relation to recent transmission was the 
requirement o f 100% RFLP pattern matching. However, the results demonstrate a relatively high 
level o f relatedness among a large number o f different patterns. If banding patterns differing by one 
to three bands, as defined earlier, were considered to be phylogenetically linked, 82% of Freegold 
Health Region isolates fall into 23 families of identical or nearly identical patterns.
Two dominate families o f genetically related strains, Family 1 and Family 2, were identified and 
harboured 50 and 24 isolates respectively. Isolates in these two families account for 38.3% of the total 
number o f isolates from the Freegold Health Region. Strains in each family share more than two-thirds 
o f their IS6110-containing restriction fragments, suggesting that M. tuberculosis strains in these two 
RFLP family groupings might have descended from expanded clones generated either cyclically in the 
past or as a result o f recent spread. This interpretation assumes that IS6110 or genes are not 
horizontally transferred in M. tuberculosis. Unfortunately, it is not yet possible to translate the RFLP 
IS6110 patterns in terms o f time that has passed since the branching o f a common ancestral clone. To 
do that, it would be necessary to know the average pace o f the molecular clock o f IS6110, that is, its 
average transposition frequency (Small and van Embden 1994).
The finding that a high percentage of isolates in Family 1 (78%) and Family 2 (70%) of miners sharing 
a mine shaft provides good epidemiological evidence that some near identical isolates within a RFLP- 
family could be linked to recent infection. Although, IS6110 fingerprint patterns were stable after 
multiple passages o f M. tuberculosis strains in guinea pigs for two months, and in macrophage and
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liquid culture for six months, this element is potentially capable o f transposition, duplication and 
excision within the genome. Sequential isolates can yield one or more additional bands in chronic 
excretors (Cave et al. 1994; Das et al. 1993) and during outbreaks o f tuberculosis (Chevrel-Dellagi 
et al. 1993; Daley et al. 1993; Mazurek et al. 1991; Small et al. 1993; and Takahashi et al. 1993).
In the present study, clustered isolates comprising identical band patterns were more common among 
members of the dominant Family 1. The largest cluster of 8 isolates (Table 2.2) was found among this 
group of strains. This phenomenon o f clusters within family may be interpreted as evidence that the 
members within each cluster in a family had some selective advantage. However, this might also be 
an artefact created during the expansion of a clone into RFLP family which may, as a matter of course, 
also contain identical strains (i.e., IBP clusters).
The nature o f the force (s) that contributed to the selection and dissemination o f strains o f these two 
families is unknown. Patients from these two dominant RFLP families did not differ significantly in 
their demographic characteristics from patients whose isolates were in other families or patients who 
harboured individual strains. Cases within Family 1, members o f Family 2 and isolates in the 
heterogenous group were equally distributed between HIV-seropositive and HIV-seronegative miners. 
This is in keeping with previous studies in Tanzania and Thailand (Yang et al. 1995) which could not 
demonstrate different patterns of IS6110- associated RFLPs between strains from HIV-positive 
patients and isolates infecting patients who did not contract HIV infection.
The recent spread o f HIV in the Freegold Health Region mines at the time o f the present study was 
therefore unlikely to be the main driving force behind the expansion o f the clones that became Family 
1 and Family 2. Although retreatment o f patients was shown to be associated with cluster formation
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in the present study and by Godfrey-Faussett et al. (2000) erractic treatment o f tuberculosis is also not 
likely to be an important factor in the spread o f these families in the mines, as DOTS is applied 
consistently to all miners with tuberculosis. Duration o f employment in miners was also not shown to 
be significantly associated with these clusters.
A possible clue to the dominance o f these two RFLP families is their statistically significant 
association with the Freddies mine. Three miners with CL 1 isolates within FM 1 and 2 with CL 8 
isolates in FM 2 provide direct evidence o f recent transmission involving miners from this mine. These 
two clones were also the largest encountered in the mines and comprised 8 and 5 isolates respectively. 
It is possible that both RFLP families have become dominant in the mines because of recent and 
possibly past outbreaks in the mines (as evidenced by FM 1 and FM 2 -related clusters in the Freddies 
mine and the largest clusters in the study belonging to these two families) rather than acquisition of the 
strains elsewhere and the patients subsequently presenting with reactivation tuberculosis in the mines.
Possible properties o f these two families that may account for the propensity to spread, such as the 
ability to cause disease in BCG-vaccinated patients or tendency to be more infectious in causing 
pulmonary disease remain to be studied. Based on the findings reported by Valway et al. (1998) 
repudiated to some extent by Manca et al. (1999) and North et al. (1999), rates of growth of 
representatives o f these families in the lungs o f an aerosol animal model or lung, spleen and liver 
counts in an intravenous model as well as those of Zhang et al. (1999) in human macrophages, may 
help to elucidate aspects of the transmission and pathogenicity o f M. tuberculosis strains (see Chapter 
4). Studies to identify the genes and gene products could lead to the identification o f virulence factors 
of the tubercle bacillus that are important for aggressive in vivo growth or the propensity for easy 
transmission of disease. This in turn, could lead to the development o f a subunit vaccine that targets
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a critical virulence factor. Furthermore, if specific host factors which interact with virulence factors 
are identified, tests to identify persons at high risk for active disease could be developed, as was 
suggested by Bellamy et al. (1998) who linked variations in the NRAMP1 gene encoding the natural- 
resistance-associated macrophage protein 1 with susceptibility to tuberculosis in West Africans.
2.4.7. Strains isolated from HIV-seropositive patients
The pathogenesis o f HIV-related tuberculosis involves primary or secondary exogenous infection and 
reactivation o f previously acquired dormant bacteria in highly susceptible HIV-infected individuals. 
Patients that are being infected simultaneously by HIV and M. tuberculosis are likely to experience 
an accelerated progression to overt tuberculosis. A large proportion (61.9%) o f isolates from HIV- 
seropositive patients in this study belonged to RFLP clusters based on full identity. The results are 
consistent with recent data from New York City, showing that 57% of new tuberculosis cases in HIV- 
seropositive patients were due to recent transmission (Alland et al. 1994). Although, recent 
transmission was high among HIV-seropositive individuals in the present study, the prevalence of 
HIV (13.4%) at the time o f the study was found to be relatively low in the Freegold Health Region 
mines. In the absence o f evidence that HIV co-infection played a prominent role in accelerating the 
escalation o f tuberculosis in miners in 1994, it may be postulated that factors promoting transmission 
in the mine environment (silica dust, overcrowding and the type o f ventilation) interacting with sources 
of the organism (mainly cases with cavitary tuberculosis), facilitated the generation of a pool of 
infective aerosols, and, that once miners became infected, stress-related factors (Petersen et al. 1991) 
and/or frequent viral and other infections ( McChesney and Goldstone, 1987) including infection with 
HIV, could have suppressed cell-mediated immunity, leading to a shorter period between infection and 
development o f active tuberculosis. Since 1994, however, the rate o f HIV infections in miners at 
Freegold Health Region mines increased dramatically to 45% in patients with tuberculosis in 1996,
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while the incidence o f tuberculosis in this mines increased to 2476/100 000 in 1996 (Churchyard et al. 
1999). The contribution o f HIV infection and AIDS to this recent escalating in the transmission of 
tuberculosis in Freegold Health Region miners has not been clearly documented but it may have been 
considerable.
By comparing the RFLP patterns o f HIV-related M. tuberculosis with the RFLP patterns of non-HIV- 
related isolates, it was found that the DNA fingerprints exhibited similar polymorphism in the two 
groups. Fourteen IBP clusters were shared by two or more isolates in the HIV-positive patients and 
eleven in the HIV-seronegative groups. This difference was not statistically significantly (P= 0.08). 
Yang et al. (1995), reported an similar risk o f infection with a defined M. tuberculosis clone for HIV- 
seropositive and HIV-seronegative individuals.
It might be expected that HIV-related tuberculosis could also be associated with low-virulent clones 
of mycobacteria which would be able to infect immunocompromised hosts. However, from the present 
study no indication was found that particular clones of M. tuberculosis were predominant in cases of 
HIV-related tuberculosis.
2.4.9. Limitations of the study
The current study has several limitations which have been discussed earlier in various sections of this 
chapter. Two major failings however, require emphasis. First, only approximately 50% of all patients 
hospitalised at EOH with culture-proven tuberculosis during 1994 were included in the present study.
Apart from the fact that the lower number o f cases available for analysis could have affected the 
number o f clusters in the mining community at the time, the low number also reduced the power of 
statistical analyses. Second, a six months’ survey will underestimate recent transmission. Because
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RFLP analysis can only be used to analyse microbiologically-confirmed cases, persons who became 
infected but whose infection remained dormant during the six months o f the study cannot be identified. 
As the high-risk period for developing tuberculosis is considered to be approximately 2 years after 
acquisition o f infection, a period o f at least 2 years would be required for optimal evaluation of the 
rate of transmission. In populations with active transmission, the proportion o f clustered isolates 
increases when the period is longer than six months, as demonstrated previously in a French Polynesia 
population (Torrea et al. 1995).
Another important limitation was the failure to perform secondary DNA typing on low copy number 
isolates, in order to identify subclusters or eliminate ‘false clusters’ o f apparently identical isolates. 
Furthermore, the lack o f detailed information based on patient interviews using an appropriate 
questionnaire which could have identified additional risk factors.
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3. THE POPULATION STRUCTURE OF DRUG-RESISTANT MYCOBACTERIUM  
TUBERCULOSIS ISOLATES IN RELATION TO RECENT TRANSMISSION AND PRIMARY 
AND ACQUIRED DRUG RESISTANCE
3.1. Introduction
The introduction o f effective chemotherapy in the 1960's and subsequent advances in the use of drug 
combinations made tuberculosis a curable disease, while intermittent therapy on an outpatient basis 
and more recently the success o f directly observed therapy short course (DOTS) constitute progress 
in the successful management o f tuberculosis. Despite this potentially favourable situation, the 
incidence o f tuberculosis in South Africa is increasing, and a most disturbing aspect of the problem 
is the emergence o f multidrug-resistant (MDR) tuberculosis caused by strains resistant to both 
isoniazid and rifampicin, which poses a threat to individual patients(prolonged, toxic and expensive 
treatment with poor cure rates) to communities and to control programme efforts (World Health 
Organisation 1997). With the incipient HIV/AIDS explosion in South Africa, extensive spread of drug 
resistance as encountered in outbreaks in the USA (Hewlett et al. 1993; Campbell et al. 1993; Valway 
etal. 1994) could occurred in the South African mines and could make tuberculosis extremely difficult 
to control. It is therefore both timely and appropriate to reappraise the problem o f drug resistance in 
order to learn more about the source o f infection and delineate outbreaks due to these resistant strains.
It is currently accepted, on the basis o f concepts formulated during the pre-HIV era, that drug resistance 
in patients with tuberculosis can take on two forms. Firstly, acquired drug resistance occurs as a result 
of treatment which is poorly conceived or poorly adhered to, allowing the emergence o f naturally 
occurring drug-resistant mutants causing clinical disease (Lipsitch and Levin 1998; Mitchison 1998)
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The second situation arises when a resistant strain from a patient with pulmonary tuberculosis 
subsequently infect and cause disease in another individual who may or may not have been previously 
infected with M. tuberculosis. This results in the occurrence of primary drug resistance, i.e. the strains 
infecting patients are already drug-resistant at the time of infection. Small et al. (1993) demonstrated 
through the RFLP analysis o f M. tuberculosis isolates that primary drug- resistant tuberculosis can 
result from exogenous reinfection with a new multidrug- resistant strain o f M. tuberculosis during or 
after therapy for an episode o f drug-resistant tuberculosis due to another drug-resistant strain. If 
infection with an MDR strain involves a patient under treatment for disease caused by another strain, 
the process has been referred as superinfection.
The relationship between clustering, strain diversity and drug susceptibility patterns may be used to 
examine recently transmitted drug-resistant strains between miners or drug resistance acquired during 
treatment. Clonal dissemination o f recently transmitted drug-resistant isolates i.e. primary drug- 
resistant strains, will exhibit identical or near identical RFLP profiles and limited RFLP diversity 
among drug-resistant strains in a population. Resistant strains that have become endemic in mines 
over a prolonged period may also contribute to such limited clonal diversity. Acquired drug resistance, 
arising from inadequate treatment o f individual patients, on the other hand, will tend to be associated 
with a high proportion o f strains with unique RFLP patterns. Recent findings by Van Rie et al.{2000) 
however, have suggested that acquired drug resistance may include in addition to patients infected 
with strains whose resistance was truly acquired during treatment, also patients who were initially 
infected with or reinfected with a drug-resistant strain.
The two main objectives o f the investigations reported in this chapter are:
• To determine by molecular typing, using IS6110-based RFLP, the population structure o f drug- 
resistant M. tuberculosis isolates in the Freegold Health Region mines during two periods of
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1994 and 1995-1977
To determine the by molecular typing the distribution and patterns o f recent transmission of 
such strains in the Freegold Health Region mines and to relate these to the drug resistance 
status (acquired or primary drug resistance) of patients’ isolates.
An assessment o f risk factors involved in the transmission o f MDR isolates was also attempted but the 
small number o f MDR cases available for analysis, especially during the 1994 investigation militated 
against reliable findings. A risk factor analysis involving the 1995-1997 study period is however, 
included in this chapter.
3.2. Materials and methods
3.2.1. Strains
a) A total of 19 isolates from patients admitted to EOH from 1 January to 30 June 1994 which showed 
resistance to one or more antimycobacterial drugs were included for study. The isolates formed part 
of a group of 193 isolates from patients who constituted about 50% of all confirmed tuberculosis 
patients hospitalised during the study period.
b) An additional 26 MDR cultures were isolated from the same hospital during 1995-1997 and 
submitted to the National Tuberculosis Research Program (NTBRP) bank of MDR strains. All viable 
cultures o f M. tuberculosis isolated at EOH and submitted to the SAIMR laboratories as well as 
isolates from this hospital submitted directly to the SAIMR during this period were tested for 
susceptibility to antituberculosis drugs at the SAIMR and all isolates found to be MDR were sent to 
NTBRP bank for long-term storage and for references purposes. These 26 isolates were used in the
present study.
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The incidence o f and factors associated with drug-resistant tuberculosis in the mines involved in the 
present study featured in recent publication by Churchyard et al. 2000. In this publication the authors 
indicated that 83.1 % of cultures obtained from patients during the period 1994 to 1997 were submitted 
for drug susceptibility testing to at least INH and RMP (Churchyard et al. 2000).
3.2.2. Methodology and definitions
The 19 isolates from the 1994 were charcaterised by DNA fingerprinting as described in Chapter 2 
while the additional 26 MDR isolates from the NTBRP bank were similarly typed following the same 
approaches used on the 1994 isolates. All fingerprint profiles were analysed using Gelcompare 
software for the presence o f clusters o f identical and closely related strains (see Chapter 2.2.).
In patients who had not previously received antituberculous drugs (listed as new cases), bacterial 
resistance was assumed to be probably primary. In patients with a record of previous treatment) listed 
as retreatment cases), the bacterial resistance was classified as probably acquired.
Multidrug-resistant tuberculosis was defined as resistance to at least isoniazid and rifampicin while 
single-drug resistance or mono resistance denoted resistance to only one antituberculous agent.
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3.3. Results
3.3.1. Population structure of drug-resistant M. tuberculosis isolates during 1994
Drug-resistant M. tuberculosis cases were analysed by the standard DNA fingerprinting method with 
IS6110 as genetic probe. The generated IS6110 fingerprint patterns were highly variable among these 
isolates. The number o f 1S6110 copies per isolate varied from 4 to 17. The majority (94.7%) contained 
6 or more copies. Eighteen distinct patterns among 19 drug-resistant isolates were identified (Figure
3.1. )
3.3.1.1. Drug resistance profiles of 1994 isolates
All 19 isolates were resistant to INH and of these 12 were mono-resistant. O f all the isolates resistant 
to more than one drug, three complied with the definition o f MDRfresistant to both INH and RMP). 
One o f these MDR isolates was in addition resistant to ethambutol (EMB) and another to streptomycin 
(SM). The other four isolates, apart from being resistant to INH, were also resistant to streptomycin 
and ethambutol (one isolate), or in addition resistant to streptomycin (two isolates) or apart from INH 
resistance also resistant to EMB (one isolate) (Table 3.1.)
3.3.1.2. Acquired and primary drug resistance in 1994 isolates.
Listing of patients on admission regarding their treatment history as “New” or “Retreatment” is given 
in Table 3.1 and Table 3.2. It was assumed that in the case o f retreatment patients, resistance would 
most likely be acquired, while new (previously untreated) cases were categorised as primary drug
resistance.
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3.3.1.3. Geographical distribution of drug-resistant isolates of 1994
Geographical data o f the patients with drug-resistant tuberculosis isolated during 1994 study period 
are shown in Table 3.1. Seven were from Eastern Cape , 5 from Lesotho, 3 from the Free State, 1 from 
Gauteng and 2 from Mozambique. Information on the mines where the patient worked was available 
for 18 patients. One worked in FSG, 2 in FSS, 2 in Freddies, 4 in Pres Brand, 4 in Pres Steyn and 
3 in the W Holdings mine ( Table 3.1 and Table 3.2)
Table 3.1. Characteristics of 19 drug -resistant M. tuberculosis strains isolated during 1994 study period
Strain Episode type INH RM P SM EM B Cluster Family H IV  status Mine/shaft Place of origin
58901 New + + CL 1 FM 1 Negative W.Holding 05 Free State
58863 Retreatment + C L 6 FM  1 Negative Pres Steyn 04 Eastern Cape
71146 New + FM 1 Positive Pres Steyn 04 Eastern Cape
64580 NA + FM 1 Negative Pres Brand 04 Lesotho
55451 New + FM  1 Negative FSG 01 Eastern Cape
53715 New + C L 8 FM 2 Negative W  Holdings 05 Eastern Cape
53620 Retreatment + FM  2 Negative Pres Steyn 04 Lesotho
58003 (M D R) Retreatment + + + FM  2 Negative Pres Brand 03 Eastern Cape
53718 NA + C L 11 FM 3 Negative NA NA
57216 New + FM  3 Negative Pres Stein 04 Gauteng
53716 (M D R) New + + FM  3 Negative Freddies 07 Free State
60526 NA + + FM  4 Negative FSS02 Eastern Cape
53276 New + + + C L 13 FM  5 Negative Freddies 09 Mozambique
72821 New + CL 16 FM 7 Positive Pres Brand 02 Free State
66853 Retreatment + C L 16 FM 7 Negative W  Holdings 05 Mozambique
65138 New + FM 8 Negative Pres Steyn 01 Lesotho
64582 (M D R) Retreatment + + + FM  9 Negative Pres Brand 05 Eastern Cape
69225 NA + + C L 18 FM 10 Negative FSS 02 Lesotho
70309 New + CL 24 FM  23 Negative FSS 03 Lesotho
Abbreviations: INH: Isoniazid; RMP: Rif'ampicin: SM: Streptomycin: EM B: Ethambutol; ETH: Ethionomide; CL: Clusters based on 100% identical; FM  : Families; NA : Information not available 
The shaded areas comprise isolates belonging to four RF I.P  families including one cluster. C L 16; M DR multidrug-resistant
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Table 3.2. Distribution o f 19 drug-resistant M. tuberculosis isolates during 1994 study period 
according to treatment history
Characteristic Treatment history Retreatment cases New cases
Not available(NA) Acquired drug Primary drug
(n=4) resistance resistance
(n=5) (n=10)
Unique RFLP 2 1 3
Miners in 8 clusters(9) 2 2 5
RFLP family size>3(11) 2 3 6
HIV-seropositive(2) 0 0 2
Lesotho(5) 2 1 2
Eastern Cape(7) 1 3 3
Free State(3) 0 0 3
FSS(3) 2 0 1
FSG(l) 0 0 1
Freddies (2) 0 0 2
Pres Steyn (5) 0 2 3
President brand (4) 1 2 1
W.Holdings(3) 0 1 2
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Figure 3.1. RFLP patterns of 19 drug- resistant M. tubercu losis isolated during 1994 study period
100
94
3.3.1.4. RFLP-based evidence compatible with recent transmission involving primary and 
acquired drug-resistant isolates
Computer-assisted analysis o f the fingerprints revealed a single clone (two isolates) based on identical 
RFLP band patterns among drug-resistant isolates. The interesting sequence o f transmission events 
involving clone 16 where the most likely scenario suggests transmission from a patient with acquired 
drug resistance(patient 66853) to an HIV-seropositive patient with no previous treatment history 
(patient 72821) is presented in detail in section 3.3.1.5 o f this chapter.
A total o f four RFLP families comprising identical or near identical strains corresponding to the 
RFLP-based families o f drug-susceptible isolates were identified (Familiesl, 2, 3 and 7) (Table 3.1. 
and Table 3.3.). Amongst the four RFLP families there were eight clones which shared drug- 
susceptibility isolates with resistant isolates. One of these clones, (CL 16), contained two drug-resistant 
isolate, in addition to three drug-susceptible isolates (Table 2.5 and Table 3.1).
Ten possible transmission linkages based on genetic relatedness and, in addition, on identical 
resistance profiles, historic time o f isolation o f strains and treatment history could be established (Table 
3.3). O f the seven involved possible transmission to patients categorised clinically as primary drug- 
resistant. Only two patients in Family 1 were working in the same mine shaft (Pres Steyn 04) (Table
3.1.). These miners both came from the Eastern Cape but from different towns.
If one assumes, based on the findings o f Van Rie et al. (2000) that recent transmission may evolve 
strains that on clinical grounds, are categorised as acquired drug resistance (retreatment cases), then 
an additional 12 transmission linkages between isolates with identical resistance profiles are possible, 
9 from primary drug-resistant strains to acquired drug-resistant strains and 3 between acquired drug-
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resistant isolates ( see data in Table 3.1)
Three MDR tuberculosis isolates, available for RFLP typing from the Freegold Health Region in the 
1994 study period, exhibited different IS6110 DNA fingerprint patterns, and therefore failed to show 
direct evidence o f spread o f MDR tuberculosis during 1994. Two patients with MDR-tuberculosis 
reported previous treatment o f tuberculosis i.e. probably acquired resistance while the third was a new 
case (presumably primary resistance).
Eight RFLP patterns among drug-resistant strains were in clones shared by drug susceptible strains 
(Table 3.1.). As indicated earlier, only in clone CL 16 were more than one drug-resistant isolate 
represented. The two drug-resistant isolates in CL 16 were from patients working in the President 
Brand and Western Holdings mines respectively. Five CL 16 isolates were found in these two mines, 
three in President Brand, two of which being drug susceptible and two in the Western Holdings mine 
(one susceptible)( Table 2.5 and Table 3.1).
3.3.1.5. HIV status, resistant category and recent transmission
Two patients, both with isolates mono-resistant to INH, were HIV seropositive. Their isolates were 
both in the primary drug-resistant category. From Table 3.1 and Table 3.3 it can be seen that one of 
these, patient No 71146, shared the President Steyn mine 04 shaft with patient No 58863 whose 
resistance was listed as being acquired. Both isolates belonged to RFLP family 1, the latter belonged 
to clone 6. These two isolates were closely related; isolate 58863 has an additional low molecular band 
fragment, while isolate 71146 has one additional band that had a somewhat larger molecular weight. 
The band positions o f all the other fragments between the two isolates were identical (Figure 
3.1).Chronologically patient 58863's isolate preceded that of patient 71146. Although both patients
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came from the Eastern Cape, their towns o f domicile (Butterworth and Bizana) are about 230 km 
distant from each other. The evidence as presented above suggests that the HIV-seropositive patient 
71146 (primary drug-resistant, strain isolated later than isolate 58863) may have acquired his infection 
from patient 58863, who, because o f his retreatment/acquired drug resistance status, was probably 
sputum culture positive for a prolonged period (Retreatment of patients in this study was shown to be 
a statistically significant risk factor for recent transmission). The possibility is that patient 71146 
acquired his infection from another unidentified source cannot however be excluded.
More convincing evidence o f having been involved in recent transmission is presented by the second 
HIV-seropositive patient, patient No 72821 (Table 3.1). This patient’s isolate was in the same clone (CL 
16) as that o f patient 66853 who suffered from acquired INH resistance. The latter culture was isolated 
before that from patient 72821. The likely sequence o f events involving these two patients was that 
patient 66853 acquired INH resistance during therapy and transmitted his resistant clone to patient 
72821, who because o f his HIV-seropositive and compromised immune status presented clinically 
early, within the six-month period o f the study.
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Table 3.3. Possible linkages between drug-resistant isolates from 1994, based on treatment history
Linkage candidates Clone RFLP family Resistance profile 
(HRES)a
Treatment history 
New(P)b Retreated (A)c
Type of linkages'1
66853 16 7 H A A-P
72821 16 7 H P
55451 _e 1 H P.
58863 6 1 H A P,-P2; (P,-P3)f;
64580 - 1 H NA8 A-NA8; A-P„
71146 - 1 H P2 NA8-P2; (P3-NA)f
58901 1 1 HS P3 P,-NAg
53620 _ 2 H A, A,-P
53715 8 2 H P
58003 - 2 HRS A2
53716 _ 3 HR P, NAg-P2
53718 11 3 H NA8
57216 “ 3 H P,
a HRE or S resistant to isoniazid, rifampicin, ethambutol or streptomycin respectively 
b New case, not previously treated, presumed primary drug resistance, designated P, P, or P2
c Retreatment case: history of previous treatment episode/s, presumed acquired drug resistance, designated A, A, or A-, 
d Possible linkages based on genetic relatedness and in addition, identical resistance profile, historic time of isolation o f strains and 
treatment history
e Dash indicates that the linkage candidate strain was not a member of a clone 
f Linkages in brackets indicates unlikely transmission as resistance profile are not identical 
g NA=Information on treatment history not available.
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3.3.2. Population structure of MDR-tuberculosis isolates during the 1995-1997 study period
3.3.2.1. Drug resistance profiles of MDR isolates
All 26 isolates fitted the definition o f MDR (resistant to both INH and RM PfOne of these MDR 
isolates was in addition resistant to EMB and another to SM.
3.3.2.2. Geographical distribution of MDR isolates.
Forty-eight percent o f 23 patients with MDR tuberculosis come from Lesotho and 40% from Eastern 
Cape. The patients worked in four different mines (Table 3.4).
3.3.2.3. Primary and acquired drug resistance in MDR isolates
The majority of patients (20/25) received antituberculosis treatment prior to the diagnosis of MDR-TB 
and could therefore have been examples o f acquired drug resistance. Five did not receive prior 
treatment and were therefore classified as having primary drug resistance (Table 3.4). Information 
related to MDR isolates available from National Tuberculosis Research Programme indicated that in 
sixteen patients with acquired MDR-TB, the strain responsible for the first episode was found to be
sensitive to all drugs while in four patients the strain was initially resistant to INH only. As susceptible 
isolates from patients who subsequently expectorated MDR strains, were not DNA fingerprinted, it is 
possible that some o f the MDR patients acquired MDR strains through suppression o f their susceptible 
strains followed by reinfection or supeinfection with MDR strains as happened in several outbreaks 
involving MDR tuberculosis (Hewlett et al. 1993; Campbell et al. 1993; Valway et al. 1994). Based 
on available DNA fingerprinting evidence , eight isolates in four clusters provide definitive evidence 
of recent transmission. Some of the twenty isolates belonging to seven families could also possibly 
have been involved in recent transmission. Two presumed primary drug-resistant cases (387/97 
and472/96) are likely candidates while seventeen o f the nineteen isolates in RFLP families on which 
treatment history
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was available were categorised as presumably acquired drug resistance and some of these may have 
been involved in reinfection or superinfection (Table 3.4). Table 3.5 presents examples of possible 
transmission episodes among presumed acquired drug-resistant cases.
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Figure 3.2. Dendrogram showing relationship between MDR-tuberculosis isolated during 1995-1997 study period
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Table 3.4. Characteristics of 26 MDR M. tuberculosis strains isolated during 1995-1997 study period
Strain Episode type INH RMP SM EMB Cluster HIV status Family Mine/shaft Place of origin Period in mine in years
167/96 Retreatment + + c l  r Negative FM lh Freddies 05 Lesotho 16
401/97 Retreatment + + CL 3 Negative FM 1 Pres Steyn 05 Eastern Cape 26
473/96 Retreatment + + Negative FM 1 W Holdings 02 Eastern Cape 30
478/96 Retreatment + + Positive FM 1 Pres Steyn 01 Eastern Cape 7
524/96 Retreatment + + + Positive FM 1 Freddies 07 Eastern Cape NA
566/95 Retreatment + + Negative FM 5* NA NA NA
198/97 New + + Negative FM 1 Pres Steyn 03 NA NA
708/96 Retreatment + + Negative FM 5 NA NA NA
460/96 Retreatment + + CL 25 Negative FM 20* W holding 06 Lesotho NA
44/97 Retreatment + + CL 25 Negative FM 20 FSS 03 Lesotho 16
176/96 Retreatment + + CL 23' Negative FM 20 W Holdings 03 Eastern Cape 31
465/96 Retreatment + + CL 23 Negative FM 20 FSS 03 Lesotho 10
558/95 Retreatment - + CL 26 Positive FM 25 FSS 03 Natal 8
387/97 New + + CL 26 Negative FM 25 Pres Steyn 04 Lesotho 11
472/96 New + Negative FM 26 W Holdings 03 Lesotho 27
711/96 Retreatment + + Negative FM 26 W Holdings 03 Lesotho 17
709/95 Retreatment + + + Negative FM 27 Pres Stein 04 Lesotho NA
403/97 Retreatment + + Positive FM 27 W Holdings Free State 8
326/96 Retreatment + + Negative FM 28 FSS 03 Lesotho 20
469/96 Retreatment + + Negative FM 28 W Holdings Free State 8
142/96 Retreatment + + Negative Unique Pres Steyn 04 Eastern Cape 15
182/96 Retreatment + + Negative Unique Pres Steyn 05 Lesotho 22
647/97 Retreatment + + Positive Unique Pres Steyn 04 Eastern Cape 25
46/97 New + + Negative Unique Pres Steyn 07 Eastern Cape 28
530/96' Retreatment + + Positive Unique W Holdings Lesotho 15
554/95 New + + Negative Unique Pres Stein 03 Eastern Cape NA
Abbreviations INH Isoniazid. RMP rifampicin, SM streptomycin. EN1B Ethambutol. ETH Ethionomide. CL Clusters based on I00°o identical. FM Families, NA : Information not available
a) Cluster 3 and cluster 23 were also represented among the 1994 isolates
b) Family I, Family 5 and Family 20 were also represented among the 1994 isolates and FM I &FM 5 also included drug-resistant strains
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3.3.2.4. RFLP-based evidence compatible with recent transmission amongst primary and 
acquired drug-resistant isolates.
Sixteen IS6110 banding patterns were identified in 26 strains suggesting that the emergence o f MDR- 
tuberculosis in the mines have occurred in multiple clones.
Computer analysis of IS6110 DNA fingerprint patterns showed that eight out o f 26 patients (30.8%) 
patients were infected with M. tuberculosis strains belonging to one o f four clones (two isolates each 
in CL 3, CL 23, CL 25 and CL 26) and 18 (69.2%) were not. Clone 3 and clone 23 were also 
represented among the 1994 isolates. Taking into account the time o f isolation o f an isolate and its 
treatment history, eleven examples o f likely transmission amongst the eight patients represented in the 
four clones can be envisaged (Table 3.5)
Several strains showed common bands and near identical RFLP patterns and were assigned to seven 
families, such that all members of each family were identical or differed by one to three bands. Twelve 
isolates were found in three o f the seven families ( RFLP families 1, 5 and 20 respectively), and these 
families were already encountered in 1994 study. Drug-resistant isolates from the latter study were also 
represented in RFLP family 1 and RFLP family 5. The four families not observed in 1994 study (RFLP 
families 25-28; Table 3.3), were considered to be unique and were presumably introduced more 
recently in the mine. Families of strains with identical or nearly identical patterns varied in size from 
two to five, but most groups consisted o f pairs o f isolates.
Possible linkages between MDR isolates from 1995-1997 study, based on genetic relatedness and in
addition, identical resistance profile, historic time of isolation of strains and treatment history are
shown in Table 3.5
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The two miners in CL 25 were from Mafateng in Lesotho but were working in different mines. No 
other geographical links between transmission candidates could be established.
When RFLP families together with clones were considered to provide evidence o f genetic homology 
which could form the basis for transmission 5 likely transmission episodes within clones and 22 
possible episodes within families transmission could be identified (Table 3.5)
3.3.2.5. HIV status, resistance category and recent transmission
Twenty- four percent (six isolates) o f MDR tuberculosis patients were known to be infected with HIV. 
One HIV- seropositive patient (Patient 558/95) shared a clone with an HIV-seronegative patient 
(387/97). Chronologically the isolate o f patient 558/95 preceded that o f patient 387/97, suggesting 
that the HIV-positive patient 558/95 (retreatment, acquired drug-resistance) had infected patient 
387/979 (primary drug resistant). However, the two patients come from different regions and work in 
different mines. Further evidence o f possible recent transmission is presented by the second HIV­
positive patient, patient No 403/97. The isolate o f this patient and that o f patient 709/95 were both in 
the same RFLP family (FM 27). The isolate from the latter patient was in addition to INH and RMP 
also resistant to SM. Transmission was therefore only possible if this isolate lost its SM resistance 
(unlikely) or if  the discrepancy in resistance profile between the two isolates was due to a laboratory
error.
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Table 3.5. Possible linkages between M D R  isolates from 1995-1997
Linkages candidates Clone RFLP family Resistance profile Treatment history Type of linkages'1
(URLS) New (P)h 
Retreated (A)c
167/96 3 1 HR A, A, -» A,c
401/97 3 1 HR a 2
176/96 23 20 HR A, A, —* A,465/96 23 20 HR a2
460/96 25 20 HR A,
44/97 25 20 HR a2 __ t-±2
558/95 26 25 HR A A —► P
387/97 26 25 HR P
167/96 3 1 H R A, A, * A,c; A, * A,:
401/97 3 1 H R a 2 A, - *  A4: A, —* A,:
473/96 - 1 HR a 3 A;- * A3: A,—* A4:
478/96 - 1 HR A, A2 A,; A, -+ A4;
524/96 - 1 H R E A, A3 * A^ i A4 * A^
566/95
708/96 _
5
5
HR
HR
NA,
n a 2 NA, —* NA2
176/96
460/90
465/96
44/97
23
25
23
25
20
20
20
20
HR
HR
HR
HR
A,
a 2
A,
a4
A, -> A,c: A, —* A,c: 
A, —* A,c; A, —* A,c: 
A, —* A,‘: A,-* A,:c
709/95 _ 27 H RS A,
403/97 - 27 HR a 2
326/96 . 28 HR A, A| A2469/96 28 HR a 2
a HRE or S resistant to isoniazid, rifampicin, ethambutol or streptomycin respectively 
b New case, not previously treated, presumed primary drug resistance, designated P
c Retreatment case, history of previous treatment episode/s, presumed acquired drug resistance, designated A, A,, A- or A4
d Possible linkages based on genetic relatedness and in addition, identical resistance profile, historic time of isolation of strains and treatment history 
e Underlined linkages involve clones with identical RFLP band patterns 
f  Dash indicates that the linkage candidate strain was not a member of a clone
105
3.3.3. Assessment of risk factors associated with MDR tuberculosis
No difference in age, history o f prior treatment for tuberculosis, period in the mine and HIV- M. 
tuberculosis coinfection was observed between clustered patients and patients infected with individual 
strains. These data are shown in Table 3.6.
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Table 3.6. Univariate analysis o f risk factors for a patient with multi-drug resistant tuberculosis to belong to a tuberculosis transmission group based 
on clustering involving clones
Characteristic No. of patients Odds 95%
Convidence
Interval
P value
Clustered Nonclustered
Ratio
M IN E
FSG
FSS 3 2 4.80 0.44-61.15 0.15
Freddies 1 2 1.07 0.0-23.96 1
Pres Brand
Pres Steyn 2 7 061 0.05-5.17 1
W  Holdings 2 4 1.56 0.100-17.38 1
P L A C E  OF O R IG IN
Eastern Cape 2 8 0,61 0.05-5.17 0.6
Free State 0 2 0 0.00-11.55 1
Lesotho 5 7 3.06 0.40-25.93 0.39
Natal 1 0 0 Undefined 0.32
Swaziland
Mozambique
H IV  Seropositive 1 5 0.34 0.01-4.24 0.62
Retreatment 6 14 092 0.10-12 95 1
New 1 4 1,56 0.01-10.4 1
Period in the mine
1-9 years 1 1 2.29 0.03-190.42 1
10-19 4 7 1.43 0.19-10 62 1
20-29 1 4 0.49 0 01-6.21 1
30-39 1 2 1.07 0.02-23.93 1
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3.4.1. Relationship between drug resistance and RFLP types
In accordance with previous reports in the literature, drug-resistant isolates were shown to share 
cluster/s with isolate/s that were susceptible to a particular drug. These data are consistent with 
observations o f van Soolingen et al. (1991), Godfrey-Faussett et al. (1993), and Chevrel-Dellagie et 
al. (1993) who showed that after in vivo selection of drug resistance by M. tuberculosis, the DNA 
fingerprint patterns did not change.
Conversion o f antibiotic susceptibility to antibiotic resistance in M. tuberculosis strains is due to 
selection o f spontaneous mutants during noncompliance with chemotherapy. Resistance to INH has 
been associated mainly with mutations in two genetic markers: the katG gene, encoding a catalase- 
peroxidase, or the inhA gene which encodes a mycolic acid biosynthesis enzyme (Banerjee et al. 1994; 
Rouse and Morris, 1995; Zhang et al. 1992). Mutations in genes encoding the ribosomal S I2 protein 
(rpsl) and 16S rRNA (rrsj have been detected in most streptomycin-resistant strains of the tubercle 
bacillus (Finken et al. 1993; Nair et al. 1993; Honore and Cole 1994). Reduced sensitivity to 
rifampicin has been correlated with perturbations in the B subunit of RNA polymerase (Telenti et al.
1993). Missence mutations in pen A, a gene encoding pyrazinamidase/nicotinamidase, cause resistance 
to the anti-tuberculosis drug pyrazinamide. Such mutations would not be expected to change the 
fingerprint pattern, especially if they were point mutations, unless they accomplish this by introducing, 
depending on the chromosomal positions, a new Pvu \ 1 restriction site close to an IS6110 sequence. 
A deletion or insertion may be associated with a change in band position.
3.4.2. Incidence of drug resistance
Resistance to anti-tuberculosis drugs can develop during the treatment o f initial or subsequent episodes
3 .4 . D iscu ssio n
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of tuberculosis providing an example of acquired drug resistance. Resistant strains may also be 
transmitted to patients not previously infected with M. tuberculosis, resulting in primary drug 
resistance or to previously infected individuals, constituting reinfection with drug-resistant strains of 
M. tuberculosis. Exogenous reinfection with multidrug-resistant M. tuberculosis may occur either 
during therapy o f the original infection or after therapy has been completed (Small et al. 1993). In the 
1994 study, resistance to one or more anti-tuberculosis drugs was found in 9.9% of the tested isolates. 
Isolates resistant to both INH and RMP accounted for 1.6% of the total number o f isolates involved 
in the study. The prevalence o f drug-resistant M. tuberculosis in the present study is relatively low and 
is similar to earlier reports on drug-resistance in the South African gold mines (Cowie 1990) and in 
patients in the Western Cape (Weyer et al. 1995). More detailed information on drug resistance in the 
EOH mining community during the period July 1993 to June 1997 has been provided in a recent 
publication by Churchyard et al. (2000). During this period 2241 miners had culture-positive 
tuberculosis and 7.3% and 14.3% of the isolates exhibited primary and acquired resistance to INH 
respectively. Patients with retreatment pulmonary tuberculosis were significantly more likely to have 
tuberculosis with organism resistant to any drug or MDR( odds ratio 9.82, 95% Cl 2.97-33.5 and 
18.74,95% Cl 1.76-475 respectively). In this study, HIV infection was not significantly associated with 
primary or acquired drug resistance and there was no trend o f increasing resistance over time. The 
overall 8.8%(85 out o f 2095) incidence o f INH resistance was, as explained, similar to the present 
figure o f 9.8% (19 out o f 193) from the much smaller sample size study of 1994. The incidence of 
MDR isolates in the Churchyard et al. (2000) study was 1.1% (23 out o f 2095) o f which 0.67% were 
primary and 0.42% acquired drug resistance. The MDR incidence in the present study was 1.55% (3 
out o f 193).
Analysis o f MDR cases shows that during the July 1993 to June 1997 period o f the Churchyard et al.
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(2000) study, 23 MDR cases were identified while during the slightly shorter 1995-1997 study period 
o f the present investigation, 26 MDR cases featured. This apparent discrepancy was explained by Dr 
Churchyard (personal communication) who indicated that those patients with MDR tuberculosis who 
received repeated treatment courses over a prolonged period of time and who were identified as MDR 
cases prior to the study period were excluded from their study. Several MDR cases in the present study 
received multiple courses o f treatment, some of which pre-dating 1995.
3.4.3. Clonal diversity of isolates
Both isoniazid and multidrug-resistant strains showed great diversity in banding patterns. The 19 drug- 
resistant isolates analysed in 1994 reveal eighteen patterns while the 26 MDR strains isolated in a 
1995-1997 study period exhibited sixteen IS6110 banding patterns.
Clonal diversity o f drug-resistant M. tuberculosis has also been reported in San Francisco where 
resistance was relatively uncommon and occurred primarily in elderly immigrants (Small et al. 1994). 
This was in contrast with low genetic heterogeneity o f M. tuberculosis strains reported in New York, 
where drug resistance was shown to be most common in relatively young HIV-infected persons whose 
immune status and social behaviour facilitated transmission of such clones (Moss et al. 1997).
The results of the present study show that there were at least five (CL 16, CL 3, CL 23, CL 25 and 
CL 26 ) drug-resistant M. tuberculosis clones present in the mines. In two o f these (CL 3 and CL 23) 
isolates o f four and six patients respectively constituted these clones. Altogether twelve likely 
transmission episodes (one in 1994 and eleven during 1995-1997 involving these clones could be 
identified. Acquired drug resistance, arising from inadequate treatment of individual patients, will 
potentially give rise to a high proportion o f unique RFLP patterns among a pool o f drug-resistant
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strains and could reflect the degree of strain diversity in the study population. It is likely that a 
significant number o f drug-resistant strains could have arisen from inadequate treatment in the mine 
setting. Eighty percent o f all MDR-TB patients received antituberculosis treatment prior to the 
diagnosis o f MDR-TB. This high proportion of presumed acquired drug resistant occurred in the 
context of directly observed therapy (DOT) that is practised meticulously at EOH (Dr Churchyard, 
personal communication). Smear-positive patients are initially hospitalised, after which they report 
every weekday to the primary health-care facilities, where DOT is administered and recorded. 
Treatment consists o f two months of isoniazid, rifampicin, pyrazinamide, and ethambutol, followed 
by 4 months o f isoniazid and rifampicin. All patients, regardless of a history of previous tuberculosis 
treatment, received the same regimen except for those infected with MDR strains, who were treated 
according to their drug sensitivity results, which were available within 3 to 6 weeks.
Despite evidence of recent transmission (see 3. 4. 4.), it is possible that some drug-resistant, including 
MDR strains, may have acquired part or their full complement o f resistance in the past, outside the 
mining fraternity and then appeared in the mines following reactivation o f their initial drug-resistant 
infection. Many workers in the gold mines are migrant labourers who are recruited from areas where 
high frequencies of initial drug resistance have been reported, including the Eastern Cape (Kleeberg 
and Olivier 1984; Fourie et al. 1980) and Lesotho (Fourie and Knoetze 1986). These men could be 
expected to develop reactivation tuberculosis with rurally-acquired drug-resistant strains thus 
contributing towards strain diversity.
The dominant Family 1 pattern o f closely related strains described in the 1994 study period constituted 
25% of all MDR-tuberculosis isolates in the 1995-1997 study. This family therefore could be typical 
of M. tuberculosis strains circulating in the mines after becoming endemic in this environment over
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a relatively short period. On analysis o f the band patterns o f Family 1 strains, the isolates showed 
similar profiles, being either identical or differing only by one to three bands, suggesting that they may 
have shared a common ancestor that had undergone clonal expansion. Band differences in RFLP 
families may be due to the ability o f IS6110 to transpose to other sites in the chromosome, giving rise 
to the changes noted in strains within families. Such changes may occur during transmission of bacilli 
between patients (Chevrel-Dellagi et al. 1993; Daley et al. 1993; Mazurek et al. 1991; Small et al. 
1993; and Takahashi et al. 1993).
In a recent study in Cape Town, community-acquired transmission of an MDR strain labelled U was 
documented (Van Rie et al. 1999). This strain showed great RFLP similarity with the W (961-0874) 
strain responsible for an MDR outbreak in New York City (Frieden et al. 1996). The authors also 
studied mutations which led to resistance to anti-tuberculosis drugs and showed that the mutation 
conferring resistance to streptomycin in strain U(rrs 573) was different to that in strain W (rpsL43) and 
inferred from this that these two genomically-related strains arose independently in two different 
geographical locations in two very different patients groups (the Cape Town patients were HIV 
seronegative and acquired their strain in the community while the New York patients were 
predominately HIV seropositive and their strain was either nosocomically or institutionally acquired). 
These findings suggest that the W-like genomic family is prone to the development o f mutations 
conferring drug resistance. Direct comparison of the RFLP fingerprints o f drug-resistant isolates in the 
present study with those o f W or U strains failed to show close similarity.
3.4.4. Evidence of transmission
Despite great diversity of the RFLP patterns, one clone of two isolates and an additional three clones 
in RFLP families (representing 5, 3, 3 isolates) were identified among drug-resistant isolates in the
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1994 study. One likely casual transmission linkage in CL 16 and an additional possible five linkages 
amongst the RFLP family clusters were identified. Among the 26 MDR-tuberculosis patients whose 
M. tuberculosis strains were submitted for RFLP in 1995-1997 study period, 30.8% of isolates fitted 
into three clones, and 73% into six RFLP families o f identical or nearly identical band patterns. Eleven 
clone-related and a possible 22 RFLP family-related transmission linkages were suggested by the 
available information (Table 3.4)
Convincing evidence o f having been involved in recent transmission of an MDR strain two isolates 
in clone-based cluster is presented by the HIV-seropositive patient, patient No 72821 as set out in 
Section 3.2.1.5. Statistical analysis o f the small number o f HIV-seropositive patients, however, failed 
to show that HIV infection is significantly linked with clustering. In a larger study involving 448 South 
African miners with tuberculosis and a close to 50% HIV infection rate, Godfrey-Faussett et al. (2000) 
also found that HIV infection was not significantly associated with clustering. This is in contrast to the 
findings in outbreak situation in the USA were HIV infection was shown to be a risk factor (Daley et 
al. 1992; Beck-Saque et al. 1992). Interestingly, Mallory et al. (2000) found in the same mining 
population as the present study, covering the period 1 April 1993 to 31 July 1996 that HIV-seropositive 
patients had a significantly higher recurrence rates o f tuberculosis episodes than HIV seronegative 
patients (8.2 vs 2.2 per 100 persons-years) with a multivariate-adjusted incidence rate ratio of 4.9 and 
a 95% confidence interval o f 3.0 to 8.1. They also found that recurrence rate was significantly higher 
in patients receiving three antituberculosis drugs (INH, RMP and PZA) compared with the four-drug 
regimen which included EMB in addition to the other three drugs. Some of the “recurrences" 
encountered in the study may well have been as a result o f reinfection or superinfection with drug-
resistant strains.
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The present study presents clear evidence o f considerable transmission o f drug-resistant strains 
(isolates within clones), especially amongst MDR isolates during 1995-1997 period. Churchyard el al. 
(2000) also in the same mining population, but comprising large study group, showed that patients with 
retreatment tuberculosis were significantly more likely to have drug-resistant tuberculosis. This is not 
surprising as retreatment patients harbour viable bacilli for prolonged periods, providing opportunities 
for not only the emergence o f drug-resistant mutants, but also for transmission o f M. tuberculosis, 
including drug-resistant strains.
Although information on the workplace with one possible exception, involving Family 1 isolates from 
2 patients sharing a mine shaft (in the Pres Steyn mine shaft 04), failed to reveal a link between the 
members o f a clone or family, it is most likely that more undetected transmissions occurred within 
and around the mine environment. It is general practice that all persons recruited to the mines are 
screened for tuberculosis and other diseases and are putatively free o f tuberculosis. It is therefore 
likely that stress conditions in the mine may lead to reactivation o f dormant drug-resistant bacilli in 
some infected persons who acquired tuberculosis outside the mining fraternity. Such cases could 
again infect a number o f persons in a mine, resulting in clustering o f drug-resistant strains. The link 
established by labour practices in South Africa between rural regions and specific mines to which 
miners may return several times in a life time, may have helped to establish clones in a mine and in this 
way contributed towards diminished clonal diversity. Similar situations have been reported in regions 
where tuberculosis is highly endemic, e.g., Ethiopia, Tunisia and French Polynesia (Hermans el al. 
1995).
Although statistically significant evidence implicating drug resistance as a risk factor for transmission 
was lacking, transmission o f drug-resistant strains may eventually contribute substantially to the
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escalation o f drug resistance problems. Selective pressures inherent to antimicrobial therapy could 
further augment the process and result in further increases in drug-resistant tuberculosis in the mines.
The evidence o f microepidemics o f MDR-tuberculosis reported in the present study underscores the 
need for more resources to be committed to a) cohort separation o f new cases on treatment for the first 
two weeks, ideally until smear microscopy shows marked reduction in acid-fast bacilli or preferably 
when it is completely negative; b) suspected or known cases o f MDR, as well as patients requiring 
retreatment including drug failures and recurrent cases should be isolated from smear-positive patients 
on treatment for drug-susceptible tuberculosis: c) use o f rapid diagnostic tests for detection o f drug 
resistance; d) revise treatment policies especially with regard to retreatment cases. At least two drugs 
to which isolates are susceptible should be administered in combination to the patient; e) ensure that 
drugs are taken correctly, especially during intensive treatment phase (Churchyard et al. 2000).
3.4.5. Primary and acquired drug resistance in the mines
In 1994 study, a higher proportion of cases o f primary resistant tuberculosis (mainly mono-resistant 
strains) than o f acquired resistant tuberculosis was recorded by clinical definition. The use o f RFLP 
analysis o f these isolates showed only one IBP/clone cluster comprising two isolates. The low rate of 
transmission o f singly resistant strains may be related to the fact that patients infected with these 
strains, in contrast with to those infected with MDR organisms, are not infectious for long periods 
because the initial phase o f a standard treatment regimen will provide at least two drugs to which the 
bacterium is sensitive.
Twenty out o f 25 MDR (80%) in 1995-1997 study were retreatment (acquired drug resistance) cases. 
This finding accords with those o f surveillance studies worldwide (Pabloz et al. 1997; Cohn et al.
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1997).
Although the isolates associated with retreatment could be related to treatment failures and therefore 
be regarded as examples o f acquired drug resistance, they may also be due to reinfection with drug- 
resistant strains(Van Rie et al.2000). Eight MDR cases were found to be in 4 clusters of 2 isolates 
each. The clusters seen in this group of patients strongly suggest recent transmission of drug -resistant 
strains in patients receiving treatment for drug-susceptible tuberculosis. Such treatment would afford 
a selective advantage to MDR strains and could cause outbreaks as was seen in the USA (Hewlett et 
al. 1993; Campbell et al. 1993; Valway et al. 1994). These findings contrast with the generally 
accepted idea that multidrug-resistant tuberculosis occurs only exceptionally in new cases but mainly 
in chronic cases, as a consequence o f sequential selection o f drug-resistant mutant o f M. tuberculosis 
organism (Crofton et al. 1996). Recently Van Rie et al. (2000) recorded a similar experience where 
they found in a highly tuberculosis endemic population in Cape Town, clusters containing drug- 
resistant M. tuberculosis cases. Some o f these would have been classified as acquired drug resistance 
based on their treatment history.
3.4.6. Risk factors
Because of small numbers, it was not possible to properly assess retreatment of patients as a risk factor 
for drug-resistant tuberculosis. However, in a study comprising a much larger group o f patients, from 
the EOH mining population, patients who failed primary antituberculosis treatment, were found to be 
significantly associated with drug-resistant tuberculosis by Churchyard et al. (2000). This is not 
surprising, as retreatment cases are more likely to have harboured large numbers o f tubercle bacilli for 
prolonged periods, providing opportunities to select for drug-resistant mutants during retreatment 
episodes. As shown in Chapter 2, the present study did show that retreatment o f patients was
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significantly associated with the risk o f transmission of M. tuberculosis strains. Although this finding 
applied to predominantly drug-susceptible strains, it is likely that it would also hold for drug-resistant 
strains, which could, as was the case for as the susceptible strains, be expectorated for prolonged 
periods by retreatment patients. As mentioned earlier, Godfrey-Faussett et al. (2000) also found 
retreatment of tuberculosis patients to be a significant risk factor for transmission of tuberculosis.
A possible role for HIV infection as a risk factor for transmission in the present study could also not 
be established and the small numbers available for analysis again compromised statistical evaluation. 
With the escalation number of HIV/AIDS in South Africa and in the mines, it can be anticipated that 
more infectious tuberculosis cases will be hospitalised or attend HIV/AIDS clinics and also meet at 
social or sporting gatherings where opportunities for transmission are favourable, resulting in an 
increase in MDR tuberculosis will increase. As some cases will be on anti-tuberculosis treatment, 
selection of resistant clones will be facilitated and may spread to contacts who are being treated for 
tuberculosis, creating conditions favourable for the selective transmission of MDR strains. Furthermore, 
the shorter period between infection and active disease in immunocompromised HIV-positive patients 
could lead to a rapidly increasing the infectious pool of M  tuberculosis strains and in this way promote 
the spread o f MDR strains.
A factor which was not studied in the present study nor assessed as a risk factor for acquisition of drug 
resistance in other reports in the literature, but which may be important in this country in future is 
possible interference with pharmacokinetics of anti-mycobacterial drugs by anti-retroviral agents used 
in the treatment o f HIV-disease (Garcia et al. 1997). Rifampicin is an essential component of the 
recommended regimen for tuberculosis. The protease inhibitors used for treatment of HIV-disease 
increase the serum levels o f the rifabutins (rifampin and rifabutin) and thus increase the risk for toxicity.
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Rifampicin, through the induction o f the hepatic cytochrome p450, increases the metabolism of protease 
inhibitors and thus decrease serum concentrations-often to subtherapeutic levels.
3.4.7. Concluding remarks
In this chapter the author recorded a relatively low incidence o f drug resistance in M. tuberculosis in 
the EOH mining population (9.9.%). The majority o f resistant isolates were mono-resistant to INH. 
while 1.6% of isolates during 1994 were resistant to both INH and RMP (MDR strains). The majority 
o f INH mono-resistant isolates were categorised as primary drug-resistant, while 80% of MDR isolates 
during 1995-1997 were retreatment cases and therefore presumed to be examples o f acquired drug 
resistance.
The high proportion o f drug-resistant isolates involving ten patients during 1994 suggest a high rate of 
recent transmission but only one small clone-based cluster was found. However, based on RFLP family 
clusters, seven possible transmission linkages could be demonstrated. Although there is strong evidence 
of predominantly acquired drug resistance amongst MDR strains o fM  tuberculosis in miners, reflecting 
poor treatment outcome despite strictly administered DOTS, there is also convincing evidence of 
transmission of drug-resistant strains. Evidence o f recent transmission was based on both clustering 
( four clones involving 13 isolates during 1994 and clones involving MDR isolates during 1995-1997) 
and the demonstration o f six possible linkages in retreatment MDR cases, strongly suggest that some 
of the patients acquired their MDR strains through reinfection or superinfection.
The presence o f dominant RFLP families o f drug-resistant isolates in the mines (73% of MDR isolates 
could be linked to six RFLP families) suggest that, over time, many episodes o f transmission involving 
these strains occurred , leading to their establishment as endemic strains in the mines.
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Although a significant impact o f HIV infection on the prevalent o f drug resistance, including MDR, 
could not be demonstrated in the present study, Mallory et al. (2000) found that HIV infection amongst 
the same miners was significantly associated with recurrence o f tuberculosis which in turn were 
dependent on whether a three-drug or four-drug regimen was used for treatment. In the light of the 
present findings, identifying several clone-based clusters amongst drug-resistant strains, it is suggested 
that some o f the recurrences were due to recent transmission resulting in reinfection or superinfection.
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4. VIRULENCE STUDIES ON STRAINS OF MYCOBACTERIUM TUBERCULOSIS FROM 
THE DOMINANT RFLP FAMILY
4.1. Introduction
Advances in the molecular biology o f mycobacteria have provided new tools that facilitate more 
definitive studies o f the virulence o f M. tuberculosis. The molecular epidemiology approach of DNA 
fingerprinting based on restriction fragment length polymorphism (RFLP), has made it possible to 
identify specific isolates o f M. tuberculosis involved in outbreaks o f disease (Alland et al. 1995; 
Daley et al. 1992; Small et al. 1993, 1994). In some outbreaks, the transmission of M. tuberculosis 
was limited, whereas in others, high rates o f transmission occurred. V ariability in transmission has been 
attributed to the environment in which outbreaks occur, including the ability o f strains to resist 
dessication, and the clinical characteristics o f source patients. Some investigators reported that strains 
involved in such outbreaks may be especially virulent by showing increased growth rates in infected 
mouse lungs (Valway et al. 1998) or enhanced capacity to grow in macrophages (Zhang et al. 1999).
Despite extensive research, we still understand poorly the capacity o f the human immune response to 
eliminate M. tuberculosis and the virulence mechanisms by which the organism evades host defences. 
These two aspects o f the pathogenesis o f infection converge at the level o f the mononuclear phagocyte- 
M. tuberculosis interaction. Following activation by lymphocytes, mononuclear phagocytes serve as 
the final effectors in the killing o f tubercle bacilli in the intracellular environment of human blood 
monocytes and tissue macrophages (Fenton and Vermeulen 1996). Nevertheless, the organisms can 
survive, and even thrive, in these host phagocytes.
Virulence may be defined as the capacity o f a microorganism to overcome host defences. The mouse
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and the guinea pig have become favoured animals for studying the virulence o f mycobacteria. In mice, 
virulent strains o f M. tuberculosis grow aggressively in the lungs o f immunocompetent animals 
producing sustained pulmonary pathology, whereas avirulent strains show only limited growth (North 
and Izzo 1993; Pierce et al. 1953). These observations are independent o f the route of infection used 
in the experimental model. In the guinea pig model, on the other hand, following challenge by the 
intramuscular route, virulence is associated with the capacity of the organism to disseminate from the 
site of infection (Dunn and North 1995). Virulence may also be defined in terms of the extent to which 
an M. tuberculosis strain is able to cause lung pathology in a given period o f time (Manca et al. 1999; 
Mitchison et al. 1960, 1963) or be measured in terms o f host survival in mouse experiments (Dunn and 
North 1995).
Numerous attempts have been made to investigate virulence by in vitro studies (Silver et al. 1998; 
Zhang et al. 1998,1999). In such experiments, the virulence o f strains has usually been correlated with 
their behaviour inside phagocytes. This is because M. tuberculosis is a facultative intracellular pathogen 
and its fate within mononuclear phagocytes is an important factor in determining the outcome of 
infection. It is therefore reasonable to suppose that any characteristic enabling the bacterium to survive 
within the phagocytes will contribute to virulence.
The research recorded in this chapter represents a pilot study to determine in an animal model, possible 
differences in virulence between three MDR strains within the highly prevalent Family 1 isolates, 
between themselves, as well as compared with an international control H37Rv strain which has 
previously been shown to be fully virulent in animal studies (Manca et al. 1999; Ordway et al. 1995).
As, for reasons o f economy, only a limited number o f strains could be tested for virulence, MDR
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isolates from the present study which were incriminated as probably having caused micro-epidemics 
in miners (Chapter 3) were thought to be appropriate test strains. These strains form part of a collection 
of MDR cultures in a registry o f the National Tuberculosis Research Programme (NTRP) of the South 
African Medical Research Council and are available to researchers in South Africa and elsewhere. 
Limited but important information on the treatment history o f patients and laboratory data on isolates 
is available from the NTRP registry of MDR isolates. Three isolates on which such good information 
was available were chosen ffor virulence studies.
The demonstration o f differences in virulence amongst the three Family 1 MDR strains, which are 
genetically closely related, could form the basis of molecular studies on virulence determinants in these 
strains in the future.
Excluded from the present pilot study, but a high priority for the future would be an extension of 
animal studies to include virulence testing o f other appropriate candidate strains such as the expanded 
clone 3 within Family 1
4.2. Materials and Methods
4.2.1. M. tuberculosis cultures
Three clinical isolates belonging to the RFLP Family 1 designated MDR 473(15 IS6110 copies), 
MDR 478 (12 IS6110 copies), and MDR 524 (14 IS6110 copies) as well as H37Rv were studied. 
Although the three Family 1 strains harboured 12 to 15 IS6110 copy numbers, the band patterns were 
very similar and the three strains share eleven bands in the same positions. Twelve bands are shared by 
strains MDR 473 and MDR 524 and one o f these is not present in MDR 478. In addition MDR 473 
exhibits two prominent bands not present in MDR 478 and MDR 524 while MDR 524 shows unique
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band not seen in MDR 473 or MDR478 (Figure 3.2). M. tuberculosis stock cultures for virulence 
testing were grown in broth (Middlebrook 7H9; Difco, Detroit) enriched with 5% albumin-dextrose 
catalase (ADC) additive and 0.05% Tween 80 for 8-10 days at 37°C and stored at -70°C in lml 
ampules until required. The viability o f frozen suspensions was determined by slowly thawing 
randomly selected ampules, followed by sonication for 5s in water bath sonicator to break up any 
clumped bacilli. Serial 10- fold dilutions were then performed by plate counts o f colony forming units 
(CFUs) on agar (Middlebrook 7H11; Difco). The plates were incubated at 37°C in sealed plastic bags 
for 3-4 weeks when the colonies could be counted.
4.2.2. Catalase testing
The presence o f catalase was determined by observation o f the ability of several loopfuls of an 
M. tuberculosis culture suspended in 0.5 ml phosphate buffer to to produce oxygen(bubbles) within 
20 minutes after the addition o f 0.5 ml o f reagent consisting o f an equal volume of 30% hydrogen 
peroxide and 10% Tween 80 (Witebsky and Kruczak-Filipov 1996). The test was performed without 
heating at 68 °C, a step which is used for the identification o f Mycobacterium species.
4.2.3. Experimental animals
Inbred specific pathogen-free BALB/c female mice, 6-8 weeks old, were obtained from South African 
Vaccine Producers, Sandringham, Johannesburg. Twenty mice were used for the assessment of the 
virulence o f the strains tested: 12 mice for the determination of growth rates/organism loads in lungs 
of intravenously challenged animals, while survival time after challenge was assessed in 8 mice.
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4.2.4. Survival times
Mice were infected intravenously in the lateral tail vein at a dose o f 105- 106 colony forming units 
(CFU) of a bacterial suspension in 0.1 ml saline. The concentration o f organisms in the infective dose 
was determined in terms of CFU/ml. Mass measurements were taken daily to assess morbidity. 
Mortality was monitored for up to fifteen weeks after which surviving mice were euthanased by means 
o f cervical vertebra dislocation in order to remove organs for autopsy investigation including histology 
for evidence o f tuberculosis.
4.2.5. Determination of growth rates of M. tuberculosis strains in mouse organs
BALB/c mice were infected intravenously with 105 -KFCFU of each selected strain. The lungs and 
spleen were removed aseptically from 3 randomly selected mice at each of 10 day, 20 day, 30 day and 
40 day intervals and homogenised separately in saline. The organs were first cut into small slices 
aseptically and then sonicated for 5 seconds. A standardised volume of homogenate was diluted in 10- 
fold steps, plated on 7H11 agar, and incubated at 37°C in sealed plastic bags for 3-4 weeks, when 
colonies were counted. The colony counts were expressed as means ± standard errors of the means 
(SEM) o f the CFUs/ml obtained from 3 mice used for each strain at day 10, day 20, day 30 and day 40 
respectively.
4.3. Results
4.3.1. Growth of M. tuberculosis strains in the lungs and spleen of mice inoculated intravenously
The first experiment compared the four M. tuberculosis strains (H37Rv, MDR 473, MDR 478 and 
MDR 524) in terms o f their ability to grow in the lungs and spleen of immunocompetent mice after the 
mice were inoculated intravenously with 105 -106 CFU. The course of infection was followed for 40 
days. All strains multiplied essentially at the same rate in the lungs o f the infected mice over the first
124
20 days after which MDR 473 and MDR 524 grew faster than the other strains, reaching log,,, 7 30 
days after infection (Table 4.1; Figure 4.1)
Table 4.1. Growth of M. tu b e r c u lo s is  strains in the lungs of mice inoculated intravenously
Mean viable count in log,0CFU/mI ± SEMa at various times (Days)
Strain Day 10 Day 20 Day 30 Day 40
H37RV 2.32 ±0.32 5.20 ±0.24 6.42 ± 0.06 6.29 ± 0.19
MDR 478 2.10 ± 0.09 5.50 ± 0.15 6.14 ± 0.15 6.03 ± 0.04
MDR 473 2.70 ± 0.04 5.65 ± 0.01 6.94 ± 0.07 6.93 ± 0.19
MDR 524 2.73 ±0.01 5.90 ±0.01 7.53 ±0.03 6.92 ±0.19
a) SEM=Standard errors of the mean
For all four strains viable M. tuberculosis as evidence by CFU were detected in the spleen at 10 days. 
It was found that the elimination process involving MDR 473 and H37Rv in the spleen was slower 
compared to that o f MDR 524 and MDR 478.
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H37Rv
M D R 478
M D R 473  
MDR 524
Figure 4.1. Comparison ofgrowth of four strains of M. tu b e rc u lo s is  (H37Rv, MDR473, MDR478 and MDR 524) in lungs 
of immunocompetent mice infected intravenously with 105' 106 CFU. Data shown are mean values for three mice. Sec
Table 4.1 for the standard errors of the mean.
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The population doubling times of the different strains during the first 20 days (calculated CFU/ml on 
day 10 and 20 days) were the similar (22-25h). From 20-30 days MDR 473 and MDR 524 grew much 
faster (doubling time 45 hours) compared to H37Rv (72h ) and MDR 478 (104 h)(Table 4.2).
Table 4.2. Population doubling times of different strains of M. tu b e r c u lo s is  in lungs of infected mice.
Strain
DAYS
10-20 20-30 30-40*
H37Rv (14)b 24.7h 72h Stationary
MDR 473 (15)b 22.5h 45h Stationary
MDR 478 (12)b 21,2h 104h Slight decline
MDR 524 (14)b 22.5h 45h Slight decline
Mice were infected intravenously with 10s -106CFU inoculum. Population doubling times were calculated from the data 
points (mean CFU) obtained for days 10, 20, 30 and 40
a Growth during this period was either stationary or showed slight decline in logm CFU/ml (Figure 4 .1) 
b Figures in brackets denote IS6110 copy number per strain
4.3.2. Survival time
To determine whether there were differences in survival, mice were inoculated intravenously with the 
different strains and monitored for 15 weeks. Mice infected with MDR473 and MDR 524 began to die 
45 days after infection whereas mice infected with MDR 478 did not begin to die until day 70 (Figure
4.2. ). None of the mice challenged with H37Rv died during 105 days observation period. 1 he results 
show that on the basis o f survival time of immunocompetent mice, MDR 473 and MDR 524 were the 
most virulent (median survival times [MST], 70 and 64 respectively) followed by MDR 478 [MS 1.91 
days] and M. tuberculosis FI37Rv[MST>105 days].
127
Weeks after infection
Figure 4.2. Survival times of immunocompetent mice infected intravenously with the strains used in the experiment in 
Figure 4 .1. Median survival times were much shorter in mice infected with MDR 524, MDR 473 and MDR 478. H37Rv 
failed to kill mice during 105-day period of study. Results were obtained with 8 mice per group
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4.4.1. Virulence in animal models in relation to transmission of M. tuberculosis strains.
M. tuberculosis strains vary in the extent to which they spread in different population settings 
( Bafina et al. 1996; Valway et al. 1998; Zhang et al. 1999). This variability has been ascribed to 
differences in the generation of infectious aerosols, environmental conditions that affect organism 
survival and contact with the source patient, the likelihood of inhaling aerosols o f critical size, and the 
susceptibility o f exposed persons. Recent reports, however suggest that bacterial factors may play a role 
in variability o f transmissibility o f mycobacteria (Manca et al. 1999; Valway et al. 1998; Zhang et al. 
1999)
4.4.1.1. Findings of the present study
In the present study three MDR clinical isolates belonging to Family 1 (Chapter 3) and a control the 
H37Rv laboratory strain, were compared in terms o f their growth rates in the lungs o f infected mice, 
as well as the time taken to kill mice. The growth rates in lungs o f mice challenged with the four 
strains were similar during the first 20 days o f infection. However, when the organism loads of strain 
MDR 473 and strain MDR 524 were determined in lungs o f mice at 30 days after infection, a 10- fold 
higher number o f bacilli were found compared to the number o f bacilli isolated from the lungs o f mice 
infected with MDR 478 and H37Rv laboratory strain. On the basis o f host survival time alone, mice 
infected by the three clinical isolates o f the present study were more virulent and survived for much 
shorter periods than those infected with H37Rv.
Strain MDR 478 was less virulent than the other two MDR strains. This was demonstrated both in terms 
of generation time 20-30 days after initiation o f infection (104h for MDR 478 versus 45 h for MDR 473 
and MDR 524) the doubling time was also slower than that o f the 72h for the H37Rv strain and with
4 .4 . D iscu ssio n
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respect to MST (91 days vs 70, 64 and 105 days respectively for MDR 473, MDR 524 and H37Rv). 
These findings suggest that the MDR 478 strain had undergone a genetic change compared with other 
two member o f Family 1 examined in this study, and that, the MDR 478 may therefore prove to be 
valuable in identifying gene sequences that may be important in virulence and possibly also in terms 
of transmission. It was noted that the less virulent MDR 478 strain had fewer IS6110 copies (12) than 
the other two test strains (15 and 14 copies respectively). Whether this finding is related to the decreased 
virulence o f MDR 478 is uncertain. Theoretically mutation affecting a Pvu 11 restriction site close to 
IS6110 sequence in the chromosome or deletion or insertions could change band patterns (see section
3.4.1.)
The recent explosion o f nucleotide sequence information on M . tu b e r c u lo s is  (whole genome sequence) 
(Cole et al. 1998) and the less virulent M. bovis, Mycobacterium africanum and Mycobacterium microti 
provided evidence o f 10 deletions possibly related to virulence. In M. bovis BCG all the deletions 
relative to M tu b e r c u lo s is  (RD1-RD10) are present, while 7 corresponding deletions have been 
demonstrated in M. bovis (RD4-RD10) and fewer corresponding deletions in M. africanum and M. 
microti. Among the gene products related to these deletions are the mycobacterial invasin Mce, four 
phospholipases, including phospholipase D, epoxide hydrolase and several other proteins (Gordon et 
al. 1999). These exciting observations demonstrate how powerful studies relating to comparative 
genomics, including subtractive hybridisation (Mahairas et al. 1996), could be in the search for the 
genetic basis of physiological characteristics, host range and virulence in M. tuberculosis. The 
difference in virulence in the three MDR isolates of the present study could form the basis for 
comparative genomic studies involving the genes identified as candidates for virulence.
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4.4.1.2 Transmissibility in relation to virulence: Findings of others
Strains o f high transmissibility causing extensive outbreaks may exhibit virulence properties related 
to high growth rates in macrophages (Zhang et al. 1999) or in the lungs o f non-immunocompromised 
mice (Valway et al. 1998; Manca et al. 1999; North et al. 1999). In a macrophage model, strain 210 
which caused a large outbreak in Los Angeles, USA, multiplies significantly more rapidly in 
macrophages than isolates from small-cluster outbreaks in the same city. This finding however, was 
not consistent as the CDC1551 strain which caused a large outbreaks in Kentucky and Tennessee did 
not multiply significantly faster in macrophages than small cluster strains or unique strains that did not 
show a propensity to transmit tuberculosis to other patients, despite ample opportunity for transmission 
(unique strains were from patients from homeless shelters). Similarly, the findings in the mouse lung 
model were inconsistent as Manca et al. (1999) found that the CDC1551 strain did not multiply faster 
than H37Rv in mouse lungs and that experimental animals infected with this strain survived longer. It 
did, however cause more earlier granuloma formation than H37Rv in the lungs o f mice. North et al. 
(1999) using the CDC1551, H37Rv and M. bovis strains in a mouse model also found that CDC1551 
did not appear to be more virulent than the other strains. Based on these findings it cannot be assumed 
that the initial rate o f growth in the lungs of mice infected by the two clinical isolates (MDR 473 and 
MDR 524) is necessarily related to their high transmissibility in the mining community. Unfortunately, 
the present pilot study was not designed to examine histological changes in mouse lungs during 
different phases o f pulmonary invasion by the experimental strains.
4.4.2. Pathogenesis of early pulmonary disease in animal models
The basis o f reduced survival times o f mice infected with the three MDR strains compared to H37Rv 
in the present study remains speculative. It has been demonstrated previously (Dunn et al. 1995) that
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the M. bovis has the ability to cause earlier death than H37Rv. In the latter study, the ability of an M. 
bovis strain to cause earlier death than H37Rv was related to its ability to induce more rapid 
development of lung pathology and thereby cause earlier loss o f lung function. Although, histology 
was not performed during the various stages o f the experiments, it is possible that a similar process was 
set in motion by the three MDR strains. On this basis, it could be speculated that less protective 
immunity was elicited by the experimental M. tuberculosis strains in BALB/c against the two more 
virulent MDR 473 and MDR 524 clinical isolates compared to H37Rv, (and MDR 478), allowing 
establishment o f pathology in the lungs at an earlier stage in the presence o f cytokine responses to M 
tuberculosis cell components which differed in the respective experimental strains.
4.4.3 Cytokine production and Th clone response
The mechanisms underlying early establishment o f lung pathology o f experimental mice were not 
investigated in the present study but they may relate to an altered capacity o f the strains to induce the 
production o f cytokines and chemokines by the cells they invade, resulting in differently modulated 
Thl, Th2 or mixed Thl-Th2 responses (Barnes et al. 1993; Cher et al. 1987; Maggie et al. 1992; 
Mosmannan and Moore 1991; Kariyone et al. 1999; Cooper et al. 1993; Dalton et al. 1993; Flynn et 
al. 1993; Me Donough et al. 1993; Nathan et al. 1983; Orme et al 1992). Protective immunity 
characterised by early granuloma formation is mediated through a Thl-type pro-inflammatory 
response which results in reduced spread/dissemination o f the tubercle bacilli. Cytokines involved in 
Thl-type response are IL-12 from monocytes which stimulates INF-y production in T-lymphocytes. 
INF-y activates macrophages to produce TNF-a, IL-2 and IL-6. Activated macrophages will arrest rapid 
intracellular multiplication o f M. tuberculosis and lead to increased protective immunity. Thl-type 
cytokines are also induced by LAM and other lipids through upregulation of CD 14 receptors on 
macrophages. Th2-type response which is anti-inflammatory in nature operates through IL-10 which
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inhibits the Thl-type response and IL-4 whose effect leads to reduced granuloma formation but 
increased ability to multiply inside macrophages, followed by dissemination and death. Published 
evidence in keeping with this idea o f differential cytokine inducing capacity is seen in the demonstration 
that M. tuberculosis CDC 1551 strain induced well-organised granulomas with high levels of TNF-a, 
IL 6, IL10, IL-12 and INF-y mRNA sooner in lungs o f mice than those infected with the other strains 
including H37Rv (Manca et al. 1999). It therefore seems reasonable, as mentioned in Section 4.4.2., 
to suggest that the two virulent MDR strains in the present study with their high multiplication rate in 
mouse lungs and shorter survival times of experimental mice, caused a more rapid progression in early 
lung pathology which led to early death compared with the H37Rv strain. The two virulent MDR strains 
were therefore likely to have induced a more prominent Th2-type oriented host response than the 
H37Rv and CDC1551 strains.
4.4.4, Virulence determinants involved in early evolution of lung lesions.
In order to offer explanations o f our findings at the molecular level, present concepts on the early 
evolution o f lung lesion will be discussed briefly. The production of cytokines and chemokines by the 
infected cells is initiated by bacterial cell constituents and metabolites that M. tuberculosis strains 
liberate in their host cells. One such metabolite is lipoarabinimannan (LAM), a cell wall component 
that is considered to be a key virulence factor (Chan et al. 1991). When ingested by macrophages, it 
induces the production of TNF- a (Chatterjee et al. 1992; Moreno et al. 1989; Roach et al. 1993) while 
it may also inhibits lysosome-phagosome fusion. It is likely that acquired immunity, as expressed 
through the activation of infected lung macrophages, would be more capable o f inhibiting less virulent 
compared with more virulent strains o f M. tuberculosis. Macrophage activities induced by such strains 
will presumably be modulated by the secretion and effects o f mycobacterial products like LAM. There 
is also evidence (Chan et al. 1991) that LAM may affect the activation o f the mycobactericidal activity
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of macrophages by inhibiting the transcription o f gamma interferon-inducible genes. Thus, in lung 
macrophages, this mycobacterial product, and perhaps others, might activate the transcription of 
inflammation-inducing cytokine genes on the one hand, yet suppress transcription o f genes necessary 
for the expression o f mycobactericidal function on the other.
Other mycobacterial factors may play a role in virulence by inducing inflammatory cytokines involved 
in host tissue damage. These include the heat shock protein(HSP) and other culture filtrate proteins. 
The mycobacterial HSPs, M. tuberculosis HSP70, M. leprae HSP65, and M.bovis HSP65, when added 
to cultures o f murine macrophages, induce the expression o f mRNA for IL -la , IL-1 p, IL-6, TNF-a 
and granulocyte/macrophage colony stimulating factors. On the other hand, culture filtrate proteins are 
also likely to be key antigens required for inducing protective immunity (Retzlaff et al. 1994). Kariyone 
et al. (1999) have shown recently that a 25 peptide epitope o f antigen a (or 85B antigen) of M 
tuberculosis react with V pi 1ll+ Thl cells, resulting in the expansion o f these cells and the production 
o f IL-2 and INF-y. Immunisation with amino acid residues o f this antigen resulted in markedly 
decreased number o f CFU/ml in the mouse lungs during the first 7 days after infection. Other culture 
filtrate proteins from M. tuberculosis may also play a role and are discussed in Chapter 5.
4.4.5. Drug resistance in relation to virulence
It is generally accepted that many isoniazid-resistant strains o f M. tuberculosis possess reduced 
expression of catalase-peroxidase activity and that this loss o f activity was associated with a lower level 
of virulence in guinea-pigs( Mitchison et al. 1963. Isoniazid resistance has been shown (Heym et al. 
1995; Morris et al. 1995) to be associated with either a deletion or point mutations in the katG gene 
that encodes the heat-labile catalase-peroxidase enzyme of M  tuberculosis. As an intracellular pathogen 
capable of surviving and multiplying within host macrophages, tubercle bacilli have to survive
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exposure to macrophages killing mechanisms, including the oxidative stress response. The catalase- 
peroxidase katG is the component o f the bacterial OxyR response which is induced in oxidative stress 
and protects the bacteria against oxidative killing. Thus the loss o f a functional katG in an INH - 
resistant strain o f M. tuberculosis would be expected to lead to a reduced capacity o f the pathogen to 
survive within the intracellular environment. This was however shown not to be necessarily the case 
as drug-resistant strains may be fully virulent (Ordway et at. 1995). In the context o f this study, the 
findings also do not support the association of drug resistance with loss o f virulence. Although the 
strains used in the present study were resistant to INH, the expression o f catalase (as determined by the 
whole cell bubble assay) was positive in the three MDR strains. As is the case with INH-resistant 
strains, there is no evidence that resistance to other anti-tuberculosis drugs is associated with loss of 
virulence o f M. tuberculosis in humans.
4.4,6, Concluding remarks
In this study it was shown that two MDR strains from the RFLP Family 1 associated with high 
transmissibility are more virulent than H37Rv in terms o f host survival and increased multiplication 
in mouse lungs after twenty days o f infection. It was however, not clear whether these findings may 
be related to increased transmissibility. Up to date, no reliable in vitro or in vivo model has been 
described to assess this phenotypic trait. Discovering markers associated with increased 
transmissibility in M. tuberculosis would represent an important step in advancing our understanding 
of mycobacterial virulence. Although the use o f strain MDR 478 in future studies could assist in 
identifying virulence determinants related to mouse-lung model, it may not relate to transmissibility. 
As mentioned earlier (Section 4.4.1.2), recent study by Zhang et al. (1999) demonstrated the usefulness 
and limitations o f a human-macrophage model for transmission-related virulence in M. tuberculosis
strains. They interpreted their findings as evidence that the capacity to grow intracellularly in
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macrophages is not the only factor that affects spread of M. tuberculosis.
In an interesting recently-described in vitro model utilising a fibroblast-Mycobacterium microcolony 
assay, Byrd et al. (1998) assessed the ability o f M. tuberculosis to spread from cell to cell. The authors 
suggested that their model could prove to be useful in the study of mycobacterial pathogenesis, 
including possible correlation with clinical presentations (e.g.,miliary versus cavitary tuberculosis). It 
is also possible that the growth patterns in this model may relate to transmissibility. There is 
unfortunately as yet no reliable animal or in vitro model which consistently correlates with degrees of 
transmissibility. Further work in this field is warranted.
Future studies on the virulence and transmissibility o f MDR strains to complement the investigation 
presented here should ideally include correlation o f early pulmonary growth rates of strains and 
survival times with lung pathology and an assessment o f cytokine production by strains with different 
transmissibility potential, similar to those conducted by Manca et al. (1999). The inclusion of 
macrophage studies on the strains investigated thus far is also envisaged, if  appropriate resources 
become available. Direct comparison of our strains and the CDC 1551 strain and possibly other strains 
such as the Los Angeles 210 in terms of the survival time, lung pathology and cytokine production 
could be rewarding. Further attempts at identifying virulence factors directly linked to transmissibility
exhibited by clones including our own Family 1 strain and others such as the W-strain from New York 
(Bafina et al. 1996 and the U strain from Cape Town (van Rie et al. 1999) should also receive a high
priority.
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5: MOLECULAR AND BIOCHEMICAL CHARACTERISATION OF ISOLATES WITH 
DIFFERENT VIRULENCE LEVELS IN MICE
5.1. Introduction
As demonstrated by Ordway et al. (1995), clinical isolates o f M. tuberculosis exhibit a broad range of 
in vivo growth rates in target mouse organs, which followed no clear trend in terms of geographical 
source, degree o f drug resistance or rate o f growth in vitro. This led to the grouping of strains into three 
virulence categories based on the growth rates of M. tuberculosis strains in experimental animals (slow, 
moderate and rapid growth). Those strains classified with moderate growth rates had in vivo growth 
characteristics similar to the laboratory strain (Erdman) o f M. tuberculosis, whereas rapidly growing 
virulent strains tended to grow much faster over the first 20 days o f the infection (Ordway et al. 1995). 
It has been suggested that the latter group o f strains could be responsible for the rapid progression of 
disease and early fatal outcomes sometimes seen in immunocompromised patients with tuberculosis.
Culture filtrate proteins (CFPs) including, early secretory proteins (ESP) o f standard ATCC strains of 
M. tuberculosis have been studied extensively (Abou-Zeid et al. 1988; Andersen et al. 1991; Collins 
et al. 1988; Nagai et al. 1991; Rosenkrands et al. 1998). Some o f these proteins are recognised by T 
cells and are thought to play an important role on the pathogenesis o f tuberculosis (Andersen et al. 
1991; Hasl(f)v et al. 1995; Rosenkrands et al. 1998; S(f)rensen et al. 1995).
Sonnenberg and Belisle of the Mycobacteriology Research Laboratories, Department of Microbiology, 
Colorado State University, Fort collins, investigated the culture filtrate proteins (CFPs) profile of
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M. tuberculosis H37Rv. When the author o f this thesis was studying at Fort Collins, he was assigned 
the task to characterise CFPs from strains exhibiting different degrees of virulence in the mouse lung 
model. It was anticipated that isolates from Family 1 which showed extensive spread in the Welkom 
mines, would be included with sstrains o f varying degrees of virulence available at Fort Collins. 
Unfortunately because o f recently imposed rigid restrictions on the importation o f potentially dangerous 
microbial organisms to the USA, the strains could not be made available in time for inclusion in the 
studies. It was however, considered appropriate to include the findings o f the Fort Collins studies 
conducted by the author o f the present thesis as they relate to strains with an increased potential for 
transmission and could, at a later stage be applied to the Welkom strains.
The main aim o f the study recorded in this chapter was to identify a protein or proteins in culture 
filtrates o f M. tuberculosis strains o f varying degrees o f virulence in the mouse model that may be 
linked to virulence and therefore serve as a candidate virulence determinant/s for future study.
A secondary aim was to ascertain whether fingerprint patterns of these strains could be linked to 
distinct protein profiles or unique strain-associated proteins. At the time when this study was initiated 
at Fort Collins, no information was available on possible links between the presence of virulence 
determinants in strains and DNAIS6110-based fingerprinting of isolates. It had, however, already been 
established that strains expressing certain phenotypic characteristics with known genetic bases, such as 
resistance to antimicrobial agents, could occur within RFLP clusters with identical band patterns 
together with members which fail to express the phenotypic trait. Despite this knowledge, it was decided 
that attempts to link DNA fingerprint with virulence could still yield useful information, as it is 
theoretically possible that the position o f virulence -related genes on the M. tuberculosis chromosome
could affect RFLP band patterns.
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5.2. Materials and methods
The initial virulence studies on the isolates were performed at the Colorado State University (CSU), Fort 
Collins, USA. For the in vivo experiments conducted by Ordway et al. (1995) at Fort Collins, bacterial 
isolates were grown in nutrient 7H9 broth containing 0.05% Tween 80. Aliquots were frozen at -70°C, 
thawed and diluted in sterile pyrogen-free saline to a concentration o f 5x 104 viable bacilli per ml. A 
volume of 10ml was then added to the venturi nebulizer unit of a Middlebrook Aerosol Generation 
device (Glas-Col, Terre Haute, Ind.) and C57BL/6 mice were exposed to an aerosol for 30-min period. 
This routinely resulted in the implantation o f 20 to 50 bacilli in the lungs o f these animals. The number 
of bacteria in the lungs o f test animals was monitored against time by harvesting of mice by C 0 2 
inhalation, plating o f serial dilutions of individual whole-organ homogenate on nutrient 7H11 agar, and 
then counting o f bacterial colony formation 2 to 3 weeks later after incubation at 37°C in humidified 
air. For comparison, the growth of the virulent laboratory strain M. tuberculosis Erdman was also 
determined. Growth patterns fell into three categories, low, moderate and highly virulent.
All subsequent experimental work recorded in this chapter was performed by me at CSU.
5.2.1. DNA fingerprinting
The procedure for RFLP typing o f 29 M. tuberculosis isolates from Colorado State University was 
described in Chapter 2
5.2.2. Growth of M. tuberculosis and preparation of culture filtrate proteins.
Initially M. tuberculosis strains were inoculated from 1ml frozen stocks o f approximately 10 CFU/ml 
onto 7H11 agar and were incubated for three weeks. Bacterial cells were scraped from the plates into 
100ml glycerol-alanine salts (GAS) medium and incubated with gentle agitation at 37°C for 14 days. 
The resultant culture was used to inoculate fresh 400ml GAS media and were grown in bottles by
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rolling for 14 days at 37°C. Bacterial cells were harvested by filtration through a 0.22pm filter. The 
culture filtrate was concentrated by an amicon filtration system.
5.2.3. Two-dimensional PAGE of culture filtrate proteins
Separation o f culture filtrate proteins by 2-D PAGE was based on the method described by O' 
Farrell(1975). After vacuum drying o f culture filtrates o f M. tuberculosis strains, 70 micrograms of 
dried filtrates were suspended in 30pl o f isolectric focusing sample buffer (9M urea, 2% Nonidet P-40, 
5% p- mercaptoethanol, 5% Pharmalytes (pH 3 to 10: Pharmacia Biotech, Piscataway, N.J), and 
incubated for 3 h at 20°C. An aliquot of25pg of protein was applied to a 6 % polyacrylamide isoelectric 
focusing tube gel (1.5mm by 6.5 cm) containing 5% Pharmalytes (pH 3 to 10 and 4 to 6.5 in a ratio of 
1:4). The proteins were focused for 3 hours at lkV with lOmM H3 P 0 4 and 20 mM NaOH as the 
catholytes and anolytes, respectively. The tube gels were subsequently immersed in sample transfer 
buffer (Dunbar et al. 1990) for 30 min and placed on preparative SDS-polyacrylamide gel (7.5 cm by 
10 cm by 1.5mm) by 0.75 mm) containing a 6% stack over a 15% resolving gel. Electrophoresis in the 
second dimension was carried out at 20mA per gel for 0.3 h followed by 30mA per gel for 1.8 h. 
Proteins were visualised by staining with silver nitrate (Morrissey 1981). The MW scale was calibrated 
with standard proteins (Pharmacia).
5.3. Results
5.3.1. RFLP typing
M. tuberculosis clinical isolates with defined in vivo growth characteristics were examined for their 
IS6110- associated RFLP patterns and protein profiles. O f the 29 clinical isolates subjected to RFLP 
analysis (Ordway et al. 1995), 22, 5, and 2 were previously grouped (in terms o f virulence) as rapid, 
moderate and slow growing strains in mouse lungs, respectively. In all, the number o f the IS6110 copies
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per isolate ranged from 1 to 20 (Table 5.3.1, Figure 5.1). Among the 22 clinical isolates displaying the 
rapid in vivo growth phenotype, 14 different IS6110 RFLP patterns were observed, while all strains 
categorised as having slow or moderate in vivo growth phenotypes showed different RFLP patterns. 
Three RFLP clusters (representing 7, 3 and 2 isolates) were identified among the clinical isolates 
(clusters carrying less than 4 copies excluded).(Table 5.3.1 and Figure 5.1. One isolate, CSU 24 from 
the 3 membered cluster, CL 3 was categorised as a low virulence strain. The isolates in the largest 
cluster, CL 1, had hybridisation patterns that were similar to each other and to those referred to as W- 
strains (CSU 85, CSU 86 and CSU 87, “W” strains were associated with outbreaks of multidrug- 
resistant tuberculosis in hospital C in New York City, in a State correctional facility, and subsequently 
in four other New York hospitals (Bifani et al. 1996).
141
Table 5.3.1. Summary o f R F LP  analysis o f A/. tuberculosis with different virulence levels in mice
STRA IN SO U R C E V IR U L E N C E IS6110 C O P IES C LU ST ER 12 kDA protein M DR
C SU  11 K High 18 1 Weak No
CSU  35 N JC High 18 1 positive Yes
CSU  39 N J C High 18 1 positive Yes
CSU  85 PHRI High 18 1 negative Yes
CSU  86 PHRI High 18 1 negative Yes
CSU  87 PHRI High 18 1 Weak Yes
CSU  109 B.Bishai High 18 1 positive N l)
CSU  92 Shinnick High 4 2 negative ND
CSU  93/CDC 1551 Shinnick High 4 2 negative No
CSU  22 C High 13 3 Weak Yes
CSU  24 C Low 14 3 Weak No
C SU  25 C High 14 3 positive No
CSU  12 K High 4 Weak No
CSU  19 C High 10 positive No
CSU  26 C High 12 positive No
C SU  28 C High 11 Weak No
C SU  31 N JC High 9 negative Yes
CSU  32 N JC High 10 negative Yes
CSU  37 N JC High 12 positive No
CSU  44 N JC High 15 negative Yes
CSU  107 B  Kreiswick High 2 positive N l)
CSU  108 B.Kreiswick High 4 negative ND
CSU 15 K Moderate 13 negative No
CSU  17 K Moderate 13 negative No
CSU  18 K Moderate 2 negative No
C SU  21 C Moderate 3 negative Yes
CSU  23 C Moderate 1 negative No
CSU  20 C Low 16 negative No
CSU  27 C Low 4 negative No
H37Rv ATCC 27294 High 14 negative No
Determined by the ability to grow in the lungs of C57BL/6 mice exposed to a low-dose aerosol of bacilli Growth was classified relative to that of the type strain Erdman K. James 
Kilbum, Centers for Disease Control and prevention, Atlanta, GA; C, Ray Cho, Seoul, Republic of Korea; NJC, National Jewish
Center for Immunology and Respiratory Medicine, Denver, CO; PHRI, Public Health Research Institute ; ND, not done.
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Figure 5.1. Dendrogram based on computer-generated comparison of DNA fingerprints obtained from 29 isolates showing 
differences in virulence in mice. Abbreviations Rv, Ra and Erd are laboratory M. tu b e rc u lo s is  strains H37Rv, H37Ra and
Erdman strains respectively.
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5.3.2. Culture filtrate proteins profiles of M. tuberculosis patient isolates by 2-D PAGE
The 2-D electrophoresis o f culture filtrate proteins (CFPs) profile o f the reference strain H37Rv was 
previously studied by Sonnenberg and Belisle (1997). Comparison o f the CFPs among clinical isolates 
and to the reference map o f M. tuberculosis H37Rv demonstrated several differences not clearly linked 
to transmissibility or virulence between individual strains. However, one basic protein at 12 kDa ( 
protein spot 7 in Figures 5.2-5.6) was particularly notable in that it was abundant in strains CSU 19, 25. 
26,35, 37, 39, 87 and 109 (all in highly virulence group), weakly expressed in strains CSU 11, 12,22, 
24, 31 and 107 (except for CSU 24, which was categorised as low virulence, all were classified as 
highly virulent), and was absent from several strains including H37Rv (Sonnenberg and Belisle 1997) 
(Figures 5.2- 5.6).
Other proteins (protein spots 1,2, 3,4,5,6 and 8) appeared to be differentially expressed by the clinical
isolates (Figures 5.2- 5.6).
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F ig u re  5.2 . 2-D Profile of culture filtrate proteins of M y c o b a c te r iu m  tu b e r c u lo s is  strain CSU 3
Protein spots 1-8 are proteins that were cited in the text as being differentially produced
'M
\
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Figure 5.3. 2-D Profile of the culture filtrate protein o f Mycobacterium tuberculosis 
strain CSU 22. Protein spots 1-8 are proteins that were cited in the text as being 
differentially produced.
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F ig u re  5.4 . 2-D Profile of culture filtrate proteins of M y c o b a c te r iu m  tu b e r c u lo s is  strain CSU 24.
Protein spots 1-8 are proteins that were cited in the text as being differentially produced
147
F igu re. 5 .5 . 2-D profile of the culture filtrate of M y c o b a c te r iu m  tu b e r c u lo s is  strain CSU 25.
Protein spots 1-8 are an examples of proteins that are cited in the text as being differentially
produced.
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F igu re  5 .6 . 2-D Profile of culture filtrate proteins of M y c o b a c te r iu m  tu b e r c u lo s is  strain CSU
109. Protein spot 1-8 are proteins that were cited in the text as being differentially produced
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5.4. Discussion
5.4.1. Relationship between RFLP-based DNA fingerprinting and virulence
Strain differentiation by DNA RFLP has been used mainly for epidemiological purposes of 
M. tuberculosis infection. In the present study, an attempt was made to link the molecular and the 
phenotypic characteristics o f M. tuberculosis isolates from patients by comparing the DNA fingerprint 
obtained by RFLP using IS6110 and the in vivo growth phenotype in mouse lungs. In addition, early 
secretory proteins expressed by the different strains were characterised and fingerprint patterns of the 
strains were matched with protein profile to establish possible links between a distinct protein profile 
and the presence o f strain specific proteins.
RFLP studies based on IS6110 presented in this chapter demonstrated great diversity among strains with 
a similar virulence phenotype, suggesting that the emergence o f a particular virulence phenotypic trait 
has occurred in multiple clones o f M. tuberculosis. These results further suggest that more than one 
factor could be responsible for the growth characteristics of individual strains o f M. tuberculosis 
observed in the mouse model.
The basic premise inherent in any typing system is that epidemiologically related isolates are derived 
from the clonal expansion of a single precursor and, consequently, will share characteristics that differ 
from those o f epidemiologically unrelated isolates. In studies in Europe and the USA, isolates o f M 
tuberculosis with matching fingerprints have always been cultured either from the same individual or 
from individuals between whom transmission o f infection was likely. Even though strains within RFLP 
families, resembling each other, with only a few band differences are more common in regions where 
tuberculosis is highly endemic, there is sufficient identity between isolates to make matching fingerprint 
patterns very rare without an identifiable epidemiological link (Flermans et al. 1995). In the present
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study, molecular typing demonstrated that the number o f IS6110 elements and the RFLP pattern were 
independent o f the in vivo growth phenotype. This was best exemplified by CSU 24 and 25, which 
yielded identical RFLP patterns but have different in vivo growth characteristics. Additionally, CSU 
35 and 39 had matching RFLP patterns and in vivo growth characteristics, but were subsequently shown 
by Rhoades and Orme (1997) to have differing susceptibilities to reactive nitric oxide intermediates. 
This phenomenon suggest that insertion sequence-associated polymorphism is accumulating more 
rapidly than mutations relating to the virulence phenotype.
5.4.2. Candidates for virulence determinants among culture filtrate proteins of M. tuberculosis
The proteins o f M. tuberculosis and other mycobacterial species have been extensively studied in terms 
of their biochemical, immunological and molecular characteristics (Abou-Zeid et al. 1988; Andersen 
et al. 1991; Collins et al. 1988; Nagai et al. 1991; Rosenkrands et al. 1998). Sonnenberg and Belisle 
in 1997 determine the CFPs profile o f M. tuberculosis H37Rv. However, in the case o f M. 
tuberculosis, no report has appeared in the literature on variation in protein profiles among a wide array 
o f different clinical isolates. The present study shows clear evidence o f variation in protein profiles. 
Since M. tuberculosis has been one o f the most important human pathogens that has long caused disease 
entities ranging from inapparent to life-threatening, it is to be expected that heterogeneity would exist 
due to spontaneous mutations among strains over time. Furthermore these results do not come as a 
surprise, given the recent observation that several M. tuberculosis isolates lack the gene encoding MPT 
40 (Weil et al. 1996), while the loss o f katG activity in many isoniazid-resistant strains of M 
tuberculosis is associated with the concurrent over expression o f AhpC (Sherman et al. 1996).
One basic protein at approximately 12 kDa was particularly notable in that it was differentially 
expressed among clinical isolates. There was no correlation between the expression of this protein and
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DNA fingerprint as the protein was absent in three o f the six members o f cluster 1. The significance 
of the expression o f this protein in highly virulent strains is unclear, although it must be noted that other 
highly virulent strains lack this protein. The fact that this protein was not found in any of the eight 
strains of lesser virulence, suggests that it may be related to one o f a number o f virulence determinants. 
Decreased virulence in mutants o f parent strains exhibiting this protein may confirm its status as a 
candidate virulence determinant. Cloning of the gene encoding this protein could form the basis of 
further genetic studies to establish the nature o f the virulence determinants. Studies on the in vitro effect 
of this protein on macrophage interaction compared with low virulence strains may be rewarding as has 
been shown in models evaluating surface proteins o f cell wall components o f mycobacteria and other 
pathogenic bacteria (Bliska et al. 1992; Pauls et al. 1996). Also, studies on the interaction of this 
protein with T-cells and the induction o f cytokines such as interferon-gamma following T-cell 
proliferative responses could be performed. Authors o f a previous study pointed out that only a few of 
12 previously characterised secreted proteins were recognised by T-cells isolated from tuberculosis 
patients suggesting a number o f as yet undefined antigenic targets amongst secreted antigens (Boeson 
et al. 1995)
Using isocitrate dehydrogenase, a cytoplasmic enzyme as an indicator o f an autolysis of 
M. tuberculosis in culture, Andersen et a/. (1991) have shown that autolysis is maximal at 14 days 
incubation (an early phase o f growth decline) and that autolysis increases rapidly during the late 
logarithmic growth phase. The analysis o f the culture filtrate proteins o f the clinical isolates M. 
tuberculosis in the present study was performed on 2-week-old cultures and represents the profiles of 
proteins released into the culture supernatant composing both early secretory and intracellular, 
including cell wall proteins. Thus, it cannot be claimed that these studies were a true measure of gene 
expression relating to early secretory proteins which are thought to be important in the initiation of
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infection. To ensure that gene expression is evaluated, protein analyses must use proteins metabolically 
labelled with 32S-methionine or 32S-cystine (Sonnenberg et al. 1995).
It should be noted that the culture filtrate represents only a small proportion o f the gene products of M 
tuberculosis and additional analyses focussing specifically on cell wall, cytosol and membrane proteins 
will most likely yield additional proteins.
Furthermore, protein analysis o f a variety o f clinical isolates with well-defined clinical history is 
warranted. This type of basic proteomic analysis will allow the correlation o f protein profiles with 
pathology, geographical distribution, or epidemiological aspects such as outbreaks, including their 
initiation and termination. Additionally, the continued molecular characterisation of M. tuberculosis 
by 2-D PAGE gel coupled with such powerful techniques as liquid chromatography-mass spectro- mass 
spectrometry (LC-MS-MS) will supplement the wealth o f information that is now being derived from 
the M. tuberculosis genomic sequencing. Suitable animal model able to differentiate transmissibility 
between strains could be another valuable tool to identify virulence determinates related to
transmissibility (see Chapter 4).
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6. NEW PERSPECTIVES ON RECENT INFECTION VERSUS REACTIVATION OF 
TUBERCULOSIS IN FREEGOLD HEALTH REGION MINES
6.1. Introduction.
The findings recorded in this thesis provide strong evidence that a substantial component of the disease 
load o f tuberculosis in the mine environment is due to recent transmission. They also point to 
transmission cycles in the mine which over time resulted in the establishment of nearly identical strains 
with DNA fingerprints differing only by a few bands on RFLP-based typing. There was also sufficient 
heterogeneity o f strains indicating infections that were acquired from multiple sources outside the 
mines and finally found their way in respiratory secretions in miners at the mines following 
reactivation. In this chapter the author will attempt to place his findings into perspective and to propose 
further studies and possible control strategies emanating from his investigations
6.2. The case for recent transmission
It is generally accepted that clustered isolates with identical RFLP band patterns (IBPs) provide strong 
evidence o f recent infection by these strains. Close geographical links between patients represented in 
such clusters, e.g. working in the same mine shaft, lend support to the likelihood of recent infection. 
In most cases, such infections resulted in disease during the miner’s stay in the mine, usually less than 
18 months, suggesting a relatively short period between infection and disease. It is therefore likely that 
the mine environment is conducive to early disease development following infection. Such an enhanced 
process may either follow o f primary infection or reinfection which occurred after a primary infection 
in the past. In both instances a lowering of cell-mediated immunity (CMI), possibly brought on by 
physical or mental stress or viral infections which temporarily depress CMI, is required. It is not 
possible to accurately quantify the prevalence o f recent transmission in miners in the FHR mines.
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However, the occurrence o f 14 cases (21%) with an identical RFLP profiles shared in mine shafts, 6 
o f whom having worked in only two separate mine shafts during the short study period of six months, 
provides strong circumstantial evidence of recent transmission in the mines. As miners working in the 
same shaft also tended to share sleeping quarters, it is likely that transmission in the more confined 
space o f the sleeping quarters may have occurred more frequently than in the mine shafts. If one 
considers that some of the strains belonging to the nearly identical RFLP families were almost definitely 
also responsible for recent transmission, one has to conclude that a transmission problem of substantial 
dimensions exists in the mines. In addition to the miners with proven disease following recent 
transmission, there are many others who became infected but who did not develop disease during the 
study period recorded in this thesis.
6.3. Endemicity of RFLP families
As explained elsewhere in this thesis the term “endemicity” as used in this thesis denotes the process 
whereby strains o f M. tuberculosis with identical or nearly identical RFLP band patterns become 
established in the mines as a result o f repeated cycles o f transmission in miners leading to varying 
periods o f dormancy followed by reactivation. In the process some of the strains within clusters 
comprising RFLP family genotypes, may fortuitously have been present in the mines at the time of the 
present investigation and may therefore have been acquired some time in the past rather than recently. 
It is likely that the initial acquisition o f such strains occurred in the mines as there was no evidence of 
a preponderance o f strains within such RFLP families in specific regions from where the migrant miners 
come. As it is common practice for miners to return to the same mine on being re-employed, it is 
possible for miners to acquire infection in a mine initially without becoming ill and subsequently 
experience reactivation when they return to the same mine. It is therefore quite feasible for RFLP family 
strains to become established in mines. Quantification o f endemic strains as opposed to recent infection
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based on IBP and RFLP family genotyping is not possible from the data available. However, at least 
some o f the patients who could not be linked by mine shaft/sleeping quarters may fall in the endemic 
strain category. Prospective studies utilising base-line tuberculin skin testing on arrival in a mine 
followed by six-month monitoring could be used in future studies to resolve this problem.
6.4. Reactivation tuberculosis in the mine
There is good evidence that reactivation tuberculosis is common in the mines. This is exemplified by 
the high degree o f heterogeneity o f RFLP patterns amongst the isolates, while analysis of the 
fingerprints o f drug-resistant strains showing great genetic diversity, again indicates that the patients 
acquired their infections from diverse sources probably outside the mines. Furthermore the frequency 
of drug-resistant strains parallel those encountered in rural areas where adherence to treatment is likely 
to be much more erratic than is the case in the mines where good treatment practices prevail.
The much higher incidence o f tuberculosis in the mines can be ascribed to either an increased rate of 
transmission or an increased propensity o f the patients to acquire reactivation tuberculosis under mining 
conditions or both. Data from the present study suggest that both processes operate simultaneously and 
also interact with and augment each other: factors depressing CMI will lead to more reactivation cases 
as well as shorten the period between recent infections and disease, while an increase in transmission 
rates will lead to more initially asymptomatic cases who may become reactivated in future, affecting 
tuberculosis in the mines but also the regions feeding the mines with mine workers. Evidence of the 
major impact o f HIV infection/AIDS on this cycle in recent years has recently been reported by 
Churchyard et al. (1999).
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6.5. Risk factors associated with transmission.
HIV-infection has been shown to be an important risk factor for transmission of M. tuberculosis in 
hospital-based and other outbreaks (Alland et al. 1994; Small et al. 1994). In the present, as well as in 
the Godfrey-Faussett et al. (2000) study, HIV-infection was not shown to be a significant risk factor for 
cluster formation. This may change as the HIV epidemic increases in severity and more miners progress 
to AIDS.
O f utmost importance was the identification o f retreatment o f tuberculosis as a risk factor for 
transmission amongst miners by the Godfrey-Faussett et al. (2000) and confirmed by the present study. 
Retreatment patients are a prolonged source o f tubercle bacilli present in large numbers in respiratory 
secretions and preventive measures should be focussed on this group of miners
6.6. Control measures
Having established that transmission leading to early disease does occur in the FGR mines, probably 
at a high rate, control measures should focus on a) prevention o f transmission and b) identifying and 
ideally diminishing the risk o f CMI depression in the miners.
Early detection o f active tuberculosis disease is important to contain the infectious pool in the mines. 
This could be facilitated by a programme of regular weighing o f miners with recording of weight loss, 
monitoring o f viral, especially respiratory infections, as well as occurrence o f night sweats and 
persistent cough. The specific aim o f such a program would be the early diagnosis o f tuberculosis by 
smear microscopy or chest radiography. As acute viral infections may compromise CMI, preventive 
measures against transmission o f such infections should be considered.
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Mine administrators should also decide on the feasibility o f serological monitoring of HIV infection 
which could assist in identifying candidates for CMI depression. Strongly positive tuberculosis skin test 
reactors (interpretation suitably adjusted in the case o f HIV-positive individuals) or converters would 
be candidates for preventive treatment, either in the form of INH for six to 12 months or a shorter course 
such as a combination o f RMP and PZA which has recently been shown to be cost-effective under USA 
conditions (Halsey et al. 1998). As the risk o f infection is much higher than in the USA, effectiveness 
of the latter regimen in the mine environment may be inappropriate. Attention to measures aimed at 
minimising transmission could include improved ventilation in sleeping quarters and mine shafts and 
other locations in mines where miners are congregated into confined areas.
Dust control is vitally important as dust particles form an essential component o f droplet nuclei required 
for the respiratory spread of tuberculosis. Also long term exposure to dust may lead to varying degrees 
of silicosis, a condition which constitutes a highly increased risk o f acquiring tuberculosis.
The institution and/or maintenance o f simple hygienic measures in mines to control transmission by 
coughing as a result o f aerosol formation, e.g. the issuing o f absorbent materials (gauze tissues or 
paper towels) to miners to cover their mouths and noses when they cough and strategically placed 
paper bags for disposal, and finally, sterilization by incineration o f the sputum-soiled absorbent 
materials may also be an option.
Retreatment o f patients who failed initial therapy has been shown in this study and by Godfrey- 
Faussett et al. (2000) to be a risk factor for transmission of tuberculosis in the mines. Early detection 
of treatment failures and taking preventive measures to interrupt transmission in this group of miners 
is vitally important and should reduce the incidence o f tuberculosis. Such patients should be kept
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away from other miners until they become smear-negative for acid-fast bacilli, or preferably when 
they are culture-negative. As HIV- infection was shown in the FGR mines by other workers to 
significantly promote recurrent tuberculosis which was also related to treatment regimen (Mallory el 
al. 2000), preventive measures and treatment management of culture-/smear-positive that are HIV- 
seropositive would be major priority. Early diagnosis o f tuberculosis in HIV-seropositive patients 
would also be very important as these patients often present with atypical clinical features.
The escalating problem of HIV infection/AIDS in the mines poses a major challenge to the mining 
industry. Management strategies should be adjusted and new measures based on careful studies 
focussing on cost effectiveness should be implemented promptly. In the process due consideration 
should be given to ethical aspects o f new policies.
6. 7. Future studies
As mention earlier, prospective studies utilising RFLP technology and incorporating monitoring of 
recent infection by tuberculin skin testing could more accurately define recent infections as opposed 
to identifying dominant RFLP-based genotypes endemic in the mines (endemic strains) and 
reactivation cases.
Future studies should extend over a period o f at least two years and should cater for critical 
information on treatment history and possible geographical links which could be identified as possible 
risk factors.
Virulence determination o f strains associated with large IBP clusters to identify strains associated with 
a high transmission rate should also be considered for future investigation. Valway et al. (1998)
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described an outbreak o f tuberculosis caused by a highly virulent strain, as determined in the mouse 
lung model which also showed an enhanced capacity for transmission o f the disease. The 
identification of virulence determinants in such strains should be attempted. The 12kDa culture filtrate 
protein demonstrated in virulent strains in the present study should be investigated further. The 
absence of this protein in the strains associated with which caused the outbreak described by Valway 
et al. ( 1998) indicates that other virulence factors are important in human disease. It may also be 
rewarding to look for mutations in the natural-resistance-associated macrophage protein 1 (Nr amp 1) 
gene in South Africa using mine workers to identify NRAMP 1 polymorphism associated with host 
susceptibility to tuberculosis (Bellamy et al. 1998)
Epidemiological aspects o f future studies should include investigation of transmission in areas 
carrying a high risk of infection and activities and practices that may promote reactivation. A priority 
would be to investigate the risk o f transmission in sleeping quarters and other geographic sites 
associated with mining activities.
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